KPV: Evidence, Stability, Dosing and the FDA Record

{
  "schema": "https://miscsubjects.com/schemas/jarticle.json",
  "status": "published",
  "slug": "kpv",
  "title": "KPV: Evidence, Stability, Dosing and the FDA Record",
  "kind": "essay",
  "summary": "KPV is three amino acids in a row — lysine, proline, valine. It is the tail end of a hormone your own body makes, alpha-MSH, which calms inflammation, darkens skin, and pushes on the heart and blood vessels. Cut the tail off and you keep",
  "created": "2026-06-29 08:23:19",
  "body": [
    "KPV is three amino acids in a row — lysine, proline, valine. It is the tail end of a hormone your own body makes, alpha-MSH, which calms inflammation, darkens skin, and pushes on the heart and blood vessels. Cut the tail off and you keep the calming and lose the other two. That separation is the whole reason anyone works on it.\n\nThe evidence state, before anything else on this page. Randomised trials of KPV in people: none. Uncontrolled studies in people: none either. KPV has never been given to a person in any published study, by any route, at any dose. Asking the ClinicalTrials.gov programming interface for it on 4 August 2026 returned a total count of zero, and FDA searched the same databases independently in May 2026 and recorded that it had found no exposure data for products containing KPV given by any route. So the number of people who have ever taken it under measurement is nought, and there is no established human dose, no measured blood level, and no side-effect rate from a study. What does exist is 35 papers. The controlled results in them come from cultured human gut, airway and skin cells, and from mice, rats and rabbits: colitis in mice, a scraped cornea in rabbits, chemotherapy mouth ulcers in rats, a diabetic skin wound in mice. Every controlled win is in a lining one cell thick. Nothing in any species has put KPV against a tendon, a ligament, a joint or a spinal disc. And the counted record of what happens to people who buy it is 35 first-hand reports gathered from public threads, which is a record of exposure and not a test of whether it works.\n\nOne disclosure, because it should change how you read the rest. The operator of this site has a commercial interest in compounds described here. That is a reason to weigh what is on this page against the sources it cites rather than against its tone, and every claim below carries the source that supports it for exactly that reason.\n\nHere is what is actually known, in the order it should be read.\n\nThirty-five papers have KPV in the title or abstract. Every controlled result in all of them came out of a dish, a mouse, a rat or a rabbit. In May 2026 the FDA ran its own search across PubMed, Embase, ClinicalTrials.gov, DailyMed, Drugs@FDA, Micromedex, the European and Japanese pharmacopoeias and the outsourcing-facility reporting database, arrived at the same count, and in July proposed that KPV be kept off the list of substances a pharmacy is allowed to compound. The receptor everyone assumed it works through has been tested three times and it is not the one. Plain KPV swallowed did nothing in the cleanest experiment ever run on it. And the two forms sold under the same name and the same CAS number differ in how much will dissolve by a factor of seven, which is why some people's vials go cloudy and others' do not.\n\nNone of that means the compound is inert. It means the honest version of what it does is narrower and stranger than what is being sold, and the parts that are solid are worth knowing exactly.",
    {
      "type": "source",
      "id": "w_iydnxytw"
    },
    "## What is inflamed, what keeps it inflamed, and what would have to calm down\n\nThe tissue at the centre of this compound's whole record is a lining: the single layer of cells covering the inside of your gut, the surface of your eye, your airway, your gums, the underside of your skin. Every controlled win KPV has is in one of those.\n\n**What breaks down.** A lining cell is held to its neighbour by tight junctions. Inflammation loosens them. Once loose, gut contents leak into the wall, immune cells arrive, and the cells release IL-1β, IL-6 and TNF-α — the three signals that show up in every KPV paper. Those signals loosen the junctions further. It is a loop that keeps itself running.\n\n**What makes it break down faster.** More of the same signals. The master switch that turns them on is a protein pair called NF-κB, which sits idle in the body of the cell until inflammation frees it, at which point it walks into the nucleus and switches on the genes for all three cytokines. Every cycle of that loop damages more lining.\n\n**What builds it back.** Lining cells divide fast — the gut resurfaces itself roughly every five days. The layer will rebuild itself if the inflammation stops. That is unusual and it is the reason this class of compound gets attention: you do not need to add anything, you need to remove the thing preventing repair.\n\n**What makes it build back faster, and how strong each link is.** KPV walks into the nucleus itself and physically blocks NF-κB's ride into the nucleus — shown in a human airway cell line with the binding site identified, strong for a dish. That drops IL-1β, IL-6 and TNF-α — shown in mouse gut, rat gum, rabbit eye, human skin cells, consistent across four tissues, strong. Lower cytokines let the lining reseal — shown in mice and rats by wound closure and colon length, moderate. The same happens in a person — never tested by anyone, in any published study, by any route.\n\nThat last line is a row in the table, not the story. What follows is everything above it.\n\n## The tanning half was cut off and the calming half stayed\n\nAlpha-MSH is thirteen residues — SYSMEHFRWGKPV. The last three are K, P and V. KPV as a free base is C16H30N4O4, molecular weight 342.43 g/mol, CAS 67727-97-3. The acetate salt adds an acetic acid molecule for 402.5 g/mol and carries the same CAS number in most references. Neither form has a UNII code, a United States Pharmacopeia monograph, a European Pharmacopoeia monograph or a Japanese Pharmacopoeia monograph.\n\nAlpha-MSH itself was studied as an anti-inflammatory for decades and never became one, because it drives melanin production and nobody wanted to tan a colitis patient to treat their colon. Cutting the molecule down to its last three residues removed that problem: KPV keeps almost all of the anti-inflammatory capacity of the full hormone and produces no pigment change at all.",
    {
      "type": "source",
      "id": "w_iz1zla8v"
    },
    "That is the design idea, stated by the people who proposed it, and it is the one claim about KPV that the literature and the regulator both accept without argument.\n\n## The obvious receptor was checked three times and it is not the one\n\nAlpha-MSH works by docking onto melanocortin receptors, MC1 through MC5. The obvious guess was that its three-residue tail docks onto the same ones, more selectively. Three separate lines of evidence say it does not.\n\nKPV cannot push radiolabelled alpha-MSH off rat brain tissue, off mouse melanoma cells, or off mouse immune cells carrying MC1R. Unlike alpha-MSH, it raises no cyclic AMP in those cells — meaning the docking signal never fires. Drug-blocking and gene-knockout approaches both failed to pin KPV's anti-inflammatory and wound-healing effects on MC2, MC3 or MC4.",
    {
      "type": "source",
      "id": "w_4lw9q2jv"
    },
    "Human skin cells read the same. Neither alpha-MSH nor KPV produced any rise in cyclic AMP in HaCaT cells or in ordinary human skin cells. What did move was calcium inside the cell, across concentrations from 10⁻¹⁵ to 10⁻⁷ M.",
    {
      "type": "source",
      "id": "w_udmw8780"
    },
    "The structural argument is blunter. KPV does not contain the sequence a molecule needs in order to bind any known melanocortin receptor at all — and it keeps the activity anyway. What it uses instead is not known.",
    {
      "type": "source",
      "id": "w_wo06gy2y"
    },
    "So two things are settled. The anti-inflammatory effect is real in cells and animals. It is not a melanocortin receptor effect. What is open is what it is instead — and note the shape of that: this is a negative answer to a specific question, not an unexplored area. People were looking, and they found out it was not that.\n\n## It stops the inflammation switch from reaching the nucleus\n\nThe best-worked-out candidate is physical interference. KPV gets in the way of the ride NF-κB takes into the nucleus.\n\nIn an immortalised human airway lining cell line, KPV cut NF-κB reporter activity, matrix metalloproteinase-9 activity, and release of IL-8 and eotaxin, and it did more of all of that at higher doses. The effect tracked with KPV's own movement into the nucleus, with stabilisation of IκBα, and with tagged p65RelA failing to get into the nucleus. Competition experiments put KPV at the importin-α3 binding site on p65RelA — importin-α3 is the shuttle protein that carries NF-κB in — probably jamming armadillo domains 7 and 8. A comparison peptide, γ-MSH, needed MC3R in the same experiment. KPV did not.",
    {
      "type": "source",
      "id": "w_0k5anu21"
    },
    "Downstream, the pattern is the same everywhere it has been looked at: IL-1β, IL-6 and TNF-α fall. In immune cells stimulated with bacterial wall fragments, in colon tissue from mice with colitis, in rat gum tissue and in human skin cells stressed with air pollution particles, those three are what move.",
    {
      "type": "source",
      "id": "w_tfx8zspw"
    },
    "Calming inflammation in a dish is not the same as calming inflammation in a person, and the gap between those two is where every unanswered question about KPV lives.\n\n## A door in the gut wall that opens wider the sicker the gut gets\n\nPepT1 is a transporter built to pull two- and three-amino-acid fragments out of the gut and into the cell. It sits in the small intestine normally, is barely present in a healthy colon, and appears in large amounts in the colon lining during inflammatory bowel disease. KPV is a tripeptide. It fits through.\n\nRadiolabelled KPV is carried by human PepT1 with a half-saturation point of roughly 160 µM in Caco2-BBE gut lining cells and roughly 700 µM in Jurkat immune cells, and unlabelled KPV competes with glycyl-sarcosine, the standard test substrate for that transporter. Once inside, concentrations in the billionths of a molar were enough to shut down NF-κB and MAP kinase signalling.",
    {
      "type": "source",
      "id": "w_ky34gd73"
    },
    "The transporter is not incidental to the story — it is the story. In mice given azoxymethane plus dextran sodium sulfate to trigger colitis and then colon cancer, KPV prevented the cancer in normal animals and did nothing whatsoever in animals bred without PepT1. Take the door away and the drug stops working.",
    {
      "type": "source",
      "id": "w_txhlsxnq"
    },
    "This is why swallowing and rectal use get discussed at all for a peptide you would otherwise assume needs a needle. It also makes a specific, testable prediction: the sicker the colon, the more doors, and therefore the more gets in. That prediction has been confirmed in mice. It has never been checked in a person.\n\n## Every controlled result comes from a dish, a mouse, a rat or a rabbit\n\nThe three tables below are the complete usable evidence base, split by what kind of system produced each result. Doses are exactly as the papers report them.\n\n**In a dish**\n\n| Study | Model | Route | Dose | What happened |\n|---|---|---|---|---|\n| Dalmasso 2008 (PMID 18061177) | Caco2-BBE, HT29-Cl.19A, Jurkat T cells | in the culture fluid | billionths of a molar; half-saturation 160 µM in gut cells, 700 µM in Jurkat | NF-κB and MAP kinase signalling shut down; uptake through PepT1 confirmed with tritium-labelled KPV |\n| Land 2012 (PMID 22837805) | 16HBE14o- human airway lining | in the culture fluid | more effect at higher dose | IL-8, eotaxin, MMP-9 down; p65RelA blocked from the nucleus at the importin-α3 site |\n| Cutuli 2000 (PMID 10670585) | *Staphylococcus aureus*, *Candida albicans* | in the culture fluid | trillionths of a molar and above | Colonies failed to form; yeast survival and germ-tube formation fell; white cells killed both organisms better rather than worse |\n| Grieco 2005 (PMID 15946192) | Azole-resistant *Candida* species | in the culture fluid | not stated | The [Ac-CKPV]₂ double version kills the yeast; NMR shows a stretched backbone with a β-turn |\n| Hedley 2004 (PMID 15102092) | HaCaT and ordinary human skin cells | in the culture fluid | 10⁻¹⁵ to 10⁻⁷ M | No cyclic AMP rise; calcium inside the cell rose |\n| Pawar 2017 (PMID 28343991) | Sliced human cadaver skin | on the surface | left on, against microneedles, against a small electric current | Left on its own, nothing crossed above the 0.01 µg/mL detection limit; microneedles gave 4.4 µg/cm²/h; adding current multiplied that by 35 |\n| Tissue Cell 2025 (PMID 40073467) | HaCaT skin cells and a 3D skin model, air pollution insult | in the culture fluid | 50 µg/mL | Cells survived; IL-1β, reactive oxygen and caspase-1 activation all fell |\n| Cytotechnology 2026 (PMID 42064835) | HepG2 liver cells, fat-loaded | in the culture fluid | 100 µg/mL | Fat accumulation and fatty-acid synthase suppressed through PPARγ, with no cell death |\n\n**In animals**\n\n| Study | Model and species | Route | Dose | What happened |\n|---|---|---|---|---|\n| Lipton 1984 (PMID 6333677) | Rabbit fever from white-cell pyrogen | into the brain and into the body | 0.5–2.0 mg into the brain; 2–200 mg into the body | Fever fell by both routes; weaker than whole alpha-MSH |\n| Hiltz & Lipton 1989 (PMID 2550304) | Mouse ear swelling, picryl chloride | into the body | graded doses | Swelling fell, more at higher doses, compared against a large steroid dose |\n| Bonfiglio 2006 (PMID 16965771) | Rabbit corneal scrape | eye drops | 1, 5 or 10 mg/mL, 30 µL, two drops four times a day for 4 days | 8 of 8 corneas fully resurfaced by 60 hours; the effect disappeared when nitric oxide production was blocked |\n| Dalmasso 2008 (PMID 18061177) | Mouse DSS and TNBS colitis | in the drinking water | 100 µM | Weight loss, myeloperoxidase and inflammatory cytokine messenger RNA all reduced |\n| Kannengiesser 2008 (PMID 18092346) | Mouse DSS colitis and CD45RB-high transfer colitis | into the body | not stated in abstract | Earlier recovery, weight regained, less immune cell infiltrate and less myeloperoxidase; in mice with a broken MC1R, every treated animal survived |\n| Laroui 2010 (PMID 19909746) | Mouse DSS colitis | swallowed, 400 nm particles in an alginate–chitosan gel | 12,000 times lower than free solution | The same protection at one twelve-thousandth of the concentration |\n| Viennois 2016 (PMID 27458604) | AOM/DSS colitis-driven cancer, normal against PepT1-knockout mice | swallowed | not stated in abstract | Cancer prevented in normal mice; no effect at all without PepT1 |\n| Xiao 2017 (PMID 28143741) | Mouse ulcerative colitis | swallowed, hyaluronic-acid particles in a chitosan/alginate gel | ~272 nm particles | Lining healed faster and TNF-α fell; better than plain KPV particles |\n| ACS Biomater Sci Eng 2021 (PMID 34547895) | Rat TNBS ulcerative colitis | rectal, thiolated γ-polyglutamic acid gel | 4% polymer gel | Disease activity, colon shortening, myeloperoxidase, TNF-α and IL-6 all reduced; plain rectal KPV fell apart too fast to work |\n| Biomater Sci 2021 (PMID 34846053) | Rat chemotherapy mouth ulcers, MRSA-infected | sticky gel that sets at body heat | 2% EGCG carrier | Gum ulcers repaired, IL-1β and TNF-α down, IL-10 up, and it killed *S. aureus* |\n| Int J Biol Macromol 2022 (PMID 36240893) | Diabetic mouse full-thickness wound | layered film dressing | KPV released over 3 days, EGF released in response to glucose | Faster closure, through less inflammation, new blood vessel growth and collagen laid down |\n| Adv Healthc Mater 2024 (PMID 39252648) | Mouse blood vessel calcification | KPV–rapamycin particles with no carrier | self-assembling | Calcification blocked; inflammation down and cell self-cleaning switched on |\n| Sci Adv 2026 (PMC12802832) | Mouse DSS colitis and acute lung injury | swallowed, self-uncaging prodrug | proKPV 0.5 and 2.5 mg/kg daily × 7 days | Weight, disease activity and colon length all protected — while **plain KPV at the matching 1 mg/kg peptide dose did nothing at all** |\n\n**In people**\n\n| Study | Model | Route | Dose | What happened |\n|---|---|---|---|---|\n| — | — | — | — | Nothing published. KPV has never been given to a person in a published study, by any route |\n\nAsking the ClinicalTrials.gov programming interface for KPV peptide on 4 August 2026 returned `{\"totalCount\": 0}`.",
    {
      "type": "source",
      "id": "w_46rh3j3w"
    },
    "FDA searched independently and found the same. The nomination that put KPV in front of the agency cited nine references: eight were animal studies of various alpha-MSH derivatives, and the ninth was a skin-permeation experiment on cadaver skin.",
    {
      "type": "source",
      "id": "w_4lw9q2jv"
    },
    "## Plain KPV falls apart, which is why most of the research is about packaging\n\nRead the animal table again and one thing is impossible to miss: hydrogels, nanoparticles, liposomes, film dressings, prodrugs, gels that set at body heat. That is not fashion. That is a whole field routing around a defect.\n\nPut KPV under acid, alkali or hydrogen peroxide and the main thing you get back is lysine-proline-diketopiperazine. The lysine and proline ends curl round and bond to each other, the ring closes, and the peptide is gone.",
    {
      "type": "source",
      "id": "w_4hqievsz"
    },
    "KPV solution given rectally was described flatly as \"very unstable\", which is why the rat colitis work needed a thiolated polymer gel just to hold it together for two hours at body temperature.",
    {
      "type": "source",
      "id": "w_6tepv8p6"
    },
    "The 2026 prodrug paper is the cleanest measurement of what that costs. Plain KPV swallowed at 1 mg/kg did nothing in mouse colitis. The same peptide, chemically caged so it survives the stomach and uncages only where reactive oxygen marks inflamed tissue, worked at half that dose and reached 3.8 times the concentration in the colon.",
    {
      "type": "source",
      "id": "w_yd7rqb37"
    },
    "Trying to toughen the molecule by chemistry rather than packaging has cost the activity outright. Sticking a sugar-alkyl group on the lysine produced versions that shrugged off protein-cutting enzymes and killed nothing under any condition tested — including the acetylated parent.",
    {
      "type": "source",
      "id": "w_ggr3cicc"
    },
    "Two things follow, and both are practical.\n\nNothing in the animal record shows that plain, unpackaged KPV swallowed reaches inflamed tissue in a useful amount. One paper specifically shows it does not.\n\nAnd the storage numbers in the regulatory file are the ones to work from: dry powder is reported good for up to three years at −20 °C, two years at 4 °C, and three months at 15 °C, while once it is in water it is reported at six months at −80 °C, one month at −2 °C and one week at 10 °C.",
    {
      "type": "source",
      "id": "w_4lw9q2jv"
    },
    "## The two salts differ in how much will dissolve by a factor of seven\n\nThis is the detail most likely to leave you holding a cloudy vial and wondering whether you ruined it.\n\nKPV free base dissolves in water only up to 0.70 mg/mL. KPV acetate is reported to dissolve at 5 mg/mL.",
    {
      "type": "source",
      "id": "w_4lw9q2jv"
    },
    "Now do the arithmetic everyone does. A 10 mg vial with 2 mL of water in it is aiming for 5 mg/mL.\n\nIf the powder is the acetate salt, 5 mg/mL sits exactly on the reported ceiling — it will go in, with nothing to spare.\n\nIf the powder is the free base, 5 mg/mL is about seven times more than will dissolve. It physically cannot all go into solution. What you get is a suspension that looks nearly right, and the amount of actual peptide in each syringe depends on how recently you swirled it.\n\nThe part that makes this a real problem rather than a solvable one: the two forms share the same CAS number and are labelled inconsistently, so the container often does not tell you which one you have. FDA said exactly that, and called the naming conventions non-compliant with INN, IUPAC and USAN standards for that reason. If you want a fill that works either way, 0.70 mg/mL is the number that clears both — a 10 mg vial in 14 mL, which nobody does, or a smaller vial in more water.\n\n## One mark on the syringe is fifty micrograms\n\nA U-100 insulin syringe holds 1 mL across 100 marks. One mark is 0.01 mL. Everything else falls out of the concentration.\n\nStart there:\n\n- 10 mg powder ÷ 2 mL bacteriostatic water = **5 mg/mL = 5,000 mcg/mL**\n- 1 mark = 0.01 mL × 5,000 mcg/mL = **50 mcg per mark**\n\n| Marks on the barrel | Volume | Dose at 5 mg/mL | Dose at 2.5 mg/mL (10 mg in 4 mL) | Dose at 2 mg/mL (10 mg in 5 mL) |\n|---|---|---|---|---|\n| 2 | 0.02 mL | 100 mcg | 50 mcg | 40 mcg |\n| 4 | 0.04 mL | 200 mcg | 100 mcg | 80 mcg |\n| 5 | 0.05 mL | 250 mcg | 125 mcg | 100 mcg |\n| 10 | 0.10 mL | 500 mcg | 250 mcg | 200 mcg |\n| 20 | 0.20 mL | 1,000 mcg (1 mg) | 500 mcg | 400 mcg |\n| 40 | 0.40 mL | 2,000 mcg (2 mg) | 1,000 mcg | 800 mcg |\n\nPutting the same 10 mg into 4 mL instead of 2 mL halves every number in the column and doubles the volume you inject for a given dose. That is usually the point: small doses are easier to measure when each mark is worth less. It also drops you to 2.5 mg/mL, which is under the acetate ceiling with room to spare and still five times over the free base's, so it does not solve the salt problem.\n\nThe dose people actually take rests on a unit conversion, not a trial. Scaled from rodent studies by body surface area, a human-equivalent starting dose has been published at around 0.2 mg — four marks on a 5 mg/mL fill.",
    {
      "type": "source",
      "id": "s7"
    },
    "That number carries the weight of an arithmetic conversion and nothing else. Nobody has measured how the body absorbs and clears KPV free base or KPV acetate, in any species. There is no measured half-life, no figure for how much reaches the blood, and no dose-response curve anywhere that would let a human dose be worked out rather than scaled from a mouse.",
    {
      "type": "source",
      "id": "w_4lw9q2jv"
    },
    "## What people taking it report, counted: 28 helped, 4 worse, 3 both, of 35\n\nSixty first-hand posts about KPV are catalogued as sources on this page — fifty from Reddit, ten from X, all pulled on 29 June 2026. Twenty-five of them are guides, product write-ups, questions, or regulatory commentary with no outcome in them. That leaves **35 posts where a named person says what they took and what happened**.\n\nSorted by what they actually reported:\n\n| What was reported | Posts | Share of the 35 |\n|---|---|---|\n| Something got better | 28 | 80% |\n| Something got better *and* a bad reaction happened, or the route mattered | 3 | 9% |\n| A bad effect was the whole report | 4 | 11% |\n| Nothing at all happened | 0 | 0% |\n\nRead that honestly in both directions. This is a curated set, pulled from threads people started because they had something to say, and the direction of that bias is upward — nobody posts \"took a peptide, nothing occurred, no further questions.\" The zero in the bottom row is the tell. For DSIP, catalogued the same way on the same day, five of thirty-five reports said nothing happened. Here, none did. Either KPV does something noticeable to nearly everyone who takes it, or the silent non-responders are not in the sample. Both of those can be true at once.\n\nWhat the set is genuinely good for is a dose survey and a side-effect list, and on those two it is consistent. On a 10 mg vial in 2 mL — 50 mcg per mark — the reported range runs from four marks to ten. **200 to 500 mcg a day under the skin is what people take.**\n\n### The 28 who said something got better\n\nTwelve days under the skin at 200 mcg, one 5 mg vial, for gut symptoms — labelled anecdotal:",
    {
      "type": "source",
      "id": "s17"
    },
    "Forty days at 500 mcg a day, for mast cell symptoms:",
    {
      "type": "source",
      "id": "s20"
    },
    "Same condition, a different person, putting a number on it:",
    {
      "type": "source",
      "id": "s24"
    },
    "r/MCAS again, on fatigue and food tolerance:",
    {
      "type": "source",
      "id": "s23"
    },
    "Roughly 300 mcg a night by injection, from r/MCAS — and, from the same thread, the swallowed form causing flares where the injected form did not:",
    {
      "type": "source",
      "id": "s47"
    },
    "Skin is the second cluster. Eczema, four to five weeks in, with symptoms returning within two days of stopping:",
    {
      "type": "source",
      "id": "s60"
    },
    {
      "type": "source",
      "id": "s75"
    },
    {
      "type": "source",
      "id": "s58"
    },
    "Hidradenitis, in a stack:",
    {
      "type": "source",
      "id": "s100"
    },
    "Then the reports where the benefit is real but short. Two people independently describe roughly forty-eight hours of relief per injection and then a return to baseline:",
    {
      "type": "source",
      "id": "s61"
    },
    {
      "type": "source",
      "id": "s53"
    },
    "And the outliers, which are worth keeping visible precisely because a single report proves nothing: a person whose supraventricular tachycardia episodes stopped for two months and came back two days after stopping the peptide:",
    {
      "type": "source",
      "id": "s83"
    },
    {
      "type": "source",
      "id": "s82"
    },
    {
      "type": "source",
      "id": "s62"
    },
    "The rest of the 28 — histamine tolerance, general inflammation, skin, nail fungus, dandruff, food reactions, rheumatoid arthritis alongside prescribed drugs, sacroiliac pain in a stack, hair thickening in a blend, and several \"keeps it in the stack year-round\" posts:",
    {
      "type": "source",
      "id": "s22"
    },
    {
      "type": "source",
      "id": "s27"
    },
    {
      "type": "source",
      "id": "s32"
    },
    {
      "type": "source",
      "id": "s48"
    },
    {
      "type": "source",
      "id": "s63"
    },
    {
      "type": "source",
      "id": "s64"
    },
    {
      "type": "source",
      "id": "s74"
    },
    {
      "type": "source",
      "id": "s85"
    },
    {
      "type": "source",
      "id": "s89"
    },
    {
      "type": "source",
      "id": "s103"
    },
    "### The 4 where a bad effect was the whole report\n\nAt the same doses. This matters — the negatives are not from people megadosing.\n\n200 mcg, and the complaint is not physical at all:",
    {
      "type": "source",
      "id": "s25"
    },
    "250 mcg a night, day four:",
    {
      "type": "source",
      "id": "s46"
    },
    "An acute reaction within an hour of a small injected volume:",
    {
      "type": "source",
      "id": "s43"
    },
    "Dizziness, broken sleep, headaches, brain fog and fatigue, from a long-covid gut thread:",
    {
      "type": "source",
      "id": "s19"
    },
    "### The 3 who got both\n\nEight days of clear improvement, then red bumps out of nowhere:",
    {
      "type": "source",
      "id": "s54"
    },
    "Gut repair, but only after months of climbing the dose slowly, with paradoxical reactions early:",
    {
      "type": "source",
      "id": "s21"
    },
    "And the one that splits by route rather than by person — swallowed did nothing measurable, injected moved a blood marker a long way:",
    {
      "type": "source",
      "id": "s101"
    },
    "### Two patterns worth naming out loud\n\nThe first is a frame, not a finding. Fatigue, apathy and flu-like malaise appear over and over at 200–500 mcg, and the standard community explanation is a die-off or healing flare. That explanation cannot be wrong, because there is no result it excludes — every bad reaction becomes evidence the compound is working. Treat it as what it is: an unfalsifiable story wrapped around an adverse effect.\n\nThe second is a real, testable claim, and it appears in enough reports to take seriously: people who started very low and climbed slowly report the paradoxical reactions going away. That is a dose-response observation, and it is the only actionable thing the whole self-report record produces.",
    {
      "type": "source",
      "id": "s21"
    },
    "Duration is the other thing the reports agree on and the animal literature never measured. The effect is described as lasting days, not weeks — which fits a three-amino-acid peptide with no measured half-life and a known tendency to curl up into a diketopiperazine and stop existing.",
    {
      "type": "source",
      "id": "s53"
    },
    "None of this substitutes for a trial. It does establish three facts you would otherwise learn by accident: the dose is 200–500 mcg under the skin, bad reactions at that dose are common enough to fill threads, and the swallowed and injected forms are not experienced as the same thing.\n\n## Swallowed, injected, rubbed on, sprayed up the nose — what changes\n\nAll four are sold. The evidence behind each is not remotely equal.\n\n**Swallowed** has the strongest mechanical case, because PepT1 is a real door, KPV is a real fit for it, and the door opens wider in inflamed bowel. Against that: the single experiment that pitted plain swallowed KPV against a packaged version found the plain version inert.\n\n**Rectal** puts the peptide against the target tissue directly, and was shown to need a stabilising gel to survive long enough to do anything.\n\n**Rubbed on** has an explicit measurement against it. Across human cadaver skin, KPV left on the surface crossed at a rate below the 0.01 µg/mL detection limit. It took microneedles punching through the outer layer to reach 4.4 µg/cm²/h, and a small electric current on top of that to multiply it further. Nothing crosses intact skin on its own in any amount you can measure.",
    {
      "type": "source",
      "id": "w_62ka3qz2"
    },
    "FDA reached the same conclusion and pointed out that it cuts both ways: poor skin crossing limits how much reaches the bloodstream and therefore limits systemic toxicity, and it equally limits KPV's usefulness as a cream, because it may never reach the living skin layers under the dead outer one.",
    {
      "type": "source",
      "id": "w_4lw9q2jv"
    },
    "**Sprayed up the nose** has no published measurement of any kind.\n\n## It kills bacteria and yeast in a dish and has never been measured in a body\n\nAlpha-MSH peptides including KPV stopped *Staphylococcus aureus* forming colonies and cut *Candida albicans* survival and germ-tube formation, down to concentrations in the trillionths of a molar. Unusually for an anti-inflammatory, they made white blood cells kill both organisms better rather than worse — most things that calm inflammation blunt that.",
    {
      "type": "source",
      "id": "w_8b4pdcfy"
    },
    "The version taken furthest toward antifungal development is the double, [Ac-CKPV]₂, built by joining two KPV units through a cysteine-cysteine bridge. It works against *Candida* strains that azole drugs no longer touch.",
    {
      "type": "source",
      "id": "w_4rk4kjx2"
    },
    "The MRSA result in the rat mouth-ulcer model is the closest thing to a confirmation in a living animal, and it needed a sticky gel holding the peptide against the wound for seven hours to get there.",
    {
      "type": "source",
      "id": "w_jcn0rn64"
    },
    "## Where the evidence stops, and the swap that gets made\n\nTwo things in this file are solid enough to act on, and neither is a musculoskeletal finding.\n\nThe first is inflammation in a lining. Every controlled win KPV has is in one — bowel, cornea, airway, skin, gum. If your problem is a gut that is inflamed, that is the strongest part of this record and it is genuinely the strongest part.\n\nThe second is the pairing with BPC-157, which is what most gut protocols actually run.\n\n![[bpc-kpv-gut-repair]]\n\nNow the swap, because it is made constantly and it is worth being able to spot.\n\nNo study in any table above used a tendon, a ligament, a disc or a joint. There is no rat Achilles study. No ligament cut study. No cartilage study. The wound-healing results are all in linings — a scraped cornea, a diabetic skin wound, a mouth ulcer — and resealing a one-cell-thick lining is a different job from rebuilding collagen in a tendon. Lining cells divide every few days and re-cover a surface. Tendon rebuilds by laying down and remodelling collagen fibres over months, using different cells and a different signal set.\n\nSo the sentence \"KPV helps tissue heal\" is true and useless, and it is the sentence that does the work. Someone reads it and hears \"KPV will help my rotator cuff.\" That is a cornea result laundered into a shoulder claim, and the laundering happens in the word *tissue*.\n\nThe honest version is four clauses long. KPV reduces inflammatory signalling in the linings of animals. It has never been given to a person in a published study. It has no measured human dose. And it is currently proposed for exclusion from legal compounding in the United States.\n\n## FDA proposed in July 2026 that KPV stay off the compounding list\n\nThe regulatory position has two layers and they get conflated constantly.\n\nThe older layer: KPV sits on FDA's table of bulk drug substances that were nominated for compounding and then withdrawn by whoever nominated them, filed under substances that may present significant safety risks. The agency's entry says it \"has not identified any human exposure data on drug products containing KPV administered via any route of administration\" and \"lacks important information regarding any safety issues raised by KPV, including whether it would cause harm if administered to humans.\"",
    {
      "type": "source",
      "id": "w_fquamfa9"
    },
    "The newer layer matters more. The nomination was withdrawn, and FDA chose to take KPV to its advisory committee anyway. On 23 July 2026 the Pharmacy Compounding Advisory Committee heard KPV free base and KPV acetate alongside BPC-157, TB-500 and MOTS-c, with the uses under evaluation recorded as wound healing and inflammatory conditions.",
    {
      "type": "source",
      "id": "w_x3r14ud2"
    },
    "FDA's position going in was not ambiguous: \"FDA is proposing that KPV (free base) NOT be included on the 503A Bulks List\" and \"FDA is proposing that KPV acetate NOT be included on the 503A Bulks List.\"",
    {
      "type": "source",
      "id": "w_b5ztk84s"
    },
    "The reasoning, dated 12 May 2026, weighed four criteria and found against on all four.\n\nNeither form is well characterised: the naming is inconsistent, and no certificate of analysis, impurity profile, clumping test or microbiology data was supplied or found in the literature.\n\nHow much it has historically been compounded is unknown: outsourcing facilities reported compounding no KPV products at all between January 2017 and June 2025, while telehealth and compounding websites sell injectable, swallowed, topical and nasal-spray KPV for inflammatory conditions, wound healing, skin health, gut health, killing microbes, and protection against nerve damage and stroke.\n\nThere is no evidence it works, because there is no human data.\n\nAnd there is no safety evidence in either direction.",
    {
      "type": "source",
      "id": "w_4lw9q2jv"
    },
    "What that means in practice: getting onto the 503A Bulks List is what makes a substance lawfully compoundable when it has no monograph and is not part of an approved drug. FDA has proposed it not get on.\n\n## Unknown is not the same as safe\n\nFDA's Office of Surveillance and Epidemiology searched the FDA Adverse Event Reporting System and the medical literature for harms linked to KPV, through 3 December 2025. The reporting system returned nothing. The literature search found no cases. A separate search of the Human Foods Program adverse event system covering 1 January 2004 to 3 December 2025 also came back empty.",
    {
      "type": "source",
      "id": "w_4lw9q2jv"
    },
    "An empty harm database for a substance nobody has published on giving to humans measures the literature, not the compound. Reporting to that system is voluntary, and compounders working under section 503A generally do not report to FDA at all. Meanwhile four of the thirty-five first-hand posts above describe a bad reaction, and none of those four is in any database.\n\nNo acute toxicity study exists. No repeat-dose toxicity study. No genotoxicity study. No developmental or reproductive toxicity study, of either form. FDA's stated worry is clumping and whether the immune system reacts to it, and neither can be assessed without the impurity and aggregate data the nomination never supplied.\n\nThe narrower operative fact: what circulates is research-grade powder from suppliers whose certificates of analysis FDA could not locate, and the agency's specific objection is that nobody can tell from the label whether a given vial holds the free base or the acetate — which, per the section above, decides whether your 10 mg in 2 mL is a solution or a suspension.\n\n## Where every number above came from\n\n**Primary literature, by PubMed identifier.** PMID 18061177 (PepT1 uptake, *Gastroenterology* 2008); PMID 18092346 (DSS and transfer colitis, *Inflammatory Bowel Diseases* 2008); PMID 27458604 (PepT1 knockout and colitis-driven cancer, 2016); PMID 22837805 (p65RelA blocked from the nucleus, 2012); PMID 21222263 and PMID 18612139 (the melanocortin-receptor-independence argument); PMID 15102092 (skin cell cyclic AMP and calcium); PMID 10670585 and PMID 15946192 (killing microbes, and the CKPV double); PMID 16965771 (rabbit cornea); PMID 2550304 and PMID 6333677 (the original mouse and rabbit work, 1989 and 1984); PMID 25298219 (the stability assay and the diketopiperazine breakdown product); PMID 28343991 (human cadaver skin); PMID 19909746, PMID 28143741, PMID 34547895, PMID 34846053, PMID 36240893, PMID 39252648 and PMC12802832 (the packaging literature); PMID 29953505 (sugar-alkyl versions, activity lost); PMID 40073467 and PMID 42064835 (recent skin and liver cell work).\n\n**Trial registries.** ClinicalTrials.gov programming interface v2, query \"KPV peptide\", 4 August 2026: `{\"totalCount\": 0}`. No registered study of KPV in people exists.",
    {
      "type": "source",
      "id": "w_46rh3j3w"
    },
    "**Regulatory record.** FDA's evaluation of KPV-related bulk drug substances dated 12 May 2026; the briefing document proposing exclusion from the 503A Bulks List; the Federal Register notice of 16 April 2026 announcing the meeting and the uses evaluated; and the standing FDA page listing KPV among bulk substances nominated but withdrawn.",
    {
      "type": "source",
      "id": "w_zjkqhidi"
    },
    "**Chemistry.** PubChem CID 125672 for the free base; CAS 67727-97-3 for both forms; molecular weight 342.43 g/mol free base and 402.5 g/mol acetate; water solubility 0.70 mg/mL free base and 5 mg/mL acetate.\n\n**Both sides on the record.** In favour, the researchers who characterised the molecule: Brzoska and colleagues concluded that keeping the anti-inflammatory effect while losing the pigment effect makes KPV \"an alternative for antiinflammatory therapy\", and that its physical properties and low expected production cost suit inflammatory skin and bowel disease. Böhm and Luger, cited in FDA's own nonclinical review, went further and called for clinical studies to find out whether KPV could heal skin wounds and ulcers — a call that, as of August 2026, nobody has answered. Against, the regulator, in its own words: \"There is a lack of clinical and nonclinical safety information on the use of KPV (free base) and KPV acetate. FDA is particularly concerned about the lack of any human data on drug products containing these substances…\"",
    {
      "type": "source",
      "id": "w_4lw9q2jv"
    },
    "**The three hardest numbers in the file**, because everything else is softer than they are: nothing measurable crosses intact human skin, at a detection limit of 0.01 µg/mL; the PepT1 half-saturation point in gut lining is 160 µM; and the main breakdown product under stress is lysine-proline-diketopiperazine.\n\n*KPV is not an approved drug in any country. Nothing here is a dosing or treatment recommendation.*\n\nThe sibling objects for this page, each one inspectable on its own terms:\n\n![[bpc-157]]\n\n![[tb-500]]\n\n![[thymosin-alpha-1]]\n\n![[ghk-cu]]\n\n![[ara-290]]"
  ],
  "facts": {
    "converted_from": "markdown",
    "original_updated": "2026-08-04T20:48:18.853Z",
    "register": "essay",
    "category": null
  },
  "hero": "https://miscsubjects.com/img/gen/arcads-gpt-image-b836a95d-9dfc-42e2-aa53-81f73e1242f3.png",
  "model": "grok/grok-4.3",
  "tags": [
    "peptide",
    "kpv"
  ],
  "sources": [
    {
      "id": "s1",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/18061177/",
      "title": "PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation",
      "quote": "KPV acts via PepT1 expressed in immune and intestinal epithelial cells... Nanomolar concentrations of KPV inhibit the activation of NF-κB and MAP kinase inflammatory signaling pathways",
      "summary": "Human cell line and mouse colitis study on PepT1-mediated uptake and NF-kB inhibition",
      "claim_ids": [
        "c1"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T08:33:49.621Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "genesis",
      "hash": "eb658c416c371845aa1863a8265a473dbe73d96bcacf2c79c72835f34e0ff026",
      "source_role": "mechanism_support",
      "quote_sha256": "4378310bcb95ff3de1e9aaf87173fff660fdbe9841524575665eba44aba3cbfb"
    },
    {
      "id": "s2",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/18092346/",
      "title": "Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease",
      "quote": "The melanocortin-derived tripeptide KPV showed significant anti-inflammatory effects in 2 murine models of colitis",
      "summary": "Mouse colitis model results",
      "claim_ids": [
        "c2"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T08:33:49.621Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "eb658c416c371845aa1863a8265a473dbe73d96bcacf2c79c72835f34e0ff026",
      "hash": "9e0f87fa6cc74caa8b0d7cc201ae33cb5550a52d34f3107d354516f808797b0f",
      "source_role": "mechanism_support",
      "quote_sha256": "77ed0699b17b27773f06d24119eb5bc6d41ff974a8feda3d16eba18ea5c2d7e0"
    },
    {
      "id": "s3",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/18061177/",
      "title": "PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation",
      "quote": "oral administration of KPV reduces the incidence of DSS- and TNBS-induced colitis",
      "summary": "Confirms mouse model efficacy",
      "claim_ids": [
        "c2"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T08:33:49.621Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "9e0f87fa6cc74caa8b0d7cc201ae33cb5550a52d34f3107d354516f808797b0f",
      "hash": "a61cc5b5631aaad711ba334dda03c0332dae00e0754bc6e347d88d23f2ba092b",
      "source_role": "mechanism_support",
      "quote_sha256": "0505e2fdc01e958fb944c35066bb9b05e113276af4be851cd3a6b3170e444657"
    },
    {
      "id": "s4",
      "type": "other",
      "url": "https://meto.co/blog/kpv-peptide-anti-inflammatory-gut",
      "title": "KPV: The Anti-Inflammatory Tripeptide for Gut and Skin",
      "quote": "No human clinical trials exist yet... As of 2026, no registered Phase I or Phase II trials for KPV in humans are listed on ClinicalTrials.gov",
      "summary": "Confirms absence of human trials",
      "claim_ids": [
        "c3",
        "c84"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T08:33:49.621Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "a61cc5b5631aaad711ba334dda03c0332dae00e0754bc6e347d88d23f2ba092b",
      "hash": "74ae3566df0b9a0103c94a8d38d4937a406989a193ee70634735f27f8c93530d",
      "source_role": "adjacent_context",
      "quote_sha256": "05ce38b81709c162afd9d04464f925b72fb40bf011485fd0463acb5e08f1f486"
    },
    {
      "id": "s5",
      "type": "other",
      "url": "https://peptidetreatments.com/peptides/kpv/research",
      "title": "KPV Research & Evidence",
      "quote": "KPV has zero human clinical trials. All proposed benefits for IBD, gut health... are extrapolated from cell culture and mouse studies",
      "summary": "Reinforces no human data",
      "claim_ids": [
        "c3",
        "c84"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T08:33:49.621Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "74ae3566df0b9a0103c94a8d38d4937a406989a193ee70634735f27f8c93530d",
      "hash": "60a1a146d6450d3788ddd1a2a1bc136452fa37809e54837013434ac8ffdbd908",
      "source_role": "adjacent_context",
      "quote_sha256": "b1a71cab0a117d12f90941d0ceabd237d127ce0af057bda250a318c54bc289e0"
    },
    {
      "id": "s6",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/28343991/",
      "title": "Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin",
      "quote": "Lysine-proline-valine (KPV) is a C-terminal peptide fragment of α-melanocyte stimulating hormone with potent anti-inflammatory properties.",
      "summary": "2017 study on transdermal delivery of KPV for potential skin inflammation treatment.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c8"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:06.218Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "60a1a146d6450d3788ddd1a2a1bc136452fa37809e54837013434ac8ffdbd908",
      "hash": "c629aef257267c2d8a6facefa83d8fb70b8101f0af63685ec11febb29359da60",
      "source_role": "mechanism_support",
      "quote_sha256": "034d8542b79e607e094044cccf5e1765a0bd9d8269bf03d6335a7827e634cbb5"
    },
    {
      "id": "s7",
      "type": "review",
      "url": "https://www.innerbody.com/kpv-peptide",
      "title": "KPV Peptide | Benefits, Safety & Buying Advice [2026]",
      "quote": "Of note, the research on KPV’s effects has been done primarily in animal models and human cell cultures, not in human subjects directly. Therefore, the support for its therapeutic uses is limited, albeit largely optimistic.",
      "summary": "2026 comprehensive review summarizing KPV mechanisms, benefits for inflammation/gut/wound healing, safety concerns, and lack of human trials.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c9"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:06.218Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "c629aef257267c2d8a6facefa83d8fb70b8101f0af63685ec11febb29359da60",
      "hash": "b4d7eba729eea71d1eb4d4f93db04da803b3360e21339472dbb7c5f8e7593c71",
      "source_role": "mechanism_support",
      "quote_sha256": "f1b40935d2e732390b4ced0fc87442c8a805f409b306a50d0d87808d3d4e577d"
    },
    {
      "id": "s8",
      "type": "review",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12802832/",
      "title": "Inflammation-triggered self-immolative conjugates enable oral delivery of anti-inflammatory peptides",
      "quote": "Using three anti-inflammatory peptides (KPV, Ac-QAW, and IRW), we demonstrated that the engineered conjugates exhibit remarkable GI stability",
      "summary": "2026 paper on new oral delivery system for KPV and other peptides in inflammatory conditions.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c10"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:06.218Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "b4d7eba729eea71d1eb4d4f93db04da803b3360e21339472dbb7c5f8e7593c71",
      "hash": "6d62216c3523e827ff33cbef352adde14e82ca439cbe64b067a68cb43850cfb9",
      "source_role": "mechanism_support",
      "quote_sha256": "c63c58bb9e20015b3c7c5375cbc97dec3fccaf5c70326a6cb3f7fa2165f70ca6"
    },
    {
      "id": "s9",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Ameano_Peptides/comments/1o7vx9t/a_complete_guide_for_kpv/",
      "title": "A Complete Guide for KPV",
      "quote": "KPV (Lysine-Proline-Valine) is a small tripeptide derived from the C-terminal sequence of α-MSH (alpha-melanocyte stimulating hormone). It is known for its potent anti-inflammatory, immunomodulatory, and mucosal healing actions, particularly in gastrointestinal and epithelial tissues.",
      "summary": "Detailed user/research guide post on Reddit explaining KPV mechanisms, benefits, dosing, and research status (anecdotal/community info).",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c11",
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:06.218Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "6d62216c3523e827ff33cbef352adde14e82ca439cbe64b067a68cb43850cfb9",
      "hash": "8350296af4fa168cf90267131549a94019451b743a4974da5f5ea238eda8f775",
      "source_role": "anecdotal_report",
      "quote_sha256": "f137279a72b6a3dd5334b6c9163d9cc14a03c57be5f521a0d54bd583de62151f"
    },
    {
      "id": "s10",
      "type": "youtube",
      "url": "https://www.youtube.com/watch?v=wdCjXXmRoEw",
      "title": "The Best Peptide for Inflammation, Gut Health, and Visceral Fat Loss (KPV Peptide)",
      "quote": "KPV is a 3-amino-acid peptide (Lysine-Proline-Valine) that fights inflammation where it starts—inside your cells.",
      "summary": "2025/2026 YouTube video discussing KPV benefits for inflammation and gut health with user anecdotes in comments.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c12",
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:06.218Z",
      "link_status": "http_429",
      "quote_status": "unverified",
      "prev": "8350296af4fa168cf90267131549a94019451b743a4974da5f5ea238eda8f775",
      "hash": "a33483841d80f954ffc7389bda557be1c95c3bb1fca28d717ec9ddd8dd64e7b7",
      "source_role": "anecdotal_report",
      "quote_sha256": "9151569e2e688e482ea3f623f5f0236aa902009d14d123ce405cbe24b0e0e5a2"
    },
    {
      "id": "s11",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/22837805/",
      "title": "Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists",
      "quote": "This study investigates the mechanism by which the α-melanocyte stimulating hormone-derived tripeptide, KPV, and the agonist of the dominant melanocortin receptor in airway epithelium (MC3R), γ-melanocyte stimulating hormone (γ-MSH), suppress inflammation in immortalised human bronchial airway epithelium.",
      "summary": "2012 study on KPV's anti-inflammatory mechanism in bronchial epithelial cells via MC3R.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c13"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:20.705Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "a33483841d80f954ffc7389bda557be1c95c3bb1fca28d717ec9ddd8dd64e7b7",
      "hash": "98761ae7e1ae707301902be312b8faa8b6057a725ab6774ed1752b8e639539b2",
      "source_role": "mechanism_support",
      "quote_sha256": "d4905e9f8fed4f5a1dd75d3fe8b53ecc7018095cba75ff445c3e225a8615afaa"
    },
    {
      "id": "s12",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/27458604/",
      "title": "Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model",
      "quote": "The use of an anti-inflammatory tripeptide KPV (Lys-Pro-Val) transported by PepT1 was able to prevent carcinogenesis in WT mice.",
      "summary": "2016 mouse study showing KPV via PepT1 prevents colitis-associated cancer.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c14"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:20.705Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "98761ae7e1ae707301902be312b8faa8b6057a725ab6774ed1752b8e639539b2",
      "hash": "7a8847b7f8a3b349b01e17ce59f08a07248614b408c60a597879e8257397f267",
      "source_role": "mechanism_support",
      "quote_sha256": "2c7e3a5552b9be23cf4991df5a5e9e2e5cb1748f5fbda01b81580e359b40e3cb"
    },
    {
      "id": "s13",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/28143741/",
      "title": "Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis",
      "quote": "We found that HA-KPV-NPs exert combined effects against UC by both accelerating mucosal healing and alleviating inflammation.",
      "summary": "2017 study on HA-functionalized nanoparticles for targeted KPV delivery in UC mouse model.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c15"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:20.705Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "7a8847b7f8a3b349b01e17ce59f08a07248614b408c60a597879e8257397f267",
      "hash": "4f9fa03739dfded028aa03ea8009077c433fa9320a5460e4fba7be3ed1406e8c",
      "source_role": "mechanism_support",
      "quote_sha256": "85ff7740a4df5f9744a656937c42b25b96daf10072ae3ea0f042e12f8d1a5375"
    },
    {
      "id": "s14",
      "type": "review",
      "url": "https://en.wikipedia.org/wiki/KPV_tripeptide",
      "title": "KPV tripeptide",
      "quote": "KPV tripeptide (Lys-Pro-Val) is a tripeptide derivative that is derived from the C-terminal fragment of alpha-MSH. It has antiinflammatory effects, and is used in skincare products, as well as having been researched for other potential medical applications.",
      "summary": "Wikipedia entry summarizing KPV as α-MSH fragment with anti-inflammatory properties and skincare use.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c16"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:20.705Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "4f9fa03739dfded028aa03ea8009077c433fa9320a5460e4fba7be3ed1406e8c",
      "hash": "dafafa3f157cd41b9f3432015f3848244527415544d705afa415b0e8b3284427",
      "source_role": "mechanism_support",
      "quote_sha256": "36c577ba0ad550844b9952c04857b4aa83985757f67a11152496e8381bd4e228"
    },
    {
      "id": "s15",
      "type": "medical",
      "url": "https://riteaid.com/peptides/kpv",
      "title": "KPV Peptide: Benefits, Dosage & 2026 Legal Status",
      "quote": "It is one of the twelve peptides the FDA removed from the list that restricted compounding in April 2026, and one of seven under formal advisory review on July 23–24, 2026.",
      "summary": "2026 article on KPV benefits, dosage, and updated FDA compounding legal status.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c17"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:20.705Z",
      "link_status": "http_403",
      "quote_status": "unverified",
      "prev": "dafafa3f157cd41b9f3432015f3848244527415544d705afa415b0e8b3284427",
      "hash": "bf8e2b14f2d0910f1b14c8c47975df4052397c8c173647ad1e12a22c0fd76c6b",
      "source_role": "adjacent_context",
      "quote_sha256": "db5dc4d42f519f94a86f420acfd220fd018089299e65eb654f29d3892a756a1a"
    },
    {
      "id": "s16",
      "type": "medical",
      "url": "https://www.helimeds.com/blog/kpv-peptide",
      "title": "KPV Peptide: Comprehensive Guide to Benefits, Dosage and ...",
      "quote": "The FDAs Pharmacy Compounding Advisory Committee (PCAC) will review seven peptides to potentially allow compounders to produce them.",
      "summary": "2026 guide covering KPV chemistry, uses, and 2026 FDA review details.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c18"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:20.705Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "bf8e2b14f2d0910f1b14c8c47975df4052397c8c173647ad1e12a22c0fd76c6b",
      "hash": "10980839b7cefef32720f002ce74e68710c3649bed33d88388e2df2f50bc342d",
      "source_role": "adjacent_context",
      "quote_sha256": "1a84db2f15559700dc017faa869b3d232769f0f9768cd59c337a4a4ac2256096"
    },
    {
      "id": "s17",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Biohackers/comments/1q83047/anyone_here_with_experience_using_kpv_or_other/",
      "title": "Anyone here with experience using KPV or other peptides ...",
      "quote": "I personally tried KPV subcutaneously. 200µg for 12 days (one 5mg vial). ... Significant improvements on the Bistrol scale. I no longer suffered from nighttime duodenal pain. My seborrheic dermatitis is greatly improving. More energy. No side effects.",
      "summary": "User anecdotes on KPV subQ use for gut pain, dermatitis, energy; benefits reversed after stopping.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c19"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:20.705Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "10980839b7cefef32720f002ce74e68710c3649bed33d88388e2df2f50bc342d",
      "hash": "2b7b3fd6ea51fa66115b0e81285aba46b9933cc383ae9888d50c7e4130a26ec9",
      "source_role": "anecdotal_report",
      "quote_sha256": "533adcc69aee62aab77509204459cccc4b2886c878829f577cb24c94ddce4f29"
    },
    {
      "id": "s18",
      "type": "youtube",
      "url": "https://www.youtube.com/watch?v=5ph3S8mVuuE",
      "title": "KPV Peptide - Miracle Cure or Major Risk?",
      "quote": "Discover the science behind KPV peptide, a powerful tripeptide known for its anti-inflammatory and immune-balancing properties.",
      "summary": "Video discussing KPV science, benefits, and risks.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c20"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:20.705Z",
      "link_status": "http_429",
      "quote_status": "unverified",
      "prev": "2b7b3fd6ea51fa66115b0e81285aba46b9933cc383ae9888d50c7e4130a26ec9",
      "hash": "2a2f3b4466d1be1a1cc28da71c5646efcaa948758b5a90da63cf0a40ec7942c0",
      "source_role": "anecdotal_report",
      "quote_sha256": "757047d1739b0a636be9139584f74c5d577d7e2fbeef413b0031d85d767fc77a"
    },
    {
      "id": "s19",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1je6riv/kpv_peptide_side_effects/",
      "title": "KPV Peptide Side Effects",
      "quote": "Kpv & BPC157 both made me feel dizzy, impaired my sleep, gave me headaches and brain fog, and caused fatigue. It sucked bc I actually noticed ...",
      "summary": "User reports negative side effects from KPV including dizziness, sleep issues, headaches, brain fog, fatigue; others note it helped with MCAS inflammation or gut issues but some had to stop due to bad effects; mixed experiences with herx/die-off reactions.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c21"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:50.982Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "2a2f3b4466d1be1a1cc28da71c5646efcaa948758b5a90da63cf0a40ec7942c0",
      "hash": "badfcc90cf4ace5a36c06078c12eb28c7e02d09467a090e23bf9e84d59c33bcc",
      "source_role": "anecdotal_report",
      "quote_sha256": "27d6ddb2991b2ab09ba37cbc101d25e0ff75d6a709ada560d13166e21ad7e0d3"
    },
    {
      "id": "s20",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1je6riv/kpv_peptide_side_effects/",
      "title": "KPV Peptide Side Effects",
      "quote": "Kvp simmers down the inflammation in MCAS.. almost instantly. 40 days in. 500 MCG daily. ... What I’ve noticed is since taking some peptides it’s taken the edge off and reduce the intensity of the instant reaction. Even that I’m deeply grateful for.",
      "summary": "Positive user experience reducing MCAS inflammation and reactions quickly with daily KPV.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c22"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:50.982Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "badfcc90cf4ace5a36c06078c12eb28c7e02d09467a090e23bf9e84d59c33bcc",
      "hash": "81904e5e8e060700ddbc25d22a74fcf8b263644518c45145e77840f692a7e9dd",
      "source_role": "anecdotal_report",
      "quote_sha256": "354b8c5e7188d9cc82eb1f1f1561cd0d395f7289e987b751e19e7d93c2347fc6"
    },
    {
      "id": "s21",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1iikbxd/kpv_peptides/",
      "title": "KPV peptides",
      "quote": "It definitely helped with gut repair but it took me a long time to titrate up my dose. It did cause paradoxical reactions early on. After months, I'm just now at 1 capsule every other day.",
      "summary": "User reports KPV helped gut repair after slow titration despite initial paradoxical reactions; emphasizes starting low and slow.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c23"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:50.982Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "81904e5e8e060700ddbc25d22a74fcf8b263644518c45145e77840f692a7e9dd",
      "hash": "44ffe3f087177783cc28d6a99d69a53b09543cc03ee4b52f30871cc7c2df9adb",
      "source_role": "anecdotal_report",
      "quote_sha256": "2a4acde02fe8cca4b8a0b79879c8457ca14ae6d9e91ad9bc70fa53cd69e6739c"
    },
    {
      "id": "s22",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1iikbxd/kpv_peptides/",
      "title": "KPV peptides",
      "quote": "Start at a very low dose, you might herx. This has helped me a lot with my histamine tolerance.",
      "summary": "Positive report of KPV improving histamine tolerance, with note on possible herx reaction at start.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c24"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:50.982Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "44ffe3f087177783cc28d6a99d69a53b09543cc03ee4b52f30871cc7c2df9adb",
      "hash": "347d8111ad213ca64235106cf394dcd3ff014d5026716b6c371f14dcce819f46",
      "source_role": "anecdotal_report",
      "quote_sha256": "5f5349366a1663981f91f2b221b41616e45e5c939889066adde8726aef5b91d0"
    },
    {
      "id": "s23",
      "type": "reddit",
      "url": "https://www.reddit.com/r/MCAS/comments/1rpepqr/is_anyone_being_helped_by_peptides/",
      "title": "Is anyone being helped by peptides?",
      "quote": "KPV & GHK-Cu (injections) have helped me immensely, both in terms of fatigue and in terms of food tolerance and related symptoms.",
      "summary": "Strong positive experience with KPV reducing fatigue and improving food tolerance in MCAS context.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c25"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:50.982Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "347d8111ad213ca64235106cf394dcd3ff014d5026716b6c371f14dcce819f46",
      "hash": "505f6decbbbfaacf8a2ce2e01d91023be6defdbdfbcec00e1c9c9de80a90f4c8",
      "source_role": "anecdotal_report",
      "quote_sha256": "ea9b580f85ff9b38fdcafbc91bad75b13c11f207dcf8ad3a99586356ab878194"
    },
    {
      "id": "s24",
      "type": "reddit",
      "url": "https://www.reddit.com/r/MCAS/comments/1rpepqr/is_anyone_being_helped_by_peptides/",
      "title": "Is anyone being helped by peptides?",
      "quote": "KPV has helped me dramatically. About 80% reduction in symptoms.",
      "summary": "User reports dramatic ~80% symptom reduction from KPV.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c26"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:50.982Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "505f6decbbbfaacf8a2ce2e01d91023be6defdbdfbcec00e1c9c9de80a90f4c8",
      "hash": "03c572f9b6c8acb8aa6f79dacc544a355e8718813547804f62d384e6d72c2af2",
      "source_role": "anecdotal_report",
      "quote_sha256": "26215403736c8b18805acc9fdf17eeaba3b232e3cff6b28547892e45d753309b"
    },
    {
      "id": "s25",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Biohackers/comments/1ribbuz/kpv_fatigue_and_apathy/",
      "title": "KPV fatigue and apathy",
      "quote": "Been on 200mcg of KPV for a few days and am a little fatigue but the apathy seems a bit strong.",
      "summary": "Negative side effects reported: fatigue and strong apathy from low-dose KPV.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c27"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:50.982Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "03c572f9b6c8acb8aa6f79dacc544a355e8718813547804f62d384e6d72c2af2",
      "hash": "216fd11f233e48d3a6fbdbbb8c6faa34093a6786aa637970e16939c7ae6383d1",
      "source_role": "anecdotal_report",
      "quote_sha256": "00f25373d416e5c9c5f0e302416abc46d08b77babaeb555905151962e90e32ae"
    },
    {
      "id": "s26",
      "type": "youtube",
      "url": "https://www.youtube.com/watch?v=spOpffLj9Oo",
      "title": "This Peptide “Fixes” Your Gut... But There's a Catch",
      "quote": "I have IBS, Crohn's and celiac. Carnivore, KPV and R e t a had helped me so much . I have my life back.",
      "summary": "YouTube comment sharing positive outcome: KPV (with other interventions) resolved IBS, Crohn's, celiac symptoms dramatically.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c28"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:50.982Z",
      "link_status": "http_429",
      "quote_status": "unverified",
      "prev": "216fd11f233e48d3a6fbdbbb8c6faa34093a6786aa637970e16939c7ae6383d1",
      "hash": "8a7a4558259eda90a8da64fc2fc2e2e2b948e1cc0739118014421499dc2ce1e8",
      "source_role": "anecdotal_report",
      "quote_sha256": "d02234568b0e464f0ae167a8dc7044c214ac33b06ffd6ee742f57f5402c74232"
    },
    {
      "id": "s27",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Biohackers/comments/1s69j21/how_effective_is_kpv_peptide_is_it_really_worth_it/",
      "title": "How effective is KPV peptide? Is it really worth it?",
      "quote": "Great for overall inflammation, skin inflammation and gut health , fungus , etc. My toe nail never gets yellow anymore, dandruff completely gone ...",
      "summary": "Positive anecdotal report of KPV improving inflammation, skin, gut, and fungal issues like nail fungus and dandruff.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c29"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:52:50.982Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "8a7a4558259eda90a8da64fc2fc2e2e2b948e1cc0739118014421499dc2ce1e8",
      "hash": "cbc6885c1802a0624ffaa6898b05ca1afd2014a638e3148ffa14e0e7731b94bc",
      "source_role": "anecdotal_report",
      "quote_sha256": "57951dafac775f7bc98b63b6eda9510725e4e1d4cb83ec6c2e57b8217f55f683"
    },
    {
      "id": "s28",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/39252648/",
      "title": "KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy",
      "quote": "Herein, an anti-inflammatory peptide (lysine-proline-valine peptides , KPV ) and the autophagy activator rapamycin (RAPA) are self-assembled to form new carrier-free spherical nanoparticles (NPs), which shows good stability and biosafety.",
      "summary": "2024 study on self-assembled KPV-RAPA nanoparticles for vascular calcification, showing anti-inflammatory effects.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c30"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:53:09.305Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "cbc6885c1802a0624ffaa6898b05ca1afd2014a638e3148ffa14e0e7731b94bc",
      "hash": "90076a9cef0776f449a4fdc9bc814cde2bb2532380c58119ed663f3f86a25404",
      "source_role": "mechanism_support",
      "quote_sha256": "9ae7a8a4af062f0d32bc08d91543e9a49397e496e811eb61a6fcb3121dc2be44"
    },
    {
      "id": "s29",
      "type": "review",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11619216/",
      "title": "Bioactive peptides and proteins for tissue repair",
      "quote": "The KPV peptide from the bottom layer was rapidly released within 1 − 3 d to exert an anti-inflammatory effect during the early stages of wound healing, while ...",
      "summary": "2024 review discussing KPV in tissue repair and wound healing contexts.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c31"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:53:09.305Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "90076a9cef0776f449a4fdc9bc814cde2bb2532380c58119ed663f3f86a25404",
      "hash": "4a659e8395711061eb271e58112172ccedf0a7dadbbb441ef7c95ca5fa8d025f",
      "source_role": "mechanism_support",
      "quote_sha256": "0f19c82e79dc7bc5fe1397fb1941cfdc9a2c10b459d13385529a010d77e16e25"
    },
    {
      "id": "s30",
      "type": "medical",
      "url": "https://formationmed.com/is-kpv-peptide-safe-to-take/",
      "title": "Is KPV Peptide Safe To Take?",
      "quote": "KPV peptide can be safe to take when it is prescribed by a licensed medical provider and sourced from a licensed compounding pharmacy that ...",
      "summary": "2026 medical overview on KPV safety, benefits for inflammation, gut, skin; emphasizes supervision.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c32"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:53:09.305Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "4a659e8395711061eb271e58112172ccedf0a7dadbbb441ef7c95ca5fa8d025f",
      "hash": "a7a3d4fda1d07b827f2e7c9e38379400b201f8f958fb356c7856fb97f08f4146",
      "source_role": "adjacent_context",
      "quote_sha256": "1f4ebec2ddac30e87492fb964ff2c5c84ab8424247d548382ffe454377b23dad"
    },
    {
      "id": "s31",
      "type": "medical",
      "url": "https://newtropin.com/peptides/kpv",
      "title": "KPV Peptide: Anti-Inflammatory Mechanisms and Research",
      "quote": "Research has identified receptor expression in intestinal, dermal, and central nervous system tissues, though the pharmacokinetic profile of KPV in humans remains to be fully characterized through clinical trials.",
      "summary": "2026 clinical overview of KPV mechanisms, origin from alpha-MSH, limited human data.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:53:09.305Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "a7a3d4fda1d07b827f2e7c9e38379400b201f8f958fb356c7856fb97f08f4146",
      "hash": "959448730a5efcc25d35f29a87e9401a70b1006f9a1d3738ba9088e177bddf77",
      "source_role": "adjacent_context",
      "quote_sha256": "d0b432513e6d634dc7f1212e1fe01cf36ff2425bd7d140b30e531b5b43273908"
    },
    {
      "id": "s32",
      "type": "reddit",
      "url": "https://www.reddit.com/r/MCAS/comments/1lki5p2/best_peptides_and_brands_for_mcas_bpc157_kpv_and/",
      "title": "Best peptides and brands for MCAS ? BPC-157, KPV and ...",
      "quote": "I have been using KPV Ultra and BPC-157 since April and no longer need to eat a low histamine diet.",
      "summary": "2026 Reddit anecdotes on KPV for MCAS, mixed experiences including improvements and side effects like flushing.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c34"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:53:09.305Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "959448730a5efcc25d35f29a87e9401a70b1006f9a1d3738ba9088e177bddf77",
      "hash": "610a84254a3a81e95e5498d4a73b91e2466e89c7cdfd2b01d10ad163a5e54174",
      "source_role": "anecdotal_report",
      "quote_sha256": "cd67690d781223add7ade18cb45080b2cb76164df4dac3f999ba8245fb2cb774"
    },
    {
      "id": "s33",
      "type": "reddit",
      "url": "https://www.reddit.com/r/PeptideProgress/comments/1u17ht6/kpv_explained_simply_the_gut_inflammation_fighter/",
      "title": "KPV Explained Simply (The Gut Inflammation Fighter)",
      "quote": "KPV is a specialized peptide for a specific problem: inflammation. If you have a clear inflammatory issue, especially gut or skin related ...",
      "summary": "Recent Reddit post summarizing KPV use for gut inflammation, dosing, side effects.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c35"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:53:09.305Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "610a84254a3a81e95e5498d4a73b91e2466e89c7cdfd2b01d10ad163a5e54174",
      "hash": "7e796b2d7b7540dab8b478710d07b5c649424763b00845fd7844747eadcb2e4b",
      "source_role": "anecdotal_report",
      "quote_sha256": "b0ac0cc38b24588c2982262cbfeafb67642055f89d913422f9c608ef6d28d82d"
    },
    {
      "id": "s34",
      "type": "other",
      "url": "https://www.instagram.com/reel/DYfvjzVDjSD/",
      "title": "What is KPV and why is it being studied?",
      "quote": "Benefits of KPV peptide therapy may include: • Support for gut barrier integrity • Reduced gastrointestinal inflammation • Improved digestive ...",
      "summary": "2026 Instagram reel on KPV benefits for gut and inflammation.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:53:09.305Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "7e796b2d7b7540dab8b478710d07b5c649424763b00845fd7844747eadcb2e4b",
      "hash": "154044478c4a236df8aa7d98ea169fa701cfaf89dbe81265f3c87b8288b2c0f7",
      "source_role": "adjacent_context",
      "quote_sha256": "34717c876ab54320b18344792f01feadc20eb597a03e616b0aaf42005675b40c"
    },
    {
      "id": "s35",
      "type": "review",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/jgh3.70212",
      "title": "Anti‐Inflammatory Peptides as Promising Therapeutics for Inflammatory Bowel Disease",
      "quote": "The study conducted by Kucharzik and colleagues was a phase 2 clinical trial designed to investigate the efficacy of K(D)PT medication in UC cases.",
      "summary": "2025 review discussing KPV/K(D)PT in IBD, including references to clinical trials and anti-inflammatory potential.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:08.302Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "154044478c4a236df8aa7d98ea169fa701cfaf89dbe81265f3c87b8288b2c0f7",
      "hash": "956cffc62c4d47fab5ffa570dc9eefb05236800b3f3f4cb93df25b9000ff4b9e",
      "source_role": "mechanism_support",
      "quote_sha256": "7bf9b69b81e9dfd05c42e493c7191f2a3a0ceea643d394b56a8b3c7f9dfa1ea4"
    },
    {
      "id": "s36",
      "type": "reddit",
      "url": "https://www.reddit.com/r/NTNPerformance/comments/1talx2b/kpv_peptide_guide/",
      "title": "KPV peptide guide",
      "quote": "KPV is a naturally occurring tripeptide. Three amino acids. Lysine, proline, valine. It's the C-terminal fragment of alpha-MSH which is a hormone your body already produces",
      "summary": "User guide on Reddit explaining KPV mechanism for gut and inflammation.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c38"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:08.302Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "956cffc62c4d47fab5ffa570dc9eefb05236800b3f3f4cb93df25b9000ff4b9e",
      "hash": "a492a7658f6b03e39bb62af60c99b77ec178856e7efd89a05a19ea98b49fbde3",
      "source_role": "anecdotal_report",
      "quote_sha256": "9f4f840ba2a054958edf04e22665494d5894ef9915c5f729855a22604d13994e"
    },
    {
      "id": "s37",
      "type": "youtube",
      "url": "https://www.youtube.com/watch?v=XE0k4AW0uag",
      "title": "KPV: The Barrier Repair Peptide (Gut, Skin & Chronic Inflammation)",
      "quote": "KPV is one of the smallest peptides studied in inflammation biology — but it may be one of the most important when it comes to gut health, skin barrier repair, immune balance, and chronic inflammation, especially in midlife.",
      "summary": "YouTube video discussing KPV science, benefits for gut/skin/inflammation with anecdotal mentions.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c39"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:08.302Z",
      "link_status": "http_429",
      "quote_status": "unverified",
      "prev": "a492a7658f6b03e39bb62af60c99b77ec178856e7efd89a05a19ea98b49fbde3",
      "hash": "026d2f039b3e7cafd0ca0bb2ad62726074d652a53b89ed7d5f432ee6e5233a17",
      "source_role": "anecdotal_report",
      "quote_sha256": "003a9d832bfc61cdb0ca30f57d16eb017998525e181e1bba35b712d3a99b5b4d"
    },
    {
      "id": "s38",
      "type": "medical",
      "url": "https://healingmaps.com/kpv-peptide-anti-inflammatory-wound-healing/",
      "title": "KPV: The Anti-Inflammatory Peptide Under FDA Review",
      "quote": "Regulatory Update (April 2026): KPV is one of seven peptides scheduled for FDA Pharmacy Compounding Advisory Committee review on July 23, 2026.",
      "summary": "Article on KPV regulatory status in 2026 and preclinical evidence for inflammation/wound healing.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:08.302Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "026d2f039b3e7cafd0ca0bb2ad62726074d652a53b89ed7d5f432ee6e5233a17",
      "hash": "311e4958f51006b5906372afeda44f7bfd0617cc717272c221a841677e68671e",
      "source_role": "adjacent_context",
      "quote_sha256": "edce681d842064a2cf552a420498a7a8ec53d5dd0fe2970495e4b04265f53342"
    },
    {
      "id": "s39",
      "type": "medical",
      "url": "https://peptidebiologix.com/kpv",
      "title": "KPV — Molecular Specifications & Research Monograph",
      "quote": "The most significant clinical data comes from studies in inflammatory bowel disease patients. A pilot clinical trial investigated topical (intrarectal) administration of KPV in patients with mild to moderate ulcerative colitis.",
      "summary": "Monograph summarizing research, including pilot clinical trial data on KPV for UC.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:08.302Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "311e4958f51006b5906372afeda44f7bfd0617cc717272c221a841677e68671e",
      "hash": "3f4baf027396e7cec2cda51fe464945039a6f2ca06afca2f35a22b7aa2024c2c",
      "source_role": "adjacent_context",
      "quote_sha256": "f5e2bff33ab55cff96221b66c694d1e84253667dc0dcca3b86a5b1d3b3cdd44d"
    },
    {
      "id": "s40",
      "type": "pubmed",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6023233/",
      "title": "Structural modification of the tripeptide KPV by reductive amination",
      "quote": "The “parent” peptide , Ac- KPV -NH2 (12c) was degraded to its three constituent amino acids within 24 hours.",
      "summary": "2018 research on modifying KPV tripeptide for improved stability, showing parent KPV degrades quickly.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c42"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:37.443Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "3f4baf027396e7cec2cda51fe464945039a6f2ca06afca2f35a22b7aa2024c2c",
      "hash": "a63b0be083288912de18a3e4e6d3e76971ea2e6be94ccc54bcbf3c159e818627",
      "source_role": "mechanism_support",
      "quote_sha256": "080a04863bd88a9de081a889f8fd30e50db29ed8df7f67fd942d1aa09fd5d9a4"
    },
    {
      "id": "s41",
      "type": "reddit",
      "url": "https://www.reddit.com/r/MCAS/comments/1u92rpe/ss31_and_kpv_peptideswhat_are_your_experiences/",
      "title": "SS-31 and KPV peptides...what are your experiences?",
      "quote": "Anyone used SS-31 OR KPV? How did it help? What were you struggling with prior to starting? What MCAS symptoms did it help with? Did your fatigue improve?",
      "summary": "MCAS subreddit users discussing personal experiences with KPV for symptoms like fatigue and inflammation.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c43"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:37.443Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "a63b0be083288912de18a3e4e6d3e76971ea2e6be94ccc54bcbf3c159e818627",
      "hash": "ffeed1c1639433f41b97bb3caedb046f30cb680fadeb38423942fad2afc3a77b",
      "source_role": "anecdotal_report",
      "quote_sha256": "e4dbd26ff1ab91d2e54881718894137ca0f32bf97e7c639f0209d95966f329a7"
    },
    {
      "id": "s42",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1agb1mz/kpv_peptide/",
      "title": "Kpv peptide",
      "quote": "Apparently it can completely fix gut issues. It has immune system regulating properties and apparently can reverse MCAS.",
      "summary": "User anecdote on KPV for long COVID gut issues and MCAS reversal.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c44"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:37.443Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "ffeed1c1639433f41b97bb3caedb046f30cb680fadeb38423942fad2afc3a77b",
      "hash": "6fc1e8c6c19aebc7d1293a8ab1d73da4b500f47663cb5a3c8958678214342d6d",
      "source_role": "anecdotal_report",
      "quote_sha256": "8a101178a03cdeb718fcc36ac955d603ca476db95bf0cffb268ca9cd93275223"
    },
    {
      "id": "s43",
      "type": "reddit",
      "url": "https://www.reddit.com/r/MCAS/comments/1pd1ly4/massive_worsening_of_symptoms_after_peptide_usage/",
      "title": "Massive worsening of symptoms after peptide usage?",
      "quote": "I took 0.2 ml of BPC 157 on two consecutive days and 0.06 ml of KPV on the third day. An hour after the KPV injection, my problems started severely.",
      "summary": "Anecdotal report of negative side effects from KPV in MCAS patient.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c45"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:37.443Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "6fc1e8c6c19aebc7d1293a8ab1d73da4b500f47663cb5a3c8958678214342d6d",
      "hash": "dd5cdaaf8d382819637f5cf8c6d3c43e137205744fd2a05e36114ae474909401",
      "source_role": "anecdotal_report",
      "quote_sha256": "db4fe795d43ec1e3ce7566d57d1653ad4ab45aaa372d4ea06c5ecc3f74e9fea2"
    },
    {
      "id": "s44",
      "type": "medical",
      "url": "https://drsobo.com/blog/kpv-effectively-treats-ulcerative-colitis/",
      "title": "KPV Peptide and Ulcerative Colitis | Safe Gut Healing in Stamford CT",
      "quote": "Clinical research supports KPV’s potential as a safe, targeted therapy for inflammatory bowel disease.",
      "summary": "Medical blog discussing KPV for UC/IBD, citing mechanisms and studies (some older).",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c46"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:37.443Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "dd5cdaaf8d382819637f5cf8c6d3c43e137205744fd2a05e36114ae474909401",
      "hash": "a567d12b68fb27b1a618e6b7e375a8dd29bfc8ab16e7e55ad736e3161a331b7d",
      "source_role": "adjacent_context",
      "quote_sha256": "bc31aa6c83923f3bf59e5d1a32eead990f3ba3485339da754da11cf469220c82"
    },
    {
      "id": "s45",
      "type": "medical",
      "url": "https://www.amiv.com/blog/detail/kpv-peptide",
      "title": "KPV Peptide",
      "quote": "KPV is a powerful inflammation regulator. It blocks pro-inflammatory cytokines, such as TNF-alpha and IL-6, which are responsible for chronic inflammation.",
      "summary": "2025 medical blog on KPV as anti-inflammatory derived from alpha-MSH.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c47"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:54:37.443Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "a567d12b68fb27b1a618e6b7e375a8dd29bfc8ab16e7e55ad736e3161a331b7d",
      "hash": "1f53da713eaa8409b95da4088d388854ee40455f4e395212068f77d5871bc297",
      "source_role": "adjacent_context",
      "quote_sha256": "33a97830704ec99f9b20158f9810693a4eccc759a2d2b33a547bb9c2167b976d"
    },
    {
      "id": "s46",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Biohackers/comments/1rfebe7/kpv_side_effects/",
      "title": "KPV Side Effects.",
      "quote": "I started taking KPV subq 250 mcg once daily at night. I feel very fatigued and almost like a low grade common cold symptoms every day since I started. I’m on day 4.",
      "summary": "Multiple users report initial fatigue, flu-like/cold symptoms, dizziness, joint stiffening/herx reactions, low BP, bloating, back pain from KPV (often high starting doses like 250-500mcg subq); some note stomach/reflux improvement but stopped due to side effects; others suggest starting at 50mcg and possible herx or healing flare.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c48"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:55:06.692Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "1f53da713eaa8409b95da4088d388854ee40455f4e395212068f77d5871bc297",
      "hash": "3c514732606e2345ca41089c1d9e59d64ecefd158a4b879ec3a34f58b3cd7739",
      "source_role": "anecdotal_report",
      "quote_sha256": "6bde73d181e2a32a0869c8235ef03cf74dd912d4f6347726e315f908505ec6a2"
    },
    {
      "id": "s47",
      "type": "reddit",
      "url": "https://www.reddit.com/r/MCAS/comments/1dp073i/kpv_peptides/",
      "title": "KPV peptides",
      "quote": "I have been taking it for two weeks and I swear it’s helping with heat (it’s been heat index of over 100 every day in north Texas) intolerance, skin rashes, bloating after eating, and anxiety. ... I used to really get short of breath often from random unknown triggers",
      "summary": "Positive user reports of reduced MCAS/heat intolerance, rashes, bloating, anxiety, shortness of breath, facial swelling with injectable KPV (e.g. ~300mcg nightly); mild tiredness if dose high. Bad outcomes with oral form: flares including flushing, abdominal pain, gas, bloating (esp. with SIBO).",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c49"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:55:06.692Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "3c514732606e2345ca41089c1d9e59d64ecefd158a4b879ec3a34f58b3cd7739",
      "hash": "b263833a605aa4c80a77da6120b68603382c98212b9655d26eef0e041eac7188",
      "source_role": "anecdotal_report",
      "quote_sha256": "50f5c0df13e439aee2eee51771baa6b9a4d58d8d9c6cde0a1febf5f75ad7d3bf"
    },
    {
      "id": "s48",
      "type": "reddit",
      "url": "https://www.reddit.com/r/LongCovid/comments/1pyyxem/symptoms_almost_completely_gonepeptides_have/",
      "title": "Symptoms almost completely gone.....peptides have turned everything around",
      "quote": "I started Retatrutide (GLP) months ago, then added KPV (MCAS/gut, etc) and GhK-Cu for inflammation. ... 2.5 months in and I'm almost back to my previous self. ... aches/pains, food reactions, GI issues, dizziness, memory issues, etc are 75-80% better",
      "summary": "Detailed positive long COVID recovery story attributing major improvement (75-80% better in multiple symptoms including GI, inflammation, dizziness, memory) to stack including KPV; no side effects noted from peptides.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c50"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:55:06.692Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "b263833a605aa4c80a77da6120b68603382c98212b9655d26eef0e041eac7188",
      "hash": "6d6c6928ad9270c6ccf2f8bbe3af62fad3a44d525c0c04142a98781a964a32e1",
      "source_role": "anecdotal_report",
      "quote_sha256": "fa639e92be1434430e5b44224ca4b0cc3aae175bbd1ecb9586d884cc633e93bc"
    },
    {
      "id": "s49",
      "type": "review",
      "url": "https://www.mdpi.com/1422-0067/27/9/3890",
      "title": "Therapeutic Peptides in Aesthetic, Metabolic and ...",
      "quote": "KPV: A short anti-inflammatory peptide derived from Alpha-melanocyte-stimulating hormone (α-MSH). Research primarily in preclinical models links it to gastrointestinal tract protection, promotion of mucosal healing, and enhanced epithelial wound repair.",
      "summary": "2026 review discussing KPV's preclinical anti-inflammatory effects in gut and skin models via NF-κB/MAPK suppression.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:55:21.302Z",
      "link_status": "http_403",
      "quote_status": "unverified",
      "prev": "6d6c6928ad9270c6ccf2f8bbe3af62fad3a44d525c0c04142a98781a964a32e1",
      "hash": "a3f6e8695200ad1931e8d580a083a16ac7c8c394d56fb19d8385c6914db96d73",
      "source_role": "mechanism_support",
      "quote_sha256": "0ce9105e5c2a6646cb99f715bcc76db3b0e94ed27786a21f149d973e8cfa2e02"
    },
    {
      "id": "s50",
      "type": "medical",
      "url": "https://www.science.org/doi/10.1126/sciadv.aea2989",
      "title": "Inflammation-triggered self-immolative conjugates enable ...",
      "quote": "Using three anti-inflammatory peptides (KPV, Ac-QAW, and IRW), we demonstrated that the engineered conjugates exhibit remarkable GI stability... In colitis mice, the KPV-based conjugate (proKPV) achieved a 3.8-fold greater colonic accumulation than free KPV, with enhanced efficacy even at a 20-fold lower dose.",
      "summary": "Jan 2026 Science Advances paper on proKPV prodrug for improved oral delivery and efficacy in colitis and lung injury models.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c52"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:55:21.302Z",
      "link_status": "http_403",
      "quote_status": "unverified",
      "prev": "a3f6e8695200ad1931e8d580a083a16ac7c8c394d56fb19d8385c6914db96d73",
      "hash": "9cfca0f6782346494328faabcc9272146bb511244a0b34364fdcb764e5a1782c",
      "source_role": "adjacent_context",
      "quote_sha256": "66a95153eca11928e9f931273e26046d0b185fce3ef81c6e8cbc2a193800d6c5"
    },
    {
      "id": "s51",
      "type": "medical",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S004081662500117X",
      "title": "Lysine-Proline-Valine peptide mitigates fine dust-induced ...",
      "quote": "KPV protects keratinocytes by mitigating PM10-induced pyroptosis and holds potential as a therapeutic agent for preventing environmental pollutant-related skin inflammation.",
      "summary": "2025 Tissue and Cell study on KPV reducing oxidative stress, MAPK/NF-κB signaling, and apoptosis in keratinocytes exposed to fine dust.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c53"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:55:21.302Z",
      "link_status": "http_403",
      "quote_status": "unverified",
      "prev": "9cfca0f6782346494328faabcc9272146bb511244a0b34364fdcb764e5a1782c",
      "hash": "6a1389ae451f3174de17bbea3ce90b48a98e6d617815f9758f3131b673953649",
      "source_role": "adjacent_context",
      "quote_sha256": "2a9ee37c81a48f93640c63bbbcceb371035ac44990bc241529b781d9b53ef29b"
    },
    {
      "id": "s52",
      "type": "medical",
      "url": "https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026",
      "title": "July 23-24, 2026: Meeting of the Pharmacy Compounding ...",
      "quote": "On July 23, 2026, the Committee will discuss the following bulk drug substances... KPV-related bulk drug substances (KPV (free base)/ KPV acetate)... Wound healing and inflammatory conditions",
      "summary": "FDA advisory committee agenda for July 2026 review of KPV for 503A bulks list inclusion.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c54"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:55:21.302Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "6a1389ae451f3174de17bbea3ce90b48a98e6d617815f9758f3131b673953649",
      "hash": "a6842a40cc02af58410e6ace630575f71534df505fa2eafe5fc9b941a601308f",
      "source_role": "adjacent_context",
      "quote_sha256": "ec8a57bdb3a26fc0308c091057277ba9b8e446dab1f6b37fd58145b1dd57288f"
    },
    {
      "id": "s53",
      "type": "reddit",
      "url": "https://www.reddit.com/r/covidlonghaulers/comments/1r5ekd8/5_years_long_covid_thymosin_alpha_1_peptide_wow/",
      "title": "5 Years Long Covid - Thymosin Alpha 1 Peptide - WOW!",
      "quote": "After KPV peptide which made me feel good for like 48 hours. I am now testing Thymosin Alpha 1 Peptide... Conclusion: Effect seems to last 48-72 hours for TA-1 and 48 hours for KPV",
      "summary": "2026 user anecdote on KPV providing temporary symptom relief in long COVID, lasting ~48 hours.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c55"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:55:21.302Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "a6842a40cc02af58410e6ace630575f71534df505fa2eafe5fc9b941a601308f",
      "hash": "726959440705377199e360f6477fe9919208678af0b2b683fe00ecf2ac2b0dd6",
      "source_role": "anecdotal_report",
      "quote_sha256": "6453611d0d30512f2caf22b59c6deed74806cd35f2b659794d89488640835772"
    },
    {
      "id": "s54",
      "type": "reddit",
      "url": "https://www.reddit.com/r/KPVPeptide/",
      "title": "r/KPVPeptide",
      "quote": "I have been taking kpv for 8 days and was going great, I could feel my inflammation going down (no shoulder pain, no lower back pain, rosacea redness was way down) and then out of nowhere I started to get very little redness bumps... Could it be a herx reaction or an allergy?",
      "summary": "New subreddit with multiple user reports on KPV dosing, benefits for inflammation/skin, and side effects like tingling or herx reactions.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c56"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:55:21.302Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "726959440705377199e360f6477fe9919208678af0b2b683fe00ecf2ac2b0dd6",
      "hash": "1a5af1ce169af9b101da1b74831dfd4f4515cb27ae95a149c7eae24d60ad06cc",
      "source_role": "anecdotal_report",
      "quote_sha256": "e3d7c490649f22ba30cebcc1b80feb176811165addfd6994a1d9ec72b5cddae1"
    },
    {
      "id": "s55",
      "type": "review",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12272339/",
      "title": "Peptide-based therapeutic and delivery strategies for inflammatory bowel disease",
      "quote": "This review provides a comprehensive overview of the sources, structures, and mechanisms of therapeutic peptides for IBD management.",
      "summary": "2025 review discussing peptide strategies including KPV for IBD.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c57"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:56:20.051Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "1a5af1ce169af9b101da1b74831dfd4f4515cb27ae95a149c7eae24d60ad06cc",
      "hash": "49990dc5adf6ed420507ec3239e87b5e16ad884e1af57df3e2bac29f5984b91d",
      "source_role": "mechanism_support",
      "quote_sha256": "1f41507c85a6d2554e1526c11c113475d3efd62265fed5ec9db19e1e8ef2f6a5"
    },
    {
      "id": "s56",
      "type": "medical",
      "url": "https://www.healand.co.uk/biohacking/kpv-peptide",
      "title": "KPV Peptide | Healand Clinic",
      "quote": "KPV is the tripeptide Lys-Pro-Val, a short fragment derived from alpha-melanocyte-stimulating hormone. Research has focused on intestinal inflammation, epithelial transport and anti-inflammatory signalling in gut and skin models.",
      "summary": "Clinic overview of KPV as research peptide for inflammation, notes limited human evidence and preclinical focus.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:56:20.051Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "49990dc5adf6ed420507ec3239e87b5e16ad884e1af57df3e2bac29f5984b91d",
      "hash": "54c27e55b633eae6607472c6781728a725e327a1636d761a25e66d1b1d37d7b6",
      "source_role": "adjacent_context",
      "quote_sha256": "d8a8aea4732aa0e1edc72cabf39fd452f89293ab33e512a6f930fe2cf23fd9dc"
    },
    {
      "id": "s57",
      "type": "reddit",
      "url": "https://www.reddit.com/r/KPVPeptide/comments/1m7qu64/welcome_to_the_kpv_peptide_community_lets_talk/",
      "title": "Welcome to the KPV Peptide Community — Let’s Talk Inflammation, Recovery, and Real-Life Results",
      "quote": "I created this community because KPV deserves a deeper conversation. It’s one of the most underrated yet powerful peptides for inflammation, gut healing, injury recovery, skin flares, and even emotional regulation",
      "summary": "Reddit post starting a KPV-specific community for sharing experiences on inflammation and recovery.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c59"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:56:20.051Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "54c27e55b633eae6607472c6781728a725e327a1636d761a25e66d1b1d37d7b6",
      "hash": "c169a734a60337d22f7a5361867e4fb142ef5417b325ac3675727a07e0535388",
      "source_role": "anecdotal_report",
      "quote_sha256": "efd7ab6d9c866ff8e49e953ecb3199f2e3574c2fee52f693c751ebd33c00472a"
    },
    {
      "id": "s58",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Biohackers/comments/1to8f07/kpv_fixed_my_acne_permanently/",
      "title": "KPV Fixed my Acne Permanently",
      "quote": "After about a month or less I stopped getting any acne, and now maybe 3-4 months later I still had not gotten any acne... KPV healed my nutrient absorption, healed chronic acne and improved bio markers.",
      "summary": "User anecdote claiming permanent acne resolution and other benefits from KPV use.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c60"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:56:20.051Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "c169a734a60337d22f7a5361867e4fb142ef5417b325ac3675727a07e0535388",
      "hash": "2166d16feebd9f9dfc82c60b81f001ce0eda971aa89ded3bb954e2cf757b4dad",
      "source_role": "anecdotal_report",
      "quote_sha256": "08569877cc04bacfc7ceb5e2a41d868fac594ca9c1cf0aa10f8f40a04a3f1489"
    },
    {
      "id": "s59",
      "type": "medical",
      "url": "https://www.bhrcenter.com/peptides/kpv/",
      "title": "KPV - Beverly Hills Rejuvenation Center",
      "quote": "KPV is a naturally occurring tripeptide fragment of alpha-melanocyte stimulating hormone (α-MSH) that powerfully modulates inflammatory responses throughout the body. By targeting key inflammatory pathways, KPV supports tissue healing, reduces chronic inflammation, and promotes gut health through its unique anti-inflammatory and antimicrobial properties.",
      "summary": "Clinic page describing KPV as derived from α-MSH, its mechanisms (NF-κB inhibition, antimicrobial), benefits for gut/IBD/skin, dosing (SC/IM 200-500mcg), and safety profile with no major side effects noted.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:56:49.486Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "2166d16feebd9f9dfc82c60b81f001ce0eda971aa89ded3bb954e2cf757b4dad",
      "hash": "637804274a650b26c9359e4b129ebae9f8608db06fd18738c8c4a783a0ef1084",
      "source_role": "adjacent_context",
      "quote_sha256": "679192216b420c3060ae0c3e99880b1da8a6b850fac82ab0b740eaad1a9fe8fd"
    },
    {
      "id": "s60",
      "type": "reddit",
      "url": "https://www.reddit.com/r/eczema/comments/1sdsz9h/thoughts_on_kpv_peptide_for_eczema/",
      "title": "Thoughts on KPV Peptide for Eczema?",
      "quote": "I think it works well on me. Been on it for about 4 or 5 weeks now and I dont get flare ups anymore. Noticed that when I stopped for 2 days, my upper lip began to itch",
      "summary": "User reports good results with KPV for eczema flare-ups after 4-5 weeks; symptoms return quickly upon stopping.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c62"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:08.595Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "637804274a650b26c9359e4b129ebae9f8608db06fd18738c8c4a783a0ef1084",
      "hash": "44905383ed26e589c006e12da75ad69c515d2c63ef18a528867eb9f0a903c101",
      "source_role": "anecdotal_report",
      "quote_sha256": "ececf79fb4cb454135637f5e62bf123582c931d3f15346da008cce4c715d3ec9"
    },
    {
      "id": "s61",
      "type": "reddit",
      "url": "https://www.reddit.com/r/covidlonghaulers/comments/1qwmoc8/kpv_peptide_takes_long_covid_away/",
      "title": "KPV peptide takes Long Covid away",
      "quote": "Just want to update. KPV 500mcg~ subq peptide injection is taking my Long Covid symptoms away for 2 days. Unfortunately the long covid symptoms come back after 2 days.",
      "summary": "User reports temporary relief from long COVID symptoms (fatigue, brain fog, PEM) lasting ~48 hours per injection; notes higher baseline over time but not a cure.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c63"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:08.595Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "44905383ed26e589c006e12da75ad69c515d2c63ef18a528867eb9f0a903c101",
      "hash": "351bbf3054ddd69e31cc691c9a14d310052221c309c45dafb697668377831697",
      "source_role": "anecdotal_report",
      "quote_sha256": "44c975d900bde30682dfd8db4a270fdf39b7831bf1eb6f6e2aa16563afdcc1f3"
    },
    {
      "id": "s62",
      "type": "x",
      "url": "https://x.com/rahulmodifit/status/2069110309454061845",
      "title": "X post on KPV for nausea",
      "quote": "one of the most underrated uses of KPV might be helping with nausea from other peptides... within about 20 minutes the nausea was significantly better.",
      "summary": "User shares positive anecdotal experience using KPV to quickly reduce nausea from other peptides like cagri.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c64"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:08.595Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "351bbf3054ddd69e31cc691c9a14d310052221c309c45dafb697668377831697",
      "hash": "42a39bc3322f6e159da4978d3a225763adf6ac4a4bc77204b43944a623127b87",
      "source_role": "anecdotal_report",
      "quote_sha256": "dbf80d0f559ebb40b2c0b50b60ce1204bd4b80d424178ded941ba5db7e04348a"
    },
    {
      "id": "s63",
      "type": "reddit",
      "url": "https://www.reddit.com/r/lipedema/comments/1qydkg1/peptides/",
      "title": "Peptides",
      "quote": "I tried GHK but it stung too much and I tried both separately. Found for me KPV helps me. My skin has improved, not sure if it's helping my lipedema but my overall inflammation is down.",
      "summary": "User reports KPV helps with skin improvement and reduced overall inflammation (though not clearly lipedema-specific).",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c65"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:08.595Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "42a39bc3322f6e159da4978d3a225763adf6ac4a4bc77204b43944a623127b87",
      "hash": "68f4fda6a22c8571f5a7c8a797fa7c89b9df4bcacb440d02820a6d3100192241",
      "source_role": "anecdotal_report",
      "quote_sha256": "87ed6ac55e8e83081466568f976379e9106b966a7e1d206857b6cbef6b40011b"
    },
    {
      "id": "s64",
      "type": "reddit",
      "url": "https://www.reddit.com/r/MCAS/comments/1jc3ool/longterm_kpv_peptide/",
      "title": "Long-term kpv peptide",
      "quote": "is working incredibly well for me. Been taking it for about two weeks now. I have. It has made a world of difference.",
      "summary": "Positive user experience with long-term KPV for MCAS symptoms; dramatic improvement noted.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c66"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:08.595Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "68f4fda6a22c8571f5a7c8a797fa7c89b9df4bcacb440d02820a6d3100192241",
      "hash": "28bb51192ed8ebecd98dfec5da6c43487a991fac0ad4f3dd939a3870a204720b",
      "source_role": "anecdotal_report",
      "quote_sha256": "c96fd5b797e7bd1d1acd210e0fbfc7ea0233900457f6001b2c6f43e56134fd7d"
    },
    {
      "id": "s65",
      "type": "review",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12206851/",
      "title": "Anti‐Inflammatory Peptides as Promising Therapeutics Agent for Ulcerative Colitis and Crohn's Disease",
      "quote": "This review evaluates anti‐inflammatory peptides (AIPs) as emerging therapeutic agents, focusing on their efficacy in Ulcerative Colitis and Crohn's disease. ... KPV Has Anti‐Inflammatory Potential in Murine ...",
      "summary": "2025 review discussing anti-inflammatory peptides including KPV for IBD models, highlighting its potential in colitis.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c67"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:33.036Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "28bb51192ed8ebecd98dfec5da6c43487a991fac0ad4f3dd939a3870a204720b",
      "hash": "e4f9b5c4a47bf6cb1c02380e161ee5d83ec1da5f5d62e30c71fca67cdf3bd6de",
      "source_role": "mechanism_support",
      "quote_sha256": "9c3109248c8617f6541004be34575f5029aa84a9a3a4b200cbb43da2c36e0d54"
    },
    {
      "id": "s66",
      "type": "review",
      "url": "https://biomedgrid.com/pdf/AJBSR.MS.ID.003638.pdf",
      "title": "Recalibrating Retinal Immunity: Peptide-Based Strategies ...",
      "quote": "Bioactive peptides like thymosin β4 and melanocortin-derived KPV exhibit immunomodulatory and neuroprotective effects by restoring epithelial integrity, reducing oxidative damage, and recalibrating local immune responses. ... the tripeptide KPV (Lys-Pro-Val), derived from α-MSH, attenuates retinal inflammation and preserves barrier function in diabetic retinopathy models by modulating IL-1β and tight junction protein expression [52].",
      "summary": "2025 paper on peptide strategies for retinal immunity mentioning KPV's effects in diabetic retinopathy models.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c68"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:33.036Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "e4f9b5c4a47bf6cb1c02380e161ee5d83ec1da5f5d62e30c71fca67cdf3bd6de",
      "hash": "97448e82b533b5c3dbc50d586a728de65265b82d21aa8bb5af1a620d8679a41d",
      "source_role": "mechanism_support",
      "quote_sha256": "54e4a13dbe376a2144c3acd52b1c9c6231461672d924556d29799cfcc9afb23b"
    },
    {
      "id": "s67",
      "type": "review",
      "url": "https://www.scitechnol.com/peer-review/recent-advances-in-kpv-peptidedelivery-8OYD.php?article_id=18216",
      "title": "Recent Advances in KPV Peptide Delivery",
      "quote": "Current research updates in last decade for α-MSH analogue, Proline-Lysine-Valine (KPV) is provided in this review.",
      "summary": "Review summarizing a decade of research on KPV formulation, delivery strategies like nanoparticles, and stability improvements.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c69"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:33.036Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "97448e82b533b5c3dbc50d586a728de65265b82d21aa8bb5af1a620d8679a41d",
      "hash": "f5c7a13ae1147615e1d7f20f7370341af868c4e5f35e3cc481c26f394665986d",
      "source_role": "mechanism_support",
      "quote_sha256": "a1ba6a6a9f5b545cc6dd301550bf5cd00989126d965d518fb6a12c2396ef41d4"
    },
    {
      "id": "s68",
      "type": "reddit",
      "url": "https://www.reddit.com/r/PeptidePathways/comments/1tt6uvy/does_kpv_reset_inflammation_or_is_it_working_as/",
      "title": "Does Kpv “reset” inflammation or is it working as long as ...",
      "quote": "While treating other underlying causes For people who have used KPV for inflammation, did it feel like it helped your body calm things down and then stay better after stopping, or did the benefits only last while you were actively using it?",
      "summary": "User discussion on whether KPV provides lasting reset of inflammation or requires ongoing use; anecdotal experiences shared.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c70"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:33.036Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "f5c7a13ae1147615e1d7f20f7370341af868c4e5f35e3cc481c26f394665986d",
      "hash": "16f7ebc4ec825aedc803617bde4859462c274fe84e5de4290b010b7a46977b9d",
      "source_role": "anecdotal_report",
      "quote_sha256": "792a061b397f81b5630e0ee0dd6672adf6559b773c011588418d36f470924fb0"
    },
    {
      "id": "s69",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Peptidesource/comments/1qjdrwd/kpv_whats_your_experience/",
      "title": "KPV - what's your experience?",
      "quote": "Just added KPV to my stack (GLP3, GHKCU) after extensive review and I'm excited to see how this protocol turns out for my subject.",
      "summary": "Anecdotal user experiences with KPV in peptide stacks for various conditions.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c71"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:33.036Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "16f7ebc4ec825aedc803617bde4859462c274fe84e5de4290b010b7a46977b9d",
      "hash": "32f45995306b3a0195bbad83fdf99eb53777bed0d08a9584e7267949852d4cfc",
      "source_role": "anecdotal_report",
      "quote_sha256": "e9e31f1f975c3bf72f8dab0ec87d4bc512907e68f01e95b8688879fc34dd600e"
    },
    {
      "id": "s70",
      "type": "x",
      "url": "https://x.com/jefftangx/status/2030389563794042966",
      "title": "Peptides will unleash the greatest consumer health wave ...",
      "quote": "If implemented, this would re-legalize BPC-157, Thymosin Alpha-1, AOD-9604, Semax, Selank, KPV, and MOTS-c for compounding with a prescription.",
      "summary": "X post discussing potential re-legalization of KPV and other peptides for compounding.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c72"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:57:33.036Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "32f45995306b3a0195bbad83fdf99eb53777bed0d08a9584e7267949852d4cfc",
      "hash": "4bfdfb8586c853fbe45a6e196bdf5413a20c8cbb3d8b84b65fc5439f7ea57d24",
      "source_role": "anecdotal_report",
      "quote_sha256": "b173dbe3fb4327b7b8a332734ccd763ae82cd568cdbf4ceba79b65ef33f45bfe"
    },
    {
      "id": "s71",
      "type": "reddit",
      "url": "https://www.reddit.com/r/healthwithjessicalana/comments/17y51gq/rapid_insights_into_kpv_peptide_a_brief_overview/",
      "title": "Rapid Insights into KPV Peptide: A Brief Overview",
      "quote": "KPV peptide uses a transporter peptide called PepT1 to lower inflammation. PepT1 is responsible for absorbing small peptides from our diet, and ...",
      "summary": "Anecdotal overview of KPV mechanism and history on Reddit.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c73"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:09.565Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "4bfdfb8586c853fbe45a6e196bdf5413a20c8cbb3d8b84b65fc5439f7ea57d24",
      "hash": "17df036c6c7f1c5ce3990e70c5fe8c345d06c6f552f4a95c121247db36af0a0c",
      "source_role": "anecdotal_report",
      "quote_sha256": "dfa7744398c4ab0119330f5ce1bcb8f6e9032440b1512c4960fcd1e468622694"
    },
    {
      "id": "s72",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1dq43y7/kpv_peptide_anyone_had_luck/",
      "title": "KPV Peptide? Anyone had luck?",
      "quote": "Just started this week. Will report back 🤓",
      "summary": "User seeking or sharing experiences with KPV for long COVID gut issues.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c74"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:09.565Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "17df036c6c7f1c5ce3990e70c5fe8c345d06c6f552f4a95c121247db36af0a0c",
      "hash": "b1e06c6e5dcfb05cdce14d4833e7164aa49a4704dbb4a9bc85e402a4b6d87e1a",
      "source_role": "anecdotal_report",
      "quote_sha256": "158a5d26f646aeb13e9e72cb8d07db82f0584f779329317537e1a7d90b9690d8"
    },
    {
      "id": "s73",
      "type": "reddit",
      "url": "https://www.reddit.com/r/HairlossResearch/comments/1evbxf6/forgotten_hair_loss_peptide_by_loreal_kpv/",
      "title": "Forgotten Hair Loss Peptide by L'Oreal: KPV",
      "quote": "KPV (Lysine-Proline-Valine) is a small peptide with potential benefits for hair health, especially in treating androgenetic alopecia.",
      "summary": "Reddit discussion on KPV patented by L'Oreal for hair growth and anti-inflammatory effects.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c75"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:09.565Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "b1e06c6e5dcfb05cdce14d4833e7164aa49a4704dbb4a9bc85e402a4b6d87e1a",
      "hash": "79177f35f4468b2f5f268b057fa83896d3c4f46ad070d6582e543e25871d4f19",
      "source_role": "anecdotal_report",
      "quote_sha256": "a08304e316aaa390e40e7309928eac82c4523f7f9b41fccae041f452f6bbf8d5"
    },
    {
      "id": "s74",
      "type": "reddit",
      "url": "https://www.reddit.com/r/floxies/comments/148mgn6/kpv_peptide_working_well_for_mast_cell_and/",
      "title": "KPV peptide working well for mast cell and histamine symptoms",
      "quote": "KPV peptide working well for mast cell and histamine symptoms. [MEDICATION]. Been having some good results with this injectable peptide ...",
      "summary": "Anecdote of KPV helping mast cell/histamine issues in floxies community.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c76"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:09.565Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "79177f35f4468b2f5f268b057fa83896d3c4f46ad070d6582e543e25871d4f19",
      "hash": "a93732c3aa6dadd85d5f60b2e7d9d7c7338166d1cd4ddfcc9e28a764a09bdb47",
      "source_role": "anecdotal_report",
      "quote_sha256": "75016a1813b9d96a5f8b5b26da2ae3057b5c9ffb9a449d8f6a13d2f438405bdf"
    },
    {
      "id": "s75",
      "type": "reddit",
      "url": "https://www.reddit.com/r/eczema/comments/1szorjy/kpv_peptide_fixed_my_eczema/",
      "title": "KPV peptide fixed my eczema",
      "quote": "KPV peptide has healed my eczema in 2 weeks. It's not fda regulated but injecting kpv is the only thing that worked and gotten rid of my hand ...",
      "summary": "Personal success story with KPV for eczema treatment.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c77"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:09.565Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "a93732c3aa6dadd85d5f60b2e7d9d7c7338166d1cd4ddfcc9e28a764a09bdb47",
      "hash": "a4b5a44d1d668454005e65e312c2875e4ce1b1a9ed6dde1dc696d3ef6ab32b03",
      "source_role": "anecdotal_report",
      "quote_sha256": "77386dbbd22d6dcbbd8cd21b88a0beea7a67e93c0d9700703d51c1705183dd05"
    },
    {
      "id": "s76",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Hashimotos/comments/1pddx24/log_kpv_autoimmunepaintendinitis/",
      "title": "Log - KPV - Autoimmune/Pain/Tendinitis",
      "quote": "AI Summary KPV, similarity to LDN. Both KPV peptide and Low Dose Naltrexone (LDN) reduce inflammation by acting on the NF-κB pathway, ...",
      "summary": "User log on KPV for autoimmune, pain, and tendinitis.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c78"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:09.565Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "a4b5a44d1d668454005e65e312c2875e4ce1b1a9ed6dde1dc696d3ef6ab32b03",
      "hash": "b056602f6efa18cd436a0f328ee27a4b7b91ae47718af536e88f65cf52b06bb5",
      "source_role": "anecdotal_report",
      "quote_sha256": "2c26755cc5bc46fe3dccb75fee8e1eea716bcb8fe21d4d38e9cf21caaecd5f14"
    },
    {
      "id": "s77",
      "type": "pubmed",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2431115/",
      "title": "PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation",
      "quote": "This study indicates that KPV is transported into cells by PepT1 and might be a new therapeutic agent for IBD.",
      "summary": "2008 study showing KPV's anti-inflammatory effects via PepT1 transporter in intestinal cells and mouse colitis models, reducing pro-inflammatory cytokines.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c79"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:43.715Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "b056602f6efa18cd436a0f328ee27a4b7b91ae47718af536e88f65cf52b06bb5",
      "hash": "06ac21e7aa779011743b134dbd58faab5261596634327ea674fbdb3ca37a4942",
      "source_role": "mechanism_support",
      "quote_sha256": "f33b4b74e7420d6ae2f866dd41cb573b8c7916b5b049b6b8f6b406a71dcc7fc8"
    },
    {
      "id": "s78",
      "type": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/38289234/",
      "title": "Growth Factors-Loaded Temperature-Sensitive Hydrogel...",
      "quote": "... ( KPV tripeptide and epidermal growth factor). PHE-EK presented good thermosensitive properties...",
      "summary": "2024 PubMed abstract mentioning KPV tripeptide in a hydrogel for potential delivery/applications.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c80"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:43.715Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "06ac21e7aa779011743b134dbd58faab5261596634327ea674fbdb3ca37a4942",
      "hash": "dcc9d2141b7fee67ea717abb588fda25bf701c499c3ba51308d592ca81dbd46d",
      "source_role": "mechanism_support",
      "quote_sha256": "fce996d6ceb0a2df301eef8675c7dcb043c83eb0cb1f216e905064877210bb4e"
    },
    {
      "id": "s79",
      "type": "medical",
      "url": "https://www.laserskinsolutions.com/blog/the-benefits-of-peptides-bpc157-kpv-for-healing-and-gut-health/",
      "title": "The Benefits of Peptides: BPC157 & KPV for Healing and Gut Health",
      "quote": "Studies have shown that KPV can reduce inflammation in intestinal cells, preserve the gut lining, and help restore balance in the microbiome.",
      "summary": "2025 blog post discussing KPV's role in reducing gut inflammation and supporting microbiome balance, citing preclinical studies.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c3"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:43.715Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "dcc9d2141b7fee67ea717abb588fda25bf701c499c3ba51308d592ca81dbd46d",
      "hash": "064f82b414404f98cc06be20149e41bb6798507f938af299606dd3c9d960aa8d",
      "source_role": "adjacent_context",
      "quote_sha256": "38a1485dd65ec6cad4c9a822ae4eba21df9aa4ae9bf7774fa6ed0b8ba3da8ba7"
    },
    {
      "id": "s80",
      "type": "medical",
      "url": "https://formationmed.com/what-does-the-kpv-peptide-do/",
      "title": "What Does The KPV Peptide Do?",
      "quote": "KPV is a tripeptide made up of three amino acids; lysine, proline, and valine derived from the hormone alpha-Melanocyte Stimulating Hormone (α-MSH).",
      "summary": "2026 medical site article on KPV's anti-inflammatory mechanisms via NF-κB/MAPK pathways and applications for gut, skin, wound healing.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c82"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:43.715Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "064f82b414404f98cc06be20149e41bb6798507f938af299606dd3c9d960aa8d",
      "hash": "3d0f9ac96285ff50fa78f71ac2fc903e7b3a40bc8b4113d218773b3c5db5627d",
      "source_role": "adjacent_context",
      "quote_sha256": "3470fd332045983c1f30e365c4660b744571646899a16320a7460de5d3af74be"
    },
    {
      "id": "s81",
      "type": "reddit",
      "url": "https://www.reddit.com/user/LadyTeetles/comments/1eqtyrc/immune_health_and_healing_peptides_bpc157_kpv/",
      "title": "BPC-157, KPV, Thymogen Alpha 1, Gut Feeling",
      "quote": "In this post, I will share information about using peptides for immune health , peptide properties, benefits, side effects, conditions that can ...",
      "summary": "Reddit user post discussing personal experiences and info on BPC-157 and KPV for immune health and healing.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c83"
      ],
      "found_by": "grok/grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T09:58:43.715Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "3d0f9ac96285ff50fa78f71ac2fc903e7b3a40bc8b4113d218773b3c5db5627d",
      "hash": "d674074a8e3020335bfac907488d14d1efd39c22bd2c924a9c3c0cf78497a7cf",
      "source_role": "anecdotal_report",
      "quote_sha256": "59449ca42079c67f64c2096714bbbd774c9d62c22b64384f625e5563947ef799"
    },
    {
      "id": "s82",
      "type": "reddit",
      "url": "https://www.reddit.com/r/endometriosis/comments/1stumj8/has_anyone_tried_kpv_for_their_inflammation/",
      "title": "Has anyone tried KPV for their inflammation?",
      "quote": "Hi, I've recently been supplementing KPV sub q and it's helped a ton with the chaos of injuries and conditions I have. ... It made me realize that if I did end up relapsing in endo symptoms, I know my body would benefit from the kpv.",
      "summary": "User reports KPV (subq) helped significantly with inflammation from injuries, spinal cord injury, and potential endo relapse symptoms like pelvic heaviness and allodynia. Positive outcome, in remission for endo.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c87"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T15:36:36.024Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "d674074a8e3020335bfac907488d14d1efd39c22bd2c924a9c3c0cf78497a7cf",
      "hash": "e2770e23bc969d80ed5161d67638b5468d5d5db59541890163fa0a8c2d7d3838",
      "source_role": "anecdotal_report",
      "quote_sha256": "7f131ab128be84d5a6057ead4fb69f9904c82e0cf9f0851cfb8ebf391dc556a8"
    },
    {
      "id": "s83",
      "type": "reddit",
      "url": "https://www.reddit.com/r/SVTHeart/comments/1s6fv8g/kpv_peptide_for_svt_not_medical_advice_personal/",
      "title": "KPV peptide for SVT (not medical advice; personal experience)",
      "quote": "Interestingly, when I started taking KPV, for the full month of January and February 2026, I had ZERO SVT episodes… it got to a point where I was debating on cancelling my ablation... but I decided to continue to go forward with it still. As soon as I stopped taking it in preparation for my ablation (stopped KPV 2 weeks before), two days later had an episode. 2 weeks after my ablation, I was having a bunch of PVCs/PACs. ... and within days, no PVCs/PACs.",
      "summary": "User with SVT and prior injuries reports KPV eliminated SVT episodes for 2 months (from 3-4/month), episodes returned upon stopping; restarted post-ablation and resolved PVCs/PACs. Positive outcome, personal experience only.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c88"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T15:36:36.024Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "e2770e23bc969d80ed5161d67638b5468d5d5db59541890163fa0a8c2d7d3838",
      "hash": "27559079ec795c474b566e350692cea1905eb811517c3f3c3b4710173d08bc0c",
      "source_role": "anecdotal_report",
      "quote_sha256": "8961a8400012fecb14393fca95bdaf55411f077a01ff1e3339d1a7edb9c84c27"
    },
    {
      "id": "s84",
      "type": "reddit",
      "url": "https://www.reddit.com/r/tressless/comments/1rytxzu/gh_peptides_klow_blend_saved_my_hair_before_and/",
      "title": "GH peptides + KLOW blend saved my hair. before and after",
      "quote": "GHK/KLOW (I normally do three months on KLOW then cycle off a month; but I run the GHK-Cu & KPV continuously, so I’m really just cycling off the BPC/TB4) definitely thickened my hair.",
      "summary": "User reports KPV in KLOW blend helped thicken hair and reduce scalp inflammation when combined with GHK-Cu.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c89"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T15:37:03.124Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "27559079ec795c474b566e350692cea1905eb811517c3f3c3b4710173d08bc0c",
      "hash": "b55b0bec8e14a3834de02fec1a930010228cae5b12e80cd4381666dfb4072216",
      "source_role": "anecdotal_report",
      "quote_sha256": "d9c1724fa5ff43efbf127ea153925d3c6c3540d0377a254bb7adbd426d53b8d9"
    },
    {
      "id": "s85",
      "type": "reddit",
      "url": "https://www.reddit.com/r/NewCellReplacement/comments/1n6hrz2/the_future_of_regenerative_healing_bpc157_tb500/",
      "title": "The Future of Regenerative Healing: BPC-157, TB-500 ...",
      "quote": "I take BPC, TB and KPV but not the copper. I am taking them for my sacro iliac region. They really help. Amazing stuff.",
      "summary": "Positive user experience with KPV stack for sacroiliac pain and healing.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c90"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T15:37:03.124Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "b55b0bec8e14a3834de02fec1a930010228cae5b12e80cd4381666dfb4072216",
      "hash": "8cbbb8796333fe3a6332c6bf6f7ee692c906f5ee8c94a8761c16d38e18365f42",
      "source_role": "anecdotal_report",
      "quote_sha256": "35b246b50bd620282a1cf77686504557bc26e056246900ca2a1076088b917088"
    },
    {
      "id": "s86",
      "type": "reddit",
      "url": "https://www.reddit.com/r/covidlonghaulers/comments/1peun65/those_who_tried_peptides_permanent_shift_in/",
      "title": "Those who tried peptides - permanent shift in baseline?",
      "quote": "Good to know that KPV seems a little more tolerable with a possible different set of side effects . I will report back on my KPV Ultra (spray) ...",
      "summary": "User planning KPV trial, noting it may be more tolerable than other peptides.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c91"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T15:37:03.124Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "8cbbb8796333fe3a6332c6bf6f7ee692c906f5ee8c94a8761c16d38e18365f42",
      "hash": "ebee9fb16e4a50fcdc7d747679148687a4bb12ce072862a9056dc00cb8532683",
      "source_role": "anecdotal_report",
      "quote_sha256": "b396eb7d4402f10025ff1869014bafcca85bd21a432270ae9ad600210455ff39"
    },
    {
      "id": "s87",
      "type": "x",
      "url": "https://x.com/humanupgradeai/status/2069088062441767130",
      "title": "KPV peptide description",
      "quote": "KPV peptide is a three-amino-acid fragment that packs serious anti-inflammatory punch without the side effects of full alpha-MSH.",
      "summary": "X post highlighting KPV's anti-inflammatory benefits without full alpha-MSH side effects.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c92"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T15:37:03.124Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "ebee9fb16e4a50fcdc7d747679148687a4bb12ce072862a9056dc00cb8532683",
      "hash": "e42b12451b71ebb8059238d90f20212838697f173bdfced8b79fd958bcfce0de",
      "source_role": "anecdotal_report",
      "quote_sha256": "1c43cc094fc544a21c7801f5fb686ffb01b32d977ec1c38d2481b893468571af"
    },
    {
      "id": "s88",
      "type": "x",
      "url": "https://x.com/MrPept1de/status/2063810306820681817",
      "title": "KPV S tier claim",
      "quote": "I have real personal data from 15 real people ive helped and myself!! Im telling you. KPV is S tier!",
      "summary": "X post claiming strong positive results from KPV based on personal and client data.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c93"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T15:37:03.124Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "e42b12451b71ebb8059238d90f20212838697f173bdfced8b79fd958bcfce0de",
      "hash": "edb9c62542d8f1195e72bd3a27fa71e4ba28050cac8d642113f79822079c321d",
      "source_role": "anecdotal_report",
      "quote_sha256": "bedf97cd0f902b0b73d54d3746accb1cb4f7ee3194af393954e3394fcf048cc2"
    },
    {
      "id": "s89",
      "type": "reddit",
      "url": "https://www.reddit.com/r/postvasectomypain/comments/1pl4twe/peptides_kpv/",
      "title": "Peptides - KPV",
      "quote": "I'm trialing KPV injections under careful clinical monitoring (blood markers) for Autoimmune issues. ... I do feel like the KPV is helping. ... Current protocol is: ... 5mg KPV inj subQ daily ... I plan to cycle off soon on KPV, will see how I do.",
      "summary": "User reports positive anecdotal experience with 5mg daily subQ KPV for autoimmune issues under monitoring; plans to cycle off to assess. (anecdotal, not advice)",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c94"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:21.495Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "edb9c62542d8f1195e72bd3a27fa71e4ba28050cac8d642113f79822079c321d",
      "hash": "e21fb9fa3a72978ca6b92775c0ba1ab8e987fafc0599a9cfed0615573bf2da22",
      "source_role": "anecdotal_report",
      "quote_sha256": "72604b9be0ba6f3a26e957b523c44a3720ad8b451f5c85bd0037217d0f5c34c3"
    },
    {
      "id": "s90",
      "type": "reddit",
      "url": "https://www.reddit.com/r/lipedema/comments/1l850rf/reduce_inflammation_with_kpv_and_bpc157/",
      "title": "Reduce inflammation with KPV and BPC-157",
      "quote": "Hi everyone. I've been searching for peptides to manage inflammation lately. Has anyone tried KPV or BPC-157, ...",
      "summary": "Thread seeking user experiences with KPV/BPC for inflammation management in lipedema context. (anecdotal)",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c95"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:21.495Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "e21fb9fa3a72978ca6b92775c0ba1ab8e987fafc0599a9cfed0615573bf2da22",
      "hash": "1e0564555f0c4f6205c22d6880371bd12c67e8ce176c228bf100fe3fb6eacdc6",
      "source_role": "anecdotal_report",
      "quote_sha256": "c5ee4a70ead23708d659c2aff486a734f7cc5ea5ab1b14dc0554ce4d1e062569"
    },
    {
      "id": "s91",
      "type": "x",
      "url": "https://x.com/SuppMasterX/status/2071649714915709405",
      "title": "KPV peptide post",
      "quote": "🔥 KPV — IL PEPTIDE CHE NESSUNO TI RACCONTA Colon irritabile. Diverticoli. Intestino che brucia. Esiste un peptide da tre lettere che nei modelli animali di colite spegne l’infiammazione meglio del cortisone.",
      "summary": "Italian X post promoting KPV for IBS, diverticula, gut inflammation, claiming superior to cortisone in animal models. (anecdotal/promotional)",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c96"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:21.495Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "1e0564555f0c4f6205c22d6880371bd12c67e8ce176c228bf100fe3fb6eacdc6",
      "hash": "67e1d6d59419e96a71170763a015d871e9414a79dbd8a4ac2d98d4f5fd9a8372",
      "source_role": "anecdotal_report",
      "quote_sha256": "88d8cc770c6b552dc6ce9a66acebfd88c60d3a0e5bbc53c092ef5c9759777f39"
    },
    {
      "id": "s92",
      "type": "x",
      "url": "https://x.com/Breedlove22/status/2071613118762127506",
      "title": "KPV in stack",
      "quote": "(3/4) KPV A tiny peptide that comes from one of your own calming hormones, and it goes straight at inflammation in the gut. It was the steady workhorse of the stack, well tolerated with nothing to manage.",
      "summary": "X post describing KPV as effective, well-tolerated gut anti-inflammatory in personal stack. (anecdotal, not advice)",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c97"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:21.495Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "67e1d6d59419e96a71170763a015d871e9414a79dbd8a4ac2d98d4f5fd9a8372",
      "hash": "345c2f35e131712240041cbcf76931d843ffd73d9b30edefab7bcdb0c6240d41",
      "source_role": "anecdotal_report",
      "quote_sha256": "788b970908a1af6b7f54b03fd8a5e2713ffdba529fdda51d8b1e234027e68cbe"
    },
    {
      "id": "s93",
      "type": "x",
      "url": "https://x.com/HuntersGrundle/status/2071648239783223621",
      "title": "KPV recommendation",
      "quote": "Seriously take a look into KPV (a peptide). I personally know half a dozen people that it's helped tremendously with for gut and bowel health issues (chrons/ibs/etc).",
      "summary": "X user recommends KPV based on knowing multiple people helped with gut/bowel issues like Crohn's/IBS. (anecdotal)",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c98"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:21.495Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "345c2f35e131712240041cbcf76931d843ffd73d9b30edefab7bcdb0c6240d41",
      "hash": "0eabb5969e8b167882b8652f1764a1002e40aeba9443280f944c1d649e937541",
      "source_role": "anecdotal_report",
      "quote_sha256": "2452aa619a79368b84ed34d4d69a14161c364adf0f3615a584daba208a4b289a"
    },
    {
      "id": "s94",
      "type": "reddit",
      "url": "https://www.reddit.com/r/APRHealthSolutions/comments/1q3bc3r/kpv_comprehensive_guide/",
      "title": "KPV: Comprehensive Guide",
      "quote": "What Is KPV? KPV is a tripeptide fragment (Lysine–Proline–Valine) derived from the α-MSH (alpha-melanocyte-stimulating hormone) sequence.",
      "summary": "New subreddit post providing a guide on KPV as anti-inflammatory tripeptide; anecdotal dosing/side effects not detailed in snippet but promotional/research focused.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c99"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:38.717Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "0eabb5969e8b167882b8652f1764a1002e40aeba9443280f944c1d649e937541",
      "hash": "137aee92248543e3ac75119043414fcde3f6f729ce743b3e55747932e13fb360",
      "source_role": "anecdotal_report",
      "quote_sha256": "7ca222782d62246a372068de0135c8f814cb41dfd752e0371bb9d4f070e190f5"
    },
    {
      "id": "s95",
      "type": "reddit",
      "url": "https://www.reddit.com/r/OptimumFormulaReviews/comments/1qhge85/roptimumformulareviews_kpv_10mg_guide/",
      "title": "r/OptimumFormulaReviews – KPV (10mg) Guide",
      "quote": "KPV is a tripeptide fragment (Lys-Pro-Val ) derived from α-MSH. Researchers study it for gut barrier support, immune modulation, ...",
      "summary": "Product guide emphasizing research on gut/immune effects; anecdotal elements minimal.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c100"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:38.717Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "137aee92248543e3ac75119043414fcde3f6f729ce743b3e55747932e13fb360",
      "hash": "88d2c75057a55feae43c73e7ad5f0258c3e579e6da1b079fc7c3a827ee05af78",
      "source_role": "anecdotal_report",
      "quote_sha256": "09ce439e2280bd30e25f4ddf0f39365390e6548ff55a5d7b731c7c9711df3362"
    },
    {
      "id": "s96",
      "type": "reddit",
      "url": "https://www.reddit.com/r/IonPeptideGuide/comments/1rztvf6/kpv_quick_guide_the_tripeptide_targeting_gut/",
      "title": "The Tripeptide Targeting Gut Inflammation and Skin Repair",
      "quote": "KPV (Lysine-Proline-Valine ) is a naturally occurring tripeptide derived from the C-terminus of alpha-melanocyte-stimulating hormone (α-MSH).",
      "summary": "New guide on KPV for gut inflammation and skin; research-oriented.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c101"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:38.717Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "88d2c75057a55feae43c73e7ad5f0258c3e579e6da1b079fc7c3a827ee05af78",
      "hash": "98759405be18c5c653acfa218fe111a43e34f07ec855c0d5d7db60c56cb339d5",
      "source_role": "anecdotal_report",
      "quote_sha256": "e6de02f4d090a7b63d0c0e0f189f388e059ff88ce4bdfbb672b49809f93e32ca"
    },
    {
      "id": "s97",
      "type": "x",
      "url": "https://x.com/alextatem/status/2051439184452178178",
      "title": "X post on KPV science",
      "quote": "We cover the real science behind KPV , including its origin from alpha-MSH, its unique anti-inflammatory mechanisms (NF-kB & MAPK inhibition), ...",
      "summary": "Discussion of KPV mechanisms and research; no personal dosing anecdotes.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c102"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:38.717Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "98759405be18c5c653acfa218fe111a43e34f07ec855c0d5d7db60c56cb339d5",
      "hash": "98409130ff4cb6c22350035fa6da93f8f686b6054c6c21798b23bc1fb78e1015",
      "source_role": "anecdotal_report",
      "quote_sha256": "9edb7f2d273a32dd312e5854da1f721cebaced400f5f6264d15ec88436f9b6b0"
    },
    {
      "id": "s98",
      "type": "x",
      "url": "https://x.com/alexaaronlab/status/2063272321243103549",
      "title": "X post on KPV FDA and personal use",
      "quote": "KPV is one of the most underrated peptides on the FDA's July review list. KPV is among the few peptides that I keep in my stack year-round.",
      "summary": "User mentions ongoing personal use in stack; anecdotal positive (anecdotal, not advice).",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c103"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:38.717Z",
      "link_status": "ok",
      "quote_status": "verified",
      "prev": "98409130ff4cb6c22350035fa6da93f8f686b6054c6c21798b23bc1fb78e1015",
      "hash": "3ffbef8a0526c1c8cd80636cf6d39fe5f5b1c970361b9f684a1a47a608a58e01",
      "source_role": "anecdotal_report",
      "quote_sha256": "f7e97fb48b726d5d3e68ca60dde7f0997a196da5f80d0f8d43b9c84aee6bc0e0"
    },
    {
      "id": "s99",
      "type": "x",
      "url": "https://x.com/johnpaulp/status/2067238212502782185",
      "title": "X post preferring KPV",
      "quote": "KPV is by far my favorite - I would take KPV over BPC-157 and TB-500 any day.",
      "summary": "Positive anecdotal preference for KPV over others; no specific side effects or dosing.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c104"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:40:38.717Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "3ffbef8a0526c1c8cd80636cf6d39fe5f5b1c970361b9f684a1a47a608a58e01",
      "hash": "4ada6af401a768c8149d0fbb504c2df4351a319c52202db8c0aec23053dfae63",
      "source_role": "anecdotal_report",
      "quote_sha256": "c5edf2c66ab7aa09de71e6331f16cc1bf5aa3128f52dda9b6ff4e9faa6696df0"
    },
    {
      "id": "s100",
      "type": "reddit",
      "url": "https://www.reddit.com/r/Hidradenitis/comments/1pqlj24/has_anyone_tried_or_used_kpv_peptides_for_help/",
      "title": "Has anyone tried or used KPV peptides for help with HS?",
      "quote": "I take bpc157, tb500 and Kpv with glutathione. It works so good. Within 2 weeks te spots are almost gone and the ugly skin gets better also.",
      "summary": "Anecdotal report (not advice): KPV combined with other peptides helped clear HS spots and improve skin in 2 weeks. Another user: 'I take KPV 1mg 2x per day (20 day cycle so far). It seems to help somewhat for wound healing and infection. Overall it has calmed down my immune system significantly.' Possible herx reaction noted at higher doses.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c105"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:41:11.074Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "4ada6af401a768c8149d0fbb504c2df4351a319c52202db8c0aec23053dfae63",
      "hash": "6854011b934a012ceddeb693c91bfc445d10e38bb397c8523b5a9ce51311f4b7",
      "source_role": "anecdotal_report",
      "quote_sha256": "f3a545670cc3915fd7c4caac51cca6a98e4ce38868b2da62c45f3d51443dee70"
    },
    {
      "id": "s101",
      "type": "reddit",
      "url": "https://www.reddit.com/r/CIRS/comments/1q9ff17/kpv_peptide/",
      "title": "KPV peptide",
      "quote": "Oral didn’t work for me but injections worked very well! My MSH went from less than 1 to 28 in a few months.",
      "summary": "Anecdotal (not advice): Oral KPV ineffective for raising MSH in CIRS patient, but subcutaneous injections raised MSH significantly from <1 to 28; benefits included feeling better overall, less sick less often, improved gut. Another: 'KPV oral did nothing for my MSH. I suspect it needs to be subcutaneous to cross the blood brain barrier.' Dosing mentions: 500mcg injections.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c106"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:41:11.074Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "6854011b934a012ceddeb693c91bfc445d10e38bb397c8523b5a9ce51311f4b7",
      "hash": "9c47406d90fd668ff92426033062996d88090ae6369b3ad9fae8b507b60ae88e",
      "source_role": "anecdotal_report",
      "quote_sha256": "c65d210327a4d4b7bcede0bd10f5ac6fe6967c9046379b207abe2ae22614ec23"
    },
    {
      "id": "s102",
      "type": "reddit",
      "url": "https://www.reddit.com/r/BodyOptimization/comments/1r9ej1f/kpv_is_more_than_just_antiinflammation/",
      "title": "KPV Is More Than Just Anti-Inflammation",
      "quote": "When most people hear KPV, they think “anti-inflammatory peptide” and stop there. And yes, it's very good at calming chronic systemic inflammation.",
      "summary": "Thread discusses broader benefits beyond basic anti-inflammation; focuses on research and mechanisms for gut/skin/systemic use. Anecdotal elements in comments (from search) include positive inflammation reduction.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c107"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:41:11.074Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "9c47406d90fd668ff92426033062996d88090ae6369b3ad9fae8b507b60ae88e",
      "hash": "08348564e13134ee24e0d8bbcfe46f51229ca75db96b7570de137d3d087947b3",
      "source_role": "anecdotal_report",
      "quote_sha256": "9ea18d20b3dfec52141b2b93aa5995986a5eec75079b46c67ce991c87b915a46"
    },
    {
      "id": "s103",
      "type": "reddit",
      "url": "https://www.reddit.com/r/rheumatoid/comments/1rb5enm/peptides_for_ra_while_on_prescribed_immune/",
      "title": "Peptides for RA while on prescribed immune modulator?",
      "quote": "I use KPV daily for anti-inflammatory benefits . I also use thymosin alpha 1 for its immune modulation. These are in addition to HCQ and LDN.",
      "summary": "Anecdotal (not advice): Daily KPV for RA anti-inflammatory effects alongside other treatments; user reports it works well personally with tirzepatide etc. Concerns about immune impact noted.",
      "author": "",
      "publisher": "",
      "date": "",
      "claim_ids": [
        "c108"
      ],
      "found_by": "grok-4.3",
      "extra": {},
      "accessed_at": "2026-06-29T17:41:11.074Z",
      "link_status": "ok",
      "quote_status": "unverified",
      "prev": "08348564e13134ee24e0d8bbcfe46f51229ca75db96b7570de137d3d087947b3",
      "hash": "3490badc045cdf942e0dbeac3cd4432b0fb825a9929fe3b9c83ee691a4e15684",
      "source_role": "anecdotal_report",
      "quote_sha256": "0c8f44d5d812d21d3fa1f3714c6711878a8c19b9061147578bdba30963a135ff"
    },
    {
      "id": "w_4lw9q2jv",
      "url": "https://www.fda.gov/media/193346/download",
      "title": "FDA Evaluation of KPV-Related Bulk Drug Substances (KPV free base and KPV acetate) for Inclusion on the 503A Bulk Drug Substances List — PCAC briefing document, 12 May 2026",
      "quote": "There is a lack of evidence to evaluate the effectiveness of KPV (free base) and KPV acetate products for the nominated uses of wound healing and inflammatory conditions. The nomination did not include, and FDA did not find any information on the use of KPV (free base) or KPV acetate administered in humans.",
      "_id": "w_4lw9q2jv",
      "_ts": "2026-08-04T08:30:43.885Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:30:43.885Z",
      "claim_ids": [],
      "prev": "3490badc045cdf942e0dbeac3cd4432b0fb825a9929fe3b9c83ee691a4e15684",
      "hash": "fb0b00b413a666a98040ed8807129c8f7163ef19319dad00f042b844b0c95cae",
      "plain": "The agency's own review, written before the compounding committee met. It went looking for records of KPV given to a person and found none at all, which means every dose, schedule and timeline in circulation traces back to animals, dishes and word of mouth.",
      "quote_sha256": "c154186ac25f763c3d503e877366304aef66a253a42b7baf0e7baea95f78e0ec"
    },
    {
      "id": "w_zjkqhidi",
      "url": "https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026",
      "title": "July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee — FDA",
      "quote": "On July 23, 2026, the Committee will discuss the following bulk drug substances being considered for inclusion on the 503A Bulks List: BPC-157-related bulk drug substances, KPV-related bulk drug substances (KPV (free base)/ KPV acetate), TB-500-related bulk drug substances, and MOTs-C-related bulk drug substances. Uses evaluated for KPV: Wound healing and inflammatory conditions.",
      "_id": "w_zjkqhidi",
      "_ts": "2026-08-04T08:31:57.469Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:31:57.469Z",
      "claim_ids": [],
      "prev": "fb0b00b413a666a98040ed8807129c8f7163ef19319dad00f042b844b0c95cae",
      "hash": "9ec597559e735243f0e870d4191c5e48e8c274513aacb63c7d96061fa0e28626",
      "plain": "The notice that put KPV formally on the record, alongside BPC-157, TB-500 and MOTs-C, and pinned the review to two uses only. It fixes what was officially considered and when, and nothing about how the committee went.",
      "quote_sha256": "f8b4d27c3afa71041ec7e9c7965926849967284669c6fba4596920bb9e81330a"
    },
    {
      "id": "w_b5ztk84s",
      "url": "https://www.fda.gov/media/193342/download",
      "title": "FDA Briefing Document Introduction, Pharmacy Compounding Advisory Committee, July 23-24 2026 — Points to Consider",
      "quote": "3. FDA is proposing that KPV (free base) NOT be included on the 503A Bulks List. 4. FDA is proposing that KPV acetate NOT be included on the 503A Bulks List.",
      "_id": "w_b5ztk84s",
      "_ts": "2026-08-04T08:31:57.856Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:31:57.856Z",
      "claim_ids": [],
      "prev": "9ec597559e735243f0e870d4191c5e48e8c274513aacb63c7d96061fa0e28626",
      "hash": "5e38ccfea1e1c9a85884dd8ccfb72d15684e449cf5a5e3f9444dc3a1d1636df2",
      "plain": "Going into the meeting the agency's position was already no, for both the free base and the acetate salt. This is a proposal rather than a final rule, but it is the FDA reading its own evidence file before anyone testified.",
      "quote_sha256": "9e44c06ba4257724dac05c6e2d71f4cd49d3093bd968962631dfe798d8ad10e5"
    },
    {
      "id": "w_fquamfa9",
      "url": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks",
      "title": "Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks — FDA",
      "quote": "KPV — FDA has not identified any human exposure data on drug products containing KPV administered via any route of administration. FDA lacks important information regarding any safety issues raised by KPV, including whether it would cause harm if administered to humans.",
      "_id": "w_fquamfa9",
      "_ts": "2026-08-04T08:31:59.809Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:31:59.809Z",
      "claim_ids": [],
      "prev": "5e38ccfea1e1c9a85884dd8ccfb72d15684e449cf5a5e3f9444dc3a1d1636df2",
      "hash": "bbafed64a833aff61d5364b9a87f6ef7f4081fdb8d29304f35359f4fbe6ac92a",
      "plain": "The list the agency keeps of substances it considers risky to compound. What is recorded here is an absence, not an injury: with no record of a person taking it by any route, nobody can describe what a bad reaction would even look like.",
      "quote_sha256": "f546258375f374babaa714ce4b48f40783be583a7ff3e8ff3aeef334f03fa84b"
    },
    {
      "id": "w_x3r14ud2",
      "url": "https://www.federalregister.gov/documents/2026/04/16/2026-07361/pharmacy-compounding-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request",
      "title": "Pharmacy Compounding Advisory Committee; Notice of Meeting — Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List, 91 FR (16 April 2026)",
      "quote": "KPV (free base), KPV acetate — Uses evaluated: Wound healing and inflammatory conditions.",
      "_id": "w_x3r14ud2",
      "_ts": "2026-08-04T08:32:05.000Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:05.000Z",
      "claim_ids": [],
      "prev": "bbafed64a833aff61d5364b9a87f6ef7f4081fdb8d29304f35359f4fbe6ac92a",
      "hash": "5b44dcbde045cd409f8665dbd5455c4b79e3b0362f9452174a0bf2c4dc948871",
      "plain": "The formal public notice. Its use is dating and scoping the review - two chemical forms, two claimed uses - so the federal record can be checked directly instead of taken second hand from a vendor page.",
      "quote_sha256": "a413040e7eb7961a9a247f12b4576c4cc0acaf86446227597a79eabf2ee52d7b"
    },
    {
      "id": "w_ky34gd73",
      "url": "https://pubmed.ncbi.nlm.nih.gov/18061177/",
      "title": "Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 2008 (PMID 18061177)",
      "quote": "Nanomolar concentrations of KPV inhibit the activation of NF-kappaB and MAP kinase inflammatory signaling pathways, and reduce pro-inflammatory cytokine secretion. We found that KPV acts via PepT1 expressed in immune and intestinal epithelial cells. hPepT1 had a low Km of ~160 microM for KPV.",
      "_id": "w_ky34gd73",
      "_ts": "2026-08-04T08:32:08.955Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:08.955Z",
      "claim_ids": [],
      "prev": "5b44dcbde045cd409f8665dbd5455c4b79e3b0362f9452174a0bf2c4dc948871",
      "hash": "8713a85bb9d4818405b387c6bae9e6b4659bc8beffd90bede65cfbf05d4ba4bd",
      "plain": "Cells and cell lines, not people. It identifies the door KPV goes through, a gut transporter that also sits on immune cells, and shows the quieting effect appears at very low concentrations. Mechanism work, done entirely in a dish.",
      "quote_sha256": "4a3f12dc1f424864adc36d21f401a19f5102ba22a34d6c5d0e789ebae92d3f4a"
    },
    {
      "id": "w_eoa9dyim",
      "url": "https://pubmed.ncbi.nlm.nih.gov/18092346/",
      "title": "Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis 2008 (PMID 18092346)",
      "quote": "In MC1Re/e mice, KPV treatment rescued all animals in the treatment group from death during DSS colitis. These effects seem to be at least partially independent of MC1R signaling.",
      "_id": "w_eoa9dyim",
      "_ts": "2026-08-04T08:32:10.777Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:10.777Z",
      "claim_ids": [],
      "prev": "8713a85bb9d4818405b387c6bae9e6b4659bc8beffd90bede65cfbf05d4ba4bd",
      "hash": "0237ddcec145115fedfbe140ef83a0b602e5733948fe8be7bad5762ec2b21e1d",
      "plain": "Mice given a chemical that inflames the colon, in a strain bred without a working melanocortin-1 receptor. Survival in the treated group is the strongest animal result on this page, and the strain choice is the point: the effect did not run through that receptor.",
      "quote_sha256": "16156103ea30f2161bf090b245708b276f6fd5d94694942c2767c4300a05a0cb"
    },
    {
      "id": "w_wo06gy2y",
      "url": "https://pubmed.ncbi.nlm.nih.gov/21222263/",
      "title": "Brzoska T, et al. Terminal signal: anti-inflammatory effects of alpha-MSH related peptides beyond the pharmacophore. Adv Exp Med Biol 2010 (PMID 21222263)",
      "quote": "KPV, C-terminal tripeptide of alpha-MSH, which lacks the entire sequence motif required for binding to any of the known MC-Rs, retains almost all of the anti-inflammatory capacity of the full hormone, but in its activities display a lack of any pigmentary action. While the exact signaling mechanism utilized by KPV and related peptides currently is unknown...",
      "_id": "w_wo06gy2y",
      "_ts": "2026-08-04T08:32:11.328Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:11.328Z",
      "claim_ids": [],
      "prev": "0237ddcec145115fedfbe140ef83a0b602e5733948fe8be7bad5762ec2b21e1d",
      "hash": "3093018dbb1a65b314531dd7217c69cf5affac09eec828d29aaff00cb112ca22",
      "plain": "A review by the group closest to this peptide, and it states the central oddity plainly - KPV keeps most of the parent hormone's calming effect while missing the piece needed to bind any known receptor, and no one has worked out how.",
      "quote_sha256": "14742d54f70d220014c960d75b053e902d68a337649d17608006c2da5b15f1a5"
    },
    {
      "id": "w_iz1zla8v",
      "url": "https://pubmed.ncbi.nlm.nih.gov/18612139/",
      "title": "Brzoska T, Luger TA, Maaser C, Abels C, Bohm M. Alpha-melanocyte-stimulating hormone and related tripeptides. Endocr Rev 2008 (PMID 18612139)",
      "quote": "One obstacle limiting the use of alpha-MSH in inflammatory disorders is its pigmentary effect. Due to its preserved antiinflammatory effect but lack of pigmentary action, the C-terminal tripeptide of alpha-MSH, KPV, has been delineated as an alternative for antiinflammatory therapy.",
      "_id": "w_iz1zla8v",
      "_ts": "2026-08-04T08:32:12.549Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:12.549Z",
      "claim_ids": [],
      "prev": "3093018dbb1a65b314531dd7217c69cf5affac09eec828d29aaff00cb112ca22",
      "hash": "373bc6810d668b09c9f84c56e7d2b2632389a67540160963db403d9463e0f969",
      "plain": "Explains why researchers chased the three-amino-acid tail instead of the whole hormone: the tail does not darken skin. This is history and argument, not experiment - a reason to study KPV, not evidence that it does anything in a person.",
      "quote_sha256": "6c2029a66c683e87115baf8a9a5a6cd07ec78a32b49bc1884a7d0f1409a28c1a"
    },
    {
      "id": "w_0k5anu21",
      "url": "https://pubmed.ncbi.nlm.nih.gov/22837805/",
      "title": "Land SC. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action. Int J Physiol Pathophysiol Pharmacol 2012 (PMID 22837805)",
      "quote": "The KPV effect was associated with its nuclear import, IkappaBalpha stabilisation and suppressed nuclear translocation of YFP-tagged p65RelA. Competition assays revealed an interaction between KPV and the Imp-alpha3 binding site on p65RelA.",
      "_id": "w_0k5anu21",
      "_ts": "2026-08-04T08:32:15.694Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:15.694Z",
      "claim_ids": [],
      "prev": "373bc6810d668b09c9f84c56e7d2b2632389a67540160963db403d9463e0f969",
      "hash": "5f810f3d24ec73b27896b4a7c3b6d7bcc7e68b3d94dad8e156bef6c50007f1ad",
      "plain": "Human airway cells in a dish, and the proposed mechanism is unusually specific: KPV gets into the nucleus and blocks the docking site an inflammatory switch needs to get in. One lab, one cell type, nothing living.",
      "quote_sha256": "5cd86d2c1dddffb6f3e574d469de69f16695a6f8cc3a4d98c939dd7adaf9ff1a"
    },
    {
      "id": "w_8b4pdcfy",
      "url": "https://pubmed.ncbi.nlm.nih.gov/10670585/",
      "title": "Cutuli M, Cristiani S, Lipton JM, Catania A. Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol 2000 (PMID 10670585)",
      "quote": "alpha-MSH and its carboxy-terminal tripeptide (11-13, KPV) were determined to have antimicrobial influences against two major and representative pathogens: Staphylococcus aureus and Candida albicans. Antimicrobial effects occurred over a broad range of concentrations including the physiological (picomolar) range.",
      "_id": "w_8b4pdcfy",
      "_ts": "2026-08-04T08:32:17.455Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:17.455Z",
      "claim_ids": [],
      "prev": "5f810f3d24ec73b27896b4a7c3b6d7bcc7e68b3d94dad8e156bef6c50007f1ad",
      "hash": "36ada3dcba13f6f4acd0248d7cf798a166c0394a55ed57419a02010d648f71db",
      "plain": "A second, separate activity - killing staph and Candida in culture, across a wide concentration range. It was a test-tube result in 2000 and it has never been carried into a person since.",
      "quote_sha256": "b57fc7fcb341d449e2bb28b8b4a04b93c5f6e4070678ccf262fa8afd92ec47a8"
    },
    {
      "id": "w_4rk4kjx2",
      "url": "https://pubmed.ncbi.nlm.nih.gov/15946192/",
      "title": "Grieco P, et al. Three-dimensional structure of the alpha-MSH-derived candidacidal peptide [Ac-CKPV]2. J Pept Res 2005 (PMID 15946192)",
      "quote": "By inserting a Cys-Cys linker between two units of KPV, we designed the dimer [Ac-CKPV]2 that showed excellent candidacidal effects in pilot tests. [Ac-CKPV]2 was active against azole-resistant Candida spp.",
      "_id": "w_4rk4kjx2",
      "_ts": "2026-08-04T08:32:23.468Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:23.468Z",
      "claim_ids": [],
      "prev": "36ada3dcba13f6f4acd0248d7cf798a166c0394a55ed57419a02010d648f71db",
      "hash": "647dd0d66ae9443e5cfe4713679eb7cf0ad8ea7c35a245cab31e2400871ba26a",
      "plain": "Read this one for what it is not. The strong antifungal activity belongs to an engineered double molecule, two KPV units joined by a cysteine bridge, and not to the plain tripeptide sold under the KPV name.",
      "quote_sha256": "72024e4ffdcbaaa2148db96659c9d12f4239207d5cbbfe9dab92464d0b6695f6"
    },
    {
      "id": "w_4e34hn7j",
      "url": "https://pubmed.ncbi.nlm.nih.gov/16965771/",
      "title": "Bonfiglio V, et al. Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. Exp Eye Res 2006 (PMID 16965771)",
      "quote": "Rabbits were topically treated with KPV 1, 5 or 10 mg/ml (30 microl), two drops four times in a day, for 4 days. Sixty hours later, eight out of eight (100%) corneas treated with KPV or SP were completely re-epithelialized.",
      "_id": "w_4e34hn7j",
      "_ts": "2026-08-04T08:32:24.354Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:24.354Z",
      "claim_ids": [],
      "prev": "647dd0d66ae9443e5cfe4713679eb7cf0ad8ea7c35a245cab31e2400871ba26a",
      "hash": "ec3e796c0374814a7f79747fdd1bed86e6a8a29905866dd995c51a0a34707ad0",
      "plain": "Rabbit eyes, topical drops four times a day for four days - one of the very few sources here carrying a real dose and schedule. Every treated cornea closed, but so did every cornea given the comparison peptide, and the animal count is tiny.",
      "quote_sha256": "535637382aadfc08fd9c180c48f6290f2ab9d0085d501d67bcb68c96cd29a04d"
    },
    {
      "id": "w_4hqievsz",
      "url": "https://pubmed.ncbi.nlm.nih.gov/25298219/",
      "title": "Pawar S, Banga AK. Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates. Biomed Chromatogr 2015 (PMID 25298219)",
      "quote": "Under stress conditions (acid, alkali and hydrogen peroxide) KPV yielded lys-pro-diketopiperazine as major degradation product, which was identified by flow injection MS analysis. The LOD and LOQ of KPV were 0.01 and 0.25 microg/mL.",
      "_id": "w_4hqievsz",
      "_ts": "2026-08-04T08:32:25.036Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:25.036Z",
      "claim_ids": [],
      "prev": "ec3e796c0374814a7f79747fdd1bed86e6a8a29905866dd995c51a0a34707ad0",
      "hash": "83799b017372bb35de2262498094c53bb3b7c7fbce6a1dd8fce69406922936c9",
      "plain": "Chemistry, not biology. It shows what KPV turns into when it breaks down under acid, alkali or peroxide, and how little is needed to detect it. Bears on how a vial is stored and what is actually inside it, not on whether it works.",
      "quote_sha256": "d59301603d687d7b8f9488a75790ec7f2427b8b20b8557035636e43316cb15f2"
    },
    {
      "id": "w_62ka3qz2",
      "url": "https://pubmed.ncbi.nlm.nih.gov/28343991/",
      "title": "Pawar S, Toti U, Kaushik R, Banga AK. Transdermal iontophoretic delivery of lysine-proline-valine (KPV) peptide across microporated human skin. J Pharm Sci 2017 (PMID 28343991)",
      "quote": "KPV permeation was less than detectable levels (limit of detection, 0.01 microg/mL) by simple passive diffusion. However, KPV permeation was increased to 4.4 microg/cm2/h by MN treatment. ITP and ITP + MN increased the permeation rate by 8 and 35 fold, respectively, as compared to MN alone.",
      "_id": "w_62ka3qz2",
      "_ts": "2026-08-04T08:32:25.437Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:25.437Z",
      "claim_ids": [],
      "prev": "83799b017372bb35de2262498094c53bb3b7c7fbce6a1dd8fce69406922936c9",
      "hash": "8d5dcee63889692d57870c6e27b2c58c0d1f6a24223bc41397f1e7f59c23696c",
      "plain": "The direct test of whether KPV crosses skin by itself, and the answer is no - not even at the detection limit. It moved only when microneedles or an electric current pushed it. Aim this at any cream or salve claim.",
      "quote_sha256": "31ad093998262eccc89132947e44eb35e9cf03bd7f1819c7564cf7d7f742c386"
    },
    {
      "id": "w_7kfnt5ke",
      "url": "https://pubmed.ncbi.nlm.nih.gov/19909746/",
      "title": "Laroui H, et al. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Gastroenterology 2010 (PMID 19909746)",
      "quote": "By using NPs, KPV can be delivered at a concentration that is 12,000-fold lower than that of KPV in free solution, but with similar therapeutic efficacy.",
      "_id": "w_7kfnt5ke",
      "_ts": "2026-08-04T08:32:25.823Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:25.823Z",
      "claim_ids": [],
      "prev": "8d5dcee63889692d57870c6e27b2c58c0d1f6a24223bc41397f1e7f59c23696c",
      "hash": "d5f86b25c85c0159c8bcc61fc205fc052aba0c448be9cb76e16d066991a730fe",
      "plain": "Mice with colitis, where the striking number is about packaging rather than the peptide. Wrapped in particles aimed at the colon it matched a vastly larger loose dose, meaning most of the loose peptide never arrives anywhere useful.",
      "quote_sha256": "6bfea01472491597a0a840214f3084bd01050f548422b6ff8d509248755fcc13"
    },
    {
      "id": "w_ra1k085g",
      "url": "https://pubmed.ncbi.nlm.nih.gov/28143741/",
      "title": "Xiao B, et al. Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis. Mol Ther 2017 (PMID 28143741)",
      "quote": "Oral administration of HA-KPV-NPs encapsulated in a hydrogel (chitosan/alginate) exhibited a much stronger capacity to prevent mucosa damage and downregulate TNF-alpha, thus they showed a much better therapeutic efficacy against UC in a mouse model.",
      "_id": "w_ra1k085g",
      "_ts": "2026-08-04T08:32:26.194Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:26.194Z",
      "claim_ids": [],
      "prev": "d5f86b25c85c0159c8bcc61fc205fc052aba0c448be9cb76e16d066991a730fe",
      "hash": "c8372af83d621d947ea72368f53c5e520bc669da811cae19d0ff8f8012224bc6",
      "plain": "Mice again, and again the container does the work: swallowed KPV helped only when wrapped in coated particles and set in a gel. Taking the bare peptide by mouth is not what this study tested.",
      "quote_sha256": "4699bf9df331e3411044b95fa26b566971bb65abe41521bf85d75445dfd1e428"
    },
    {
      "id": "w_txhlsxnq",
      "url": "https://pubmed.ncbi.nlm.nih.gov/27458604/",
      "title": "Viennois E, et al. Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model. Cell Mol Gastroenterol Hepatol 2016 (PMID 27458604)",
      "quote": "The use of an anti-inflammatory tripeptide KPV (Lys-Pro-Val) transported by PepT1 was able to prevent carcinogenesis in WT mice. When administered to PepT1-KO mice, KPV did not trigger any of the inhibitory effect on tumorigenesis observed in WT mice.",
      "_id": "w_txhlsxnq",
      "_ts": "2026-08-04T08:32:26.588Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:26.588Z",
      "claim_ids": [],
      "prev": "c8372af83d621d947ea72368f53c5e520bc669da811cae19d0ff8f8012224bc6",
      "hash": "f56bb924097ac5f5bc0a3b2de763f5f57ced37470143e32e3108dfccdf1105b1",
      "plain": "The cleanest control in the set. Breed mice without the transporter and the benefit disappears completely, which ties the effect to that one route in. It is a tumour model in mice, and says nothing about cancer in a person.",
      "quote_sha256": "a550d8dc757bddaf604521585c80243ce1c4dc78411cf9f381b5b811004074b6"
    },
    {
      "id": "w_6tepv8p6",
      "url": "https://pubmed.ncbi.nlm.nih.gov/34547895/",
      "title": "Self-cross-linked hydrogel of cysteamine-grafted gamma-polyglutamic acid stabilized tripeptide KPV for alleviating TNBS-induced ulcerative colitis in rats. ACS Biomater Sci Eng 2021 (PMID 34547895)",
      "quote": "KPV solution is very unstable when rectally administered, compromising its therapeutic efficacy. The stability of KPV in the SH-PGA hydrogel was obviously enhanced, which was presented by detecting its anti-inflammatory activity and promoting cell migration potential after 2 h of exposure to 37 degrees C.",
      "_id": "w_6tepv8p6",
      "_ts": "2026-08-04T08:32:27.017Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:27.017Z",
      "claim_ids": [],
      "prev": "f56bb924097ac5f5bc0a3b2de763f5f57ced37470143e32e3108dfccdf1105b1",
      "hash": "cca38277f278258390ff5ad13da87839f003bdcfcb6d0ab0056ea3ed0a2f1799",
      "plain": "Rats with chemically induced colitis, and the reason for the gel is stated outright by the authors: plain KPV in solution comes apart quickly at body temperature. A stability problem, described by the people engineering around it.",
      "quote_sha256": "82a6479db5feabf12a0a1a2c2ea08e1236bdc0fe25fed8a14be4b227c9f9c035"
    },
    {
      "id": "w_jcn0rn64",
      "url": "https://pubmed.ncbi.nlm.nih.gov/34846053/",
      "title": "In situ mucoadhesive hydrogel carrying tripeptide KPV for chemotherapy-induced oral mucositis. Biomater Sci 2021 (PMID 34846053)",
      "quote": "KPV@PPP_2%E exhibited strong antibacterial efficacy against S. aureus. KPV@PPP_2%E hydrogel also had an anti-bacterial effect on MRSA-infected gingival ulcer wounds.",
      "_id": "w_jcn0rn64",
      "_ts": "2026-08-04T08:32:27.899Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:27.899Z",
      "claim_ids": [],
      "prev": "cca38277f278258390ff5ad13da87839f003bdcfcb6d0ab0056ea3ed0a2f1799",
      "hash": "e89b204f8f2b1427c8277ccc332b56975843b153db74a40f13f1e65fe099b27a",
      "plain": "An animal mouth-ulcer model with the peptide held in a sticky gel, showing a germ-killing effect in an infected wound including against a resistant strain. The gel and the peptide cannot be separated in this result.",
      "quote_sha256": "d8ab409449ee692987533035fc4e1c8e16dfa011c62f3bc4ae14030358b423a7"
    },
    {
      "id": "w_sz77rn3e",
      "url": "https://pubmed.ncbi.nlm.nih.gov/36240893/",
      "title": "Skin-adaptive film dressing with smart-release of growth factors accelerated diabetic wound healing. Int J Biol Macromol 2022 (PMID 36240893)",
      "quote": "An anti-inflammatory tripeptide (KPV) and epidermal growth factor (EGF) as biologic factors were respectively encapsulated in the bottom layer and the middle-top two layers of AGB film. KPV was firstly released within 3 day. K-E-AGB could significantly improve the repair rate of full-thickness skin wound on diabetic mice.",
      "_id": "w_sz77rn3e",
      "_ts": "2026-08-04T08:32:28.457Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:28.457Z",
      "claim_ids": [],
      "prev": "e89b204f8f2b1427c8277ccc332b56975843b153db74a40f13f1e65fe099b27a",
      "hash": "46d3e794efd2eeece28d9dab52c024fa3d1849ceb03e54d59c04587b1805e463",
      "plain": "Diabetic mice and a layered film dressing carrying two active ingredients, KPV and a growth factor. Healing improved, but the design cannot apportion that between the two, and the KPV was gone within the first few days.",
      "quote_sha256": "6cf5ca9e441111069523d8fe44cf59bd3ee0b45aeebe730f5705f8004424039b"
    },
    {
      "id": "w_yd7rqb37",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12802832/",
      "title": "Inflammation-triggered self-immolative conjugates enable oral delivery of anti-inflammatory peptides. Sci Adv 2026 (PMC12802832)",
      "quote": "In colitis mice, the KPV-based conjugate (proKPV) achieved a 3.8-fold greater colonic accumulation than free KPV, with enhanced efficacy even at a 20-fold lower dose. Oral administration of proKPV at 0.5 and 2.5 mg/kg for 7 consecutive days provided robust protection. By contrast, free KPV at 1 mg/kg showed no beneficial effects.",
      "_id": "w_yd7rqb37",
      "_ts": "2026-08-04T08:32:28.872Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:28.872Z",
      "claim_ids": [],
      "prev": "46d3e794efd2eeece28d9dab52c024fa3d1849ceb03e54d59c04587b1805e463",
      "hash": "4356a928bf0d6d7f5681f623a2619178b9d22dcb0ed03349948184b39327aa09",
      "plain": "The most useful negative here. A caged version that only uncaps inside inflamed tissue worked when swallowed; the plain peptide swallowed at a comparable dose did nothing whatever. Colitis mice, and a direct answer about oral KPV.",
      "quote_sha256": "a8f4f35f330549142cdf55a6b6354fff248698b073f4008e7705895ef8ad77e6"
    },
    {
      "id": "w_ggr3cicc",
      "url": "https://pubmed.ncbi.nlm.nih.gov/29953505/",
      "title": "Structural modification of the tripeptide KPV by reductive glycoalkylation of the lysine residue. PLoS One 2018 (PMID 29953505)",
      "quote": "Antimicrobial assays, under a variety of conditions, showed no activity for Ac-KPV-NH2 or the alpha- or epsilon-glycoalkylated analogs. Glycoalkylated peptides did, however, show stability toward proteolytic enzymes.",
      "_id": "w_ggr3cicc",
      "_ts": "2026-08-04T08:32:29.343Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:29.343Z",
      "claim_ids": [],
      "prev": "4356a928bf0d6d7f5681f623a2619178b9d22dcb0ed03349948184b39327aa09",
      "hash": "047ea0f26040d37fd67caf4633663a92193b283470a107feda86d1261e08595b",
      "plain": "A failure reported honestly. Capping the ends and hanging sugars on the lysine let the peptide survive digestive enzymes and destroyed its germ-killing power at the same time - stability and activity pulling in opposite directions.",
      "quote_sha256": "51b495554b2557620226f62050b4256b1985de8764ba3cf2fe922b8f556222d4"
    },
    {
      "id": "w_udmw8780",
      "url": "https://pubmed.ncbi.nlm.nih.gov/15102092/",
      "title": "Hedley SJ, et al. alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol 2004 (PMID 15102092)",
      "quote": "No elevation in cyclic AMP was detected in either HaCaT or normal human keratinocytes in response to alpha-MSH, KPV or ACTH peptides.",
      "_id": "w_udmw8780",
      "_ts": "2026-08-04T08:32:32.338Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:32.338Z",
      "claim_ids": [],
      "prev": "047ea0f26040d37fd67caf4633663a92193b283470a107feda86d1261e08595b",
      "hash": "5428e58479fd093fae74584d45e17a679bc824bf75dd705a374a180678adae12",
      "plain": "Human skin cells, and nothing moved: the standard second messenger stayed flat for the whole hormone and for the fragment alike. A negative result that rules out the obvious signalling route and deepens the question of how KPV acts at all.",
      "quote_sha256": "f560a484ea32e66c01654b9009c8323ef03f373ed43199cac10bf01b8c69fdc0"
    },
    {
      "id": "w_9n6nsofk",
      "url": "https://pubmed.ncbi.nlm.nih.gov/2550304/",
      "title": "Hiltz ME, Lipton JM. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J 1989 (PMID 2550304)",
      "quote": "Alpha-MSH [11-13] inhibited swelling in a dose-related fashion. The effects of graded doses of alpha-MSH [11-13] on ear swelling induced by picryl chloride in mice were compared with the effects of saline and a large dose of corticosteroid.",
      "_id": "w_9n6nsofk",
      "_ts": "2026-08-04T08:32:32.667Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:32.667Z",
      "claim_ids": [],
      "prev": "5428e58479fd093fae74584d45e17a679bc824bf75dd705a374a180678adae12",
      "hash": "61047e269a3176c49414d7cdec485910aac75f7c8953e1cbc3643db2eb786574",
      "plain": "The 1989 experiment the entire anti-inflammatory story rests on - swelling in mouse ears from an irritant, falling as the dose rose, set against a steroid. One species, one endpoint, and no human follow-up in the decades since.",
      "quote_sha256": "3e74528ebacae3dc1f68ea462249393e0a22c611c9b2724c3cefc744393fcaff"
    },
    {
      "id": "w_tfx8zspw",
      "url": "https://pubmed.ncbi.nlm.nih.gov/40073467/",
      "title": "Lysine-proline-valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-kB pathway. Tissue Cell 2025 (PMID 40073467)",
      "quote": "Treatment with 50 microg/mL of KPV restored cell viability and reduced IL-1beta secretion disrupted by PM10 exposure. In a three-dimensional (3D) skin model, KPV treatment effectively attenuated the inflammatory cell death induced by PM10.",
      "_id": "w_tfx8zspw",
      "_ts": "2026-08-04T08:32:33.079Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:33.079Z",
      "claim_ids": [],
      "prev": "61047e269a3176c49414d7cdec485910aac75f7c8953e1cbc3643db2eb786574",
      "hash": "e620533a04ff4bee5db93da088536f1e81c7e641e25c9b95d62ef784ef4cac47",
      "plain": "Skin cells and a lab-grown skin sheet exposed to particulate air pollution. It supports a cosmetic-facing claim at a dish concentration only; nothing here says how much would ever reach living skin.",
      "quote_sha256": "8b0b0dc3d8e6c2d553be91290392c1a835a4a44ae9629e2eaff4306b8f936d1c"
    },
    {
      "id": "w_aidvc3i6",
      "url": "https://pubmed.ncbi.nlm.nih.gov/42064835/",
      "title": "Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARgamma pathway in HepG2 cells. Cytotechnology 2026 (PMID 42064835)",
      "quote": "Treatment with KPV (100 microg/mL) significantly attenuated OA-induced lipid accumulation and suppressed FAS expression without inducing cytotoxicity.",
      "_id": "w_aidvc3i6",
      "_ts": "2026-08-04T08:32:33.441Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:33.441Z",
      "claim_ids": [],
      "prev": "e620533a04ff4bee5db93da088536f1e81c7e641e25c9b95d62ef784ef4cac47",
      "hash": "89968badf512e909b8c3b61c14e3b0ea628373d2ab0379417537cb19013ead49",
      "plain": "A liver cancer cell line loaded with fat, and a different claimed use altogether. This is the furthest source on the page from anything a person could act on: cells in a plate, one concentration, no animal and no body.",
      "quote_sha256": "95a4b193e0af45727fb0dbca88e2ea8dd258e62789f657256823c5c5f3c4fd17"
    },
    {
      "id": "w_y9wcuj55",
      "url": "https://pubmed.ncbi.nlm.nih.gov/39252648/",
      "title": "KPV and RAPA self-assembled into carrier-free nanodrugs for vascular calcification therapy. Adv Healthc Mater 2024 (PMID 39252648)",
      "quote": "In vivo and in vitro, KPV-RAPA NPs significantly inhibit VC in mice compared to the other treatment groups. Mechanistically, KPV-RAPA NPs inhibit inflammatory responses and activated autophagy.",
      "_id": "w_y9wcuj55",
      "_ts": "2026-08-04T08:32:35.343Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:35.343Z",
      "claim_ids": [],
      "prev": "89968badf512e909b8c3b61c14e3b0ea628373d2ab0379417537cb19013ead49",
      "hash": "46b7b3ecc89c30ad46e2e9fc042c9aeb60814963f144de62489d8b741263ada8",
      "plain": "Mice, and a two-drug particle - KPV self-assembled with rapamycin, an established immune-suppressing drug. The hardened-artery result belongs to the pair, and rapamycin is the half of it with a track record.",
      "quote_sha256": "12b91d16af42e05049f5be2cca697f9493bbd3ed45935af3ddc382c17a3f9a88"
    },
    {
      "id": "w_46rh3j3w",
      "url": "https://clinicaltrials.gov/api/v2/studies?query.term=KPV+peptide&countTotal=true",
      "title": "ClinicalTrials.gov API v2 query for KPV peptide, run 4 August 2026",
      "quote": "{\"totalCount\": 0}",
      "_id": "w_46rh3j3w",
      "_ts": "2026-08-04T08:32:35.825Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:35.825Z",
      "claim_ids": [],
      "prev": "46b7b3ecc89c30ad46e2e9fc042c9aeb60814963f144de62489d8b741263ada8",
      "hash": "dcf3dca10c1d21b267997635fded6961e75ba2afe7e671c68cd0bbf0ab945ec8",
      "plain": "A search of the federal trial registry that came back empty. Not one registered human trial of KPV exists anywhere in it. That is the whole finding, and it is why the human column of this page stays blank.",
      "quote_sha256": "16dae4b5d01d22f368cb5943c78fb9d7f819f81f8558c82d801920dbca45364d"
    },
    {
      "id": "w_iydnxytw",
      "url": "https://pubchem.ncbi.nlm.nih.gov/compound/125672",
      "title": "PubChem CID 125672 — Lys-Pro-Val",
      "quote": "MolecularFormula C16H30N4O4; MolecularWeight 342.43; IUPACName (2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoic acid",
      "_id": "w_iydnxytw",
      "_ts": "2026-08-04T08:32:36.196Z",
      "type": "source",
      "accessed_at": "2026-08-04T08:32:36.196Z",
      "claim_ids": [],
      "prev": "dcf3dca10c1d21b267997635fded6961e75ba2afe7e671c68cd0bbf0ab945ec8",
      "hash": "1a565e81b4fa3513f96703d9978e418105075ef6d0f101c93b2de519593d7597",
      "plain": "The identity card: three amino acids, 342 daltons, one exact structure. Use it to check that a product labelled KPV is the same molecule the studies above were run on.",
      "quote_sha256": "9ef56b0a9d9007d27c5f092d1ed4418fbb565f13ef8725bf089306a17b6d464b"
    }
  ],
  "claims": [
    {
      "id": "c1",
      "text": "KPV is small enough to be carried straight into the cells that line the gut, and into immune cells, by a transporter called PepT1 - the same doorway the gut normally uses to pull in short fragments of digested protein.",
      "section": "How KPV gets into the gut lining, and what it shuts off once inside",
      "tier": "preclinical",
      "source_ids": [
        "s1"
      ],
      "source_status": "sourced",
      "why_material": "Core mechanism for gut-specific action",
      "evidence_basis": "derived_inference",
      "weight": 0.22,
      "status": "active",
      "stance_scores": {
        "neutral": 0,
        "pro": 0,
        "adversary": 0
      },
      "extra": {},
      "who_claims": "system/unknown",
      "posted_by": {
        "actor": "system/unknown",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:47:26.419Z",
        "model": "grok/grok-4.3",
        "rationale": "backfilled by ledger repair"
      },
      "slot": "mechanism",
      "source_role": "mechanism_support"
    },
    {
      "id": "c300",
      "text": "Once KPV is inside the cell it damps down two of the switches that turn inflammation on: NF-κB, the master switch for inflammatory genes, and the MAP kinase relay that feeds into it.",
      "section": "How KPV gets into the gut lining, and what it shuts off once inside",
      "tier": "preclinical",
      "source_ids": [
        "s1"
      ],
      "source_status": "sourced",
      "why_material": "Second half of the original single mechanism claim, split out so each step can be checked on its own.",
      "evidence_basis": "derived_inference",
      "weight": 0.22,
      "status": "active",
      "stance_scores": {
        "neutral": 0,
        "pro": 0,
        "adversary": 0
      },
      "extra": {},
      "who_claims": "system/unknown",
      "posted_by": {
        "actor": "system/unknown",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:47:26.419Z",
        "model": "grok/grok-4.3",
        "rationale": "backfilled by ledger repair"
      },
      "slot": "mechanism",
      "source_role": "mechanism_support"
    },
    {
      "id": "c2",
      "text": "In mice given colitis with two standard chemical triggers, DSS and TNBS, KPV swallowed by mouth left the bowel wall visibly less inflamed when the tissue was examined under a microscope.",
      "section": "What KPV did in mice with inflamed bowels",
      "tier": "preclinical",
      "source_ids": [
        "s2",
        "s3"
      ],
      "source_status": "sourced",
      "why_material": "Primary animal data separating from human",
      "evidence_basis": "derived_inference",
      "weight": 0.5,
      "status": "active",
      "stance_scores": {
        "neutral": 0,
        "pro": 0,
        "adversary": 0
      },
      "extra": {},
      "who_claims": "system/unknown",
      "posted_by": {
        "actor": "system/unknown",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:47:26.419Z",
        "model": "grok/grok-4.3",
        "rationale": "backfilled by ledger repair"
      },
      "slot": "what_is_known",
      "source_role": "mechanism_support"
    },
    {
      "id": "c301",
      "text": "In that same mouse colitis work the animals given KPV scored lower on the overall disease activity index, the combined score of weight loss, stool consistency and bleeding.",
      "section": "What KPV did in mice with inflamed bowels",
      "tier": "preclinical",
      "source_ids": [
        "s2",
        "s3"
      ],
      "source_status": "sourced",
      "why_material": "Separate outcome measure from the same animal experiment, split out of a claim that carried three findings at once.",
      "evidence_basis": "derived_inference",
      "weight": 0.5,
      "status": "active",
      "stance_scores": {
        "neutral": 0,
        "pro": 0,
        "adversary": 0
      },
      "extra": {},
      "who_claims": "system/unknown",
      "posted_by": {
        "actor": "system/unknown",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:47:26.419Z",
        "model": "grok/grok-4.3",
        "rationale": "backfilled by ledger repair"
      },
      "slot": "what_is_known",
      "source_role": "mechanism_support"
    },
    {
      "id": "c302",
      "text": "Gut tissue from those KPV-fed mice was producing less of the inflammatory signalling molecules that drive the damage in colitis.",
      "section": "What KPV did in mice with inflamed bowels",
      "tier": "preclinical",
      "source_ids": [
        "s2",
        "s3"
      ],
      "source_status": "sourced",
      "why_material": "Third outcome measure from the same animal experiment, split out so it can be checked on its own.",
      "evidence_basis": "derived_inference",
      "weight": 0.5,
      "status": "active",
      "stance_scores": {
        "neutral": 0,
        "pro": 0,
        "adversary": 0
      },
      "extra": {},
      "who_claims": "system/unknown",
      "posted_by": {
        "actor": "system/unknown",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:47:26.419Z",
        "model": "grok/grok-4.3",
        "rationale": "backfilled by ledger repair"
      },
      "slot": "what_is_known",
      "source_role": "mechanism_support"
    },
    {
      "id": "c3",
      "text": "Thirteen of the sources catalogued on this page are sales pages from companies and clinics selling KPV. They describe what it does in order to sell it, so nothing on them counts as evidence.",
      "section": "KPV sold as a product: thirteen vendor and clinic pages",
      "tier": "speculative",
      "source_ids": [
        "s4",
        "s5",
        "s31",
        "s34",
        "s35",
        "s38",
        "s39",
        "s49",
        "s56",
        "s59",
        "s79",
        "s9",
        "s10"
      ],
      "source_status": "sourced",
      "why_material": "Collapsed 14 duplicate marketing claims",
      "evidence_basis": "derived_inference",
      "weight": 0.12,
      "status": "active",
      "stance_scores": {
        "neutral": 0,
        "pro": 0,
        "adversary": 0
      },
      "extra": {},
      "who_claims": "commercial vendors",
      "posted_by": {
        "actor": "system/unknown",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:47:26.419Z",
        "model": "grok/grok-4.3",
        "rationale": "backfilled by ledger repair"
      },
      "slot": "who_claims_what",
      "source_role": "adjacent_context"
    },
    {
      "id": "c7",
      "text": "Nothing on this KPV page is medical advice. It is a catalogue of what has been reported, sorted by how strong the evidence behind each report is. Decisions about your own health belong with a qualified doctor who knows your history.",
      "section": "This KPV page is a catalogue, not medical advice",
      "tier": "human",
      "weight": 0.65,
      "status": "active",
      "source_ids": [],
      "source_status": "unsourced",
      "who_claims": "system/protocol",
      "posted_by": {
        "actor": "system/protocol",
        "channel": "protocol/fill-slots",
        "ts": "2026-06-29T12:47:27.277Z",
        "model": "system/audit-repair",
        "rationale": ""
      },
      "why_material": "Required constitution slot: disclaimer",
      "slot": "disclaimer",
      "register": null,
      "challenged_by": [
        "c86"
      ]
    },
    {
      "id": "c8",
      "text": "A 2017 study tested whether KPV could be pushed through intact skin, with inflamed skin as the target. It is an experiment in delivery, and it reports nothing about outcomes in people.",
      "tier": "mechanistic",
      "weight": 0.3,
      "section": "Getting KPV to where it is needed: the delivery experiments",
      "slot": "what_is_known",
      "source_ids": [
        "s6"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s6 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c9",
      "text": "A 2026 review pulled the KPV work together - how it acts, the reports on inflammation, gut and wound healing, and the safety worries - and stated plainly that no trials in people have been completed.",
      "tier": "human",
      "weight": 0.8,
      "section": "What the KPV review papers gathered, and what they admit is missing",
      "slot": "what_is_known",
      "source_ids": [
        "s7"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s7 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c10",
      "text": "A 2026 paper described a new way of packaging KPV and similar peptides so they survive being swallowed, aimed at inflamed bowel conditions.",
      "tier": "mechanistic",
      "weight": 0.3,
      "section": "Getting KPV to where it is needed: the delivery experiments",
      "slot": "what_is_known",
      "source_ids": [
        "s8"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s8 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c11",
      "text": "A long write-up posted on Reddit walks through how KPV is thought to work, what people take it for, how they dose it and where the research stands. It is one person summarising what they have read, with no data of their own.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s9"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s9 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c12",
      "text": "A YouTube video from 2025 or 2026 covers KPV for inflammation and gut trouble. The only first-hand accounts attached to it sit in the comments underneath.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s10"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s10 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c13",
      "text": "A 2012 study worked on the cells lining the airways rather than the gut, and found KPV calmed them through a docking point called MC3R - one of the receptors the body's own anti-inflammatory hormone uses.",
      "tier": "human",
      "weight": 0.8,
      "section": "The other route: KPV acting through the MC3R docking point in airway cells",
      "slot": "mechanism",
      "source_ids": [
        "s11"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s11 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c14",
      "text": "A 2016 mouse study reported that KPV, carried in through the PepT1 doorway, cut the number of bowel tumours that normally follow long-running colitis in these animals.",
      "tier": "preclinical",
      "weight": 0.5,
      "section": "What KPV did in mice with inflamed bowels",
      "slot": "what_is_known",
      "source_ids": [
        "s12"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s12 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c15",
      "text": "In 2017 researchers coated tiny carrier particles with hyaluronic acid so they would stick to inflamed bowel, loaded them with KPV, and tested them in mice with ulcerative colitis.",
      "tier": "preclinical",
      "weight": 0.5,
      "section": "Getting KPV to where it is needed: the delivery experiments",
      "slot": "what_is_known",
      "source_ids": [
        "s13"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s13 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c16",
      "text": "The Wikipedia entry describes KPV as the three-amino-acid tail end of alpha-MSH, a hormone the body makes itself, and notes that it turns up as an ingredient in skincare products.",
      "tier": "human",
      "weight": 0.8,
      "section": "Where KPV comes from: the tail end of a hormone the body already makes",
      "slot": "what_is_known",
      "source_ids": [
        "s14"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s14 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c17",
      "text": "A 2026 article covers what KPV is taken for and how it is dosed, and updates where it sits in the rules governing what compounding pharmacies are allowed to make.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "Where KPV stands with the FDA and compounding pharmacies",
      "slot": "what_is_known",
      "source_ids": [
        "s15"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s15 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c18",
      "text": "A 2026 guide sets out the chemistry of KPV, what it is taken for, and the detail of the FDA review held that year.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "Where KPV stands with the FDA and compounding pharmacies",
      "slot": "what_is_known",
      "source_ids": [
        "s16"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s16 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c19",
      "text": "People injecting KPV under the skin reported less gut pain, calmer skin rash and more energy.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people injecting KPV under the skin report",
      "slot": "who_claims_what",
      "source_ids": [
        "s17"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s17 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c303",
      "text": "The same people said those gains went into reverse once they stopped injecting KPV.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people report when they stop taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s17"
      ],
      "source_status": "sourced",
      "why_material": "The stopping observation was buried in a claim about benefits; it is the more important half for anyone deciding whether to start.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c20",
      "text": "A video runs through the science behind KPV, what people hope to get from it and what can go wrong. It is a summary of the literature, not a report of anyone's outcome.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s18"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s18 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c21",
      "text": "In one thread, people starting KPV reported dizziness, broken sleep, headaches, brain fog and fatigue.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The bad reactions people report in the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s19"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s19 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c304",
      "text": "In that same thread other people said KPV settled their mast cell inflammation or their gut, and some of them still stopped because the side effects outweighed what they were getting.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for mast cell trouble report",
      "slot": "who_claims_what",
      "source_ids": [
        "s19"
      ],
      "source_status": "sourced",
      "why_material": "The good outcomes and the bad outcomes in this thread were crammed into one claim; separating them keeps each checkable.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c305",
      "text": "Several people in that thread argued their early bad spell was a die-off reaction, sometimes called a herx reaction, that would pass on its own. Others in the same thread did not accept that reading.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The die-off argument people make about the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s19"
      ],
      "source_status": "sourced",
      "why_material": "This is an interpretation the community argues over, not an observation, and it needs to stand apart from the reported symptoms.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c22",
      "text": "One person taking KPV daily said their mast cell reactions and the inflammation behind them dropped off quickly.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for mast cell trouble report",
      "slot": "who_claims_what",
      "source_ids": [
        "s20"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s20 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c23",
      "text": "One person said KPV helped their gut settle once they built the dose up very slowly, after the first few doses had made things worse rather than better.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for gut inflammation report",
      "slot": "who_claims_what",
      "source_ids": [
        "s21"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s21 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c306",
      "text": "That person's own conclusion was to start far below the usual dose and climb slowly.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for gut inflammation report",
      "slot": "who_claims_what",
      "source_ids": [
        "s21"
      ],
      "source_status": "sourced",
      "why_material": "Their dosing conclusion is a separate assertion from their reported outcome.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c24",
      "text": "One person in a long-COVID gut thread said KPV improved how much histamine they could take in from food before reacting.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for mast cell trouble report",
      "slot": "who_claims_what",
      "source_ids": [
        "s22"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s22 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c307",
      "text": "That same person warned that the first days on KPV brought a rough patch before anything got better.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The die-off argument people make about the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s22"
      ],
      "source_status": "sourced",
      "why_material": "A warning about the first days is a different assertion from a reported benefit and belongs on its own.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c25",
      "text": "One person with mast cell activation syndrome, where the body's histamine-releasing cells fire off too easily, said KPV lifted their fatigue and widened the range of food they could eat without reacting.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for mast cell trouble report",
      "slot": "who_claims_what",
      "source_ids": [
        "s23"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s23 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c26",
      "text": "Another person in that same thread put their whole symptom load at roughly 80% lower on KPV than it had been before.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for mast cell trouble report",
      "slot": "who_claims_what",
      "source_ids": [
        "s24"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s24 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c27",
      "text": "One person taking a low dose of KPV reported that what it gave them was fatigue and a heavy flatness of mood, and nothing else.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The bad reactions people report in the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s25"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s25 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c28",
      "text": "A comment under a YouTube video says KPV, alongside several other things the person changed at the same time, cleared up symptoms they put down to IBS, Crohn's disease and celiac disease. With that many changes at once, nothing in the account separates KPV from the rest.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for gut inflammation report",
      "slot": "who_claims_what",
      "source_ids": [
        "s26"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s26 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c29",
      "text": "One person reported that KPV calmed their inflammation generally and improved both their skin and their gut.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for gut inflammation report",
      "slot": "who_claims_what",
      "source_ids": [
        "s27"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s27 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c308",
      "text": "That same person said stubborn fungal complaints, nail fungus and dandruff, cleared while they were taking KPV.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Skin, hair and nail reports from people taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s27"
      ],
      "source_status": "sourced",
      "why_material": "A fungal outcome is a separate and unusual assertion from a general anti-inflammatory one.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c30",
      "text": "A 2024 study built particles out of KPV and rapamycin that hold themselves together with no carrier material at all, aimed at calcium build-up in the walls of blood vessels.",
      "tier": "mechanistic",
      "weight": 0.3,
      "section": "KPV outside the gut: blood vessels, eyes and wounds",
      "slot": "what_is_known",
      "source_ids": [
        "s28"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s28 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c309",
      "text": "Those KPV and rapamycin particles lowered the inflammation running alongside the calcium build-up in that 2024 model.",
      "tier": "mechanistic",
      "weight": 0.3,
      "section": "KPV outside the gut: blood vessels, eyes and wounds",
      "slot": "what_is_known",
      "source_ids": [
        "s28"
      ],
      "source_status": "sourced",
      "why_material": "The result is separable from the description of what was built.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c31",
      "text": "A 2024 review of peptides and proteins studied for tissue repair lists KPV among them and places it in the wound healing work. It is a survey of what others have done and adds no new data.",
      "tier": "human",
      "weight": 0.8,
      "section": "What the KPV review papers gathered, and what they admit is missing",
      "slot": "what_is_known",
      "source_ids": [
        "s29"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s29 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c32",
      "text": "A 2026 clinic write-up covers KPV for inflammation, gut and skin, and its position on safety is that anyone taking it should be under a doctor's supervision.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "Clinic write-ups about KPV, and what they rest on",
      "slot": "what_is_known",
      "source_ids": [
        "s30"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s30 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c34",
      "text": "A 2026 thread on mast cell problems carries mixed accounts of KPV, with some people saying they improved on it.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for mast cell trouble report",
      "slot": "who_claims_what",
      "source_ids": [
        "s32"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s32 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c310",
      "text": "Others in that same 2026 mast cell thread reported side effects on KPV, flushing among them.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The bad reactions people report in the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s32"
      ],
      "source_status": "sourced",
      "why_material": "The bad outcomes in the thread were folded into a claim about the good ones.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c35",
      "text": "A recent Reddit post sets out what people take KPV for in gut inflammation, how they dose it and which side effects come up. It gathers other people's reports rather than adding one.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s33"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s33 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c38",
      "text": "A guide posted on Reddit explains how KPV is thought to work in the gut and against inflammation. The author reports no outcome of their own.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s36"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s36 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c39",
      "text": "A YouTube video covers KPV for gut, skin and inflammation, with a handful of first-hand mentions dropped in alongside the science.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s37"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s37 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c42",
      "text": "A 2018 paper recorded the central problem with KPV: the plain molecule breaks down quickly once it is in the body.",
      "tier": "mechanistic",
      "weight": 0.3,
      "section": "Getting KPV to where it is needed: the delivery experiments",
      "slot": "what_is_known",
      "source_ids": [
        "s40"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s40 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c311",
      "text": "That 2018 work rebuilt the KPV molecule chemically, adding to it in a way meant to make it last longer before it falls apart.",
      "tier": "mechanistic",
      "weight": 0.3,
      "section": "Getting KPV to where it is needed: the delivery experiments",
      "slot": "what_is_known",
      "source_ids": [
        "s40"
      ],
      "source_status": "sourced",
      "why_material": "What the researchers built is a separate fact from what they observed about plain KPV.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c43",
      "text": "People in a mast cell subreddit compared notes on KPV for symptoms including fatigue and inflammation. It is a pile of personal accounts with no measure held in common between them.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for mast cell trouble report",
      "slot": "who_claims_what",
      "source_ids": [
        "s41"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s41 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c44",
      "text": "One person described taking KPV for gut problems that began with long COVID, and said their mast cell reactions went back the other way.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for long COVID report",
      "slot": "who_claims_what",
      "source_ids": [
        "s42"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s42 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c45",
      "text": "One person with mast cell activation reported that their symptoms got markedly worse after they took KPV.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The bad reactions people report in the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s43"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s43 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c46",
      "text": "A clinic blog argues the case for KPV in ulcerative colitis and Crohn's disease, resting on the proposed mechanism and on studies, some of them decades old.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "Clinic write-ups about KPV, and what they rest on",
      "slot": "what_is_known",
      "source_ids": [
        "s44"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s44 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c47",
      "text": "A 2025 medical blog describes KPV as an anti-inflammatory fragment cut from the end of alpha-MSH, a hormone the body produces itself.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "Where KPV comes from: the tail end of a hormone the body already makes",
      "slot": "what_is_known",
      "source_ids": [
        "s45"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s45 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c48",
      "text": "In a side effects thread, several people starting KPV reported fatigue, flu-like or cold-like symptoms, dizziness, stiffening joints, low blood pressure, bloating and back pain.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The bad reactions people report in the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s46"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s46 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c312",
      "text": "Most of the bad first reactions in that thread followed high starting doses, in the range of 250 to 500 micrograms injected under the skin.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The KPV doses people say they took, and what followed",
      "slot": "who_claims_what",
      "source_ids": [
        "s46"
      ],
      "source_status": "sourced",
      "why_material": "The dose is the actionable detail and was buried inside a list of symptoms.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c313",
      "text": "A few people in that thread said their stomach and reflux improved on KPV and stopped anyway, because the side effects outweighed the gain.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The bad reactions people report in the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s46"
      ],
      "source_status": "sourced",
      "why_material": "A benefit reported by people who still stopped is a distinct observation from the side effects themselves.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c314",
      "text": "The advice that came back in that thread was to start around 50 micrograms, and to read an early flare as either a die-off reaction or the body reacting to repair rather than as a reason to quit.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The die-off argument people make about the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s46"
      ],
      "source_status": "sourced",
      "why_material": "The community's interpretation of an early flare drives what people do next and needs to stand on its own.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c49",
      "text": "People injecting KPV reported less heat intolerance and fewer mast cell reactions, along with fewer rashes, less bloating, less anxiety, less shortness of breath and less swelling of the face.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people injecting KPV under the skin report",
      "slot": "who_claims_what",
      "source_ids": [
        "s47"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s47 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c315",
      "text": "The nightly injected dose people described in that thread was around 300 micrograms, and mild tiredness was the main complaint when they went higher.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The KPV doses people say they took, and what followed",
      "slot": "who_claims_what",
      "source_ids": [
        "s47"
      ],
      "source_status": "sourced",
      "why_material": "The dose and the ceiling above which people felt worse were buried in a list of benefits.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c316",
      "text": "The same thread reports the swallowed form going badly for some people: flares with flushing, abdominal pain, gas and bloating, worst in those who also had bacterial overgrowth in the small intestine, known as SIBO.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Why the swallowed form of KPV goes worse for some people",
      "slot": "who_claims_what",
      "source_ids": [
        "s47"
      ],
      "source_status": "sourced",
      "why_material": "Oral and injected KPV produced opposite outcomes in the same thread, and collapsing them into one claim hides that.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c50",
      "text": "One long, detailed long-COVID recovery account puts the person 75 to 80% better across gut symptoms, inflammation, dizziness and memory.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for long COVID report",
      "slot": "who_claims_what",
      "source_ids": [
        "s48"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s48 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c317",
      "text": "That recovery was credited to a stack of several peptides taken together, KPV among them, so the account cannot say which of them did what.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for long COVID report",
      "slot": "who_claims_what",
      "source_ids": [
        "s48"
      ],
      "source_status": "sourced",
      "why_material": "The confounding is the most important fact about this report and was a trailing clause.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c318",
      "text": "The person in that account reported no side effects from any of the peptides in the stack.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for long COVID report",
      "slot": "who_claims_what",
      "source_ids": [
        "s48"
      ],
      "source_status": "sourced",
      "why_material": "A safety observation is a separate assertion from an efficacy one.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c52",
      "text": "A January 2026 paper in Science Advances describes proKPV, a sleeping form of the peptide that only unlocks into active KPV where inflammation is present, which is how it survives the trip through the stomach.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "Getting KPV to where it is needed: the delivery experiments",
      "slot": "what_is_known",
      "source_ids": [
        "s50"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s50 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c319",
      "text": "That proKPV form was tested in animal models of colitis and of lung injury, and did more in both than plain KPV given the same way.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "Getting KPV to where it is needed: the delivery experiments",
      "slot": "what_is_known",
      "source_ids": [
        "s50"
      ],
      "source_status": "sourced",
      "why_material": "What was built and what it did are separate checkable facts.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c53",
      "text": "A 2025 study in Tissue and Cell exposed skin cells to fine dust and found KPV reduced the oxidative damage that followed.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "What KPV did to skin cells in the laboratory",
      "slot": "what_is_known",
      "source_ids": [
        "s51"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s51 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c320",
      "text": "In those same dust-exposed skin cells KPV quietened the MAPK and NF-κB inflammation signals, and fewer of the cells went on to kill themselves off.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "What KPV did to skin cells in the laboratory",
      "slot": "what_is_known",
      "source_ids": [
        "s51"
      ],
      "source_status": "sourced",
      "why_material": "The signalling result is separable from the oxidative damage result in the same experiment.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c54",
      "text": "The FDA's Pharmacy Compounding Advisory Committee put KPV on the agenda of its July 2026 meeting, to decide whether it belongs on the 503A list of substances compounding pharmacies are allowed to use.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "Where KPV stands with the FDA and compounding pharmacies",
      "slot": "what_is_known",
      "source_ids": [
        "s52"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s52 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c55",
      "text": "One person with long COVID said in 2026 that each dose of KPV bought them roughly 48 hours of relief, after which the symptoms came back.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for long COVID report",
      "slot": "who_claims_what",
      "source_ids": [
        "s53"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s53 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c56",
      "text": "A subreddit set up for KPV alone carries reports on dosing, on inflammation and skin, and on side effects such as tingling and an early flare-up.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The KPV-only subreddit and what gets posted there",
      "slot": "who_claims_what",
      "source_ids": [
        "s54"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s54 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c57",
      "text": "A 2025 review of peptide approaches to inflamed bowel disease covers KPV as one of the candidates. It runs no experiment of its own.",
      "tier": "human",
      "weight": 0.8,
      "section": "What the KPV review papers gathered, and what they admit is missing",
      "slot": "what_is_known",
      "source_ids": [
        "s55"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s55 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c59",
      "text": "The opening post of that KPV subreddit invites people to say what happened to their inflammation and their recovery. It sets up a place for reports rather than making one.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The KPV-only subreddit and what gets posted there",
      "slot": "who_claims_what",
      "source_ids": [
        "s57"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s57 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c60",
      "text": "One person claims their acne cleared for good on KPV and has not come back since.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Skin, hair and nail reports from people taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s58"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s58 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c62",
      "text": "One person with eczema said their flare-ups eased after 4 to 5 weeks on KPV.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Skin, hair and nail reports from people taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s60"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s60 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c321",
      "text": "That same person said the eczema came back quickly once they stopped taking KPV.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people report when they stop taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s60"
      ],
      "source_status": "sourced",
      "why_material": "What happens on stopping is the fact most people want and it was a trailing clause.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c63",
      "text": "One person with long COVID said each injection lifted their fatigue, brain fog and post-exertional crash for about 48 hours.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for long COVID report",
      "slot": "who_claims_what",
      "source_ids": [
        "s61"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s61 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c322",
      "text": "That same person said their baseline crept upward over months on KPV, and was clear that the illness itself had not gone away.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for long COVID report",
      "slot": "who_claims_what",
      "source_ids": [
        "s61"
      ],
      "source_status": "sourced",
      "why_material": "The long-run trend and the explicit denial of a permanent fix are distinct from the 48-hour effect.",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c64",
      "text": "One person on X said KPV quickly settled the nausea that another peptide, cagrilintide, was causing them.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Single reports of KPV used against something else entirely",
      "slot": "who_claims_what",
      "source_ids": [
        "s62"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s62 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c65",
      "text": "One person with lipedema said KPV improved their skin and lowered their inflammation generally, and was careful to say it had done nothing they could pin on the lipedema itself.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Skin, hair and nail reports from people taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s63"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s63 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c66",
      "text": "One person taking KPV over a long stretch for mast cell symptoms described a dramatic improvement.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for mast cell trouble report",
      "slot": "who_claims_what",
      "source_ids": [
        "s64"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s64 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c67",
      "text": "A 2025 review of anti-inflammatory peptides in animal models of inflamed bowel disease singles KPV out among the colitis candidates. It surveys animal work and reports nothing from people.",
      "tier": "preclinical",
      "weight": 0.22,
      "section": "What the KPV review papers gathered, and what they admit is missing",
      "slot": "what_is_known",
      "source_ids": [
        "s65"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s65 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c68",
      "text": "A 2025 paper on peptides and immunity in the retina cites what KPV did in animal models of diabetic eye disease.",
      "tier": "human",
      "weight": 0.8,
      "section": "KPV outside the gut: blood vessels, eyes and wounds",
      "slot": "what_is_known",
      "source_ids": [
        "s66"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s66 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c69",
      "text": "A review covering a decade of KPV work sets out how researchers have tried to formulate it, carry it in tiny particles, and stop it breaking down before it arrives.",
      "tier": "human",
      "weight": 0.8,
      "section": "Getting KPV to where it is needed: the delivery experiments",
      "slot": "what_is_known",
      "source_ids": [
        "s67"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s67 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c70",
      "text": "A thread argues over whether KPV resets inflammation for good or only holds it down for as long as you keep taking it. The accounts in it point both ways and nobody settles the question.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people report when they stop taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s68"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s68 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c71",
      "text": "A thread collects personal accounts of KPV taken inside larger peptide stacks for a spread of conditions, with no condition, dose or measure held in common.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s69"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s69 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c72",
      "text": "An X post argues that KPV and other peptides are heading back into legal compounding, and treats that as the start of a much larger consumer wave. It is a prediction, not a report of anything that has happened.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Where KPV stands with the FDA and compounding pharmacies",
      "slot": "who_claims_what",
      "source_ids": [
        "s70"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s70 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c73",
      "text": "A short Reddit overview runs through where KPV came from and how it is thought to act. No outcome for anybody is reported in it.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s71"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s71 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c74",
      "text": "A post asks whether anyone has had luck with KPV for gut problems that followed long COVID. It is a question put to the group, not an account of a result.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for long COVID report",
      "slot": "who_claims_what",
      "source_ids": [
        "s72"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s72 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c75",
      "text": "A hair loss thread points out that L'Oreal took out a patent on KPV for hair growth and for its calming effect on inflammation, and that the idea then sat unused.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "KPV was patented by L'Oreal for hair growth",
      "slot": "who_claims_what",
      "source_ids": [
        "s73"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s73 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c76",
      "text": "One person in a group for people harmed by fluoroquinolone antibiotics said KPV worked well on their mast cell and histamine symptoms.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for mast cell trouble report",
      "slot": "who_claims_what",
      "source_ids": [
        "s74"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s74 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c77",
      "text": "One person posted that KPV cleared their eczema, and titled the post to say so outright.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Skin, hair and nail reports from people taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s75"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s75 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c78",
      "text": "One person kept a running log of KPV taken for an autoimmune thyroid condition, for pain, and for an inflamed tendon.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Single reports of KPV used against something else entirely",
      "slot": "who_claims_what",
      "source_ids": [
        "s76"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s76 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c79",
      "text": "The 2008 paper that put KPV on the map showed the same thing twice over: gut cells in a dish and mice with colitis both produced fewer inflammatory signalling molecules once KPV had been carried in through PepT1.",
      "tier": "preclinical",
      "weight": 0.5,
      "section": "What KPV did in mice with inflamed bowels",
      "slot": "what_is_known",
      "source_ids": [
        "s77"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s77 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c80",
      "text": "A 2024 abstract lists the KPV tripeptide as one ingredient in a temperature-sensitive gel, built to hold what it carries until body heat releases it.",
      "tier": "mechanistic",
      "weight": 0.3,
      "section": "Getting KPV to where it is needed: the delivery experiments",
      "slot": "what_is_known",
      "source_ids": [
        "s78"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s78 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "mechanism_support"
    },
    {
      "id": "c82",
      "text": "A 2026 medical site sets out how KPV is thought to calm inflammation through the NF-κB and MAPK switches, and lists gut, skin and wound healing as what people take it for.",
      "tier": "speculative",
      "weight": 0.12,
      "section": "Clinic write-ups about KPV, and what they rest on",
      "slot": "what_is_known",
      "source_ids": [
        "s80"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s80 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c83",
      "text": "A Reddit post pairs personal accounts of BPC-157 and KPV taken for immune health and healing. Nothing in it separates what one peptide did from the other.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s81"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s81 by ledger repair",
      "status": "active",
      "who_claims": "grok/grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "protocol/repair",
        "ts": "2026-06-29T12:50:39.299Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c84",
      "text": "Nobody knows what KPV does to a person over the long run. There is no long-term safety data in people at all.",
      "tier": "speculative",
      "weight": 0.1,
      "section": "What nobody knows about KPV in people",
      "slot": "what_is_unknown",
      "source_ids": [
        "s4",
        "s5"
      ],
      "source_status": "sourced",
      "why_material": "This claim addresses an explicit gap in the current evidence, as all benefits are extrapolated from cell and rodent studies, and no human clinical trials exist.",
      "status": "active",
      "who_claims": "kimi/moonshot-v1-8k",
      "posted_by": {
        "actor": "kimi/moonshot-v1-8k",
        "channel": "protocol/collaborate",
        "ts": "2026-06-29T13:51:51.177Z",
        "model": "kimi/moonshot-v1-8k",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c323",
      "text": "Every claimed benefit of KPV traces back to cells in a dish or to rodents. No clinical trial in people has been completed.",
      "tier": "speculative",
      "weight": 0.1,
      "section": "What nobody knows about KPV in people",
      "slot": "what_is_unknown",
      "source_ids": [
        "s4",
        "s5"
      ],
      "source_status": "sourced",
      "why_material": "The absence of human trials is the single most important fact on the page and was a subordinate clause.",
      "status": "active",
      "who_claims": "kimi/moonshot-v1-8k",
      "posted_by": {
        "actor": "kimi/moonshot-v1-8k",
        "channel": "protocol/collaborate",
        "ts": "2026-06-29T13:51:51.177Z",
        "model": "kimi/moonshot-v1-8k",
        "rationale": ""
      },
      "source_role": "adjacent_context"
    },
    {
      "id": "c86",
      "text": "The disclaimer on this page carries no source and does not need one. It states a limit on what the page is, rather than a fact about KPV that could be checked against a study.",
      "tier": "mechanistic",
      "weight": 0.4,
      "section": "Why the KPV disclaimer on this page carries no source",
      "slot": null,
      "source_ids": [],
      "source_status": "unsourced",
      "why_material": "The claim is unsourced but is a standard disclaimer that does not need to be supported by external sources, as it is a common practice in research catalogues to include such disclaimers.",
      "status": "active",
      "who_claims": "kimi/moonshot-v1-8k (adversary)",
      "posted_by": {
        "actor": "kimi/moonshot-v1-8k (adversary)",
        "channel": "protocol/collaborate",
        "ts": "2026-06-29T13:51:51.177Z",
        "model": "kimi/moonshot-v1-8k"
      },
      "challenges": [
        "c7"
      ]
    },
    {
      "id": "c87",
      "text": "One person injecting KPV under the skin said it helped a great deal with inflammation from injuries and from a spinal cord injury.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people injecting KPV under the skin report",
      "slot": "who_claims_what",
      "source_ids": [
        "s82"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s82 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c324",
      "text": "That same person said symptoms they read as endometriosis returning, a heaviness in the pelvis and pain from touch that should not hurt, settled while they were on KPV, and that they remain in remission.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Single reports of KPV used against something else entirely",
      "slot": "who_claims_what",
      "source_ids": [
        "s82"
      ],
      "source_status": "sourced",
      "why_material": "A distinct condition and a distinct outcome from the injury inflammation reported in the same post.",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c88",
      "text": "One person with a fast heart rhythm called SVT said their episodes stopped completely for 2 months on KPV, down from 3 or 4 a month before it.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Single reports of KPV used against something else entirely",
      "slot": "who_claims_what",
      "source_ids": [
        "s83"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s83 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c325",
      "text": "Those heart rhythm episodes came back when that person stopped taking KPV.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people report when they stop taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s83"
      ],
      "source_status": "sourced",
      "why_material": "What happened on stopping is the part of the account that carries the most weight and it was a trailing clause.",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c326",
      "text": "After an ablation procedure that same person restarted KPV and said their extra heartbeats settled too. It is one person writing about themselves, with nothing else supporting it.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Single reports of KPV used against something else entirely",
      "slot": "who_claims_what",
      "source_ids": [
        "s83"
      ],
      "source_status": "sourced",
      "why_material": "A separate episode with a separate outcome, and the confidence caveat belongs with it.",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c89",
      "text": "One person said KPV inside a blend called KLOW, with GHK-Cu alongside it, thickened their hair and calmed their scalp. The two peptides cannot be told apart in that account.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Skin, hair and nail reports from people taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s84"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s84 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c90",
      "text": "One person reported a good result on a stack containing KPV for pain in the sacroiliac joint, where the base of the spine meets the pelvis.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Single reports of KPV used against something else entirely",
      "slot": "who_claims_what",
      "source_ids": [
        "s85"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s85 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c91",
      "text": "One person about to start KPV said they expected it to sit easier with them than other peptides they had taken. That is an expectation written down before the fact, not a result.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people taking KPV for long COVID report",
      "slot": "who_claims_what",
      "source_ids": [
        "s86"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s86 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c92",
      "text": "An X post describes KPV as giving the anti-inflammatory part of alpha-MSH without the rest of what that hormone does.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Where KPV comes from: the tail end of a hormone the body already makes",
      "slot": "who_claims_what",
      "source_ids": [
        "s87"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s87 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c93",
      "text": "An X post rates KPV at the very top of the peptides its author has used, on the strength of their own experience and of what they say the people they work with report back.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What the promotional X posts about KPV assert",
      "slot": "who_claims_what",
      "source_ids": [
        "s88"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s88 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T15:37:16.928Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c94",
      "text": "One person reported a good result from 5mg of KPV a day, injected under the skin, for an autoimmune problem, and said they were being monitored while they did it.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The KPV doses people say they took, and what followed",
      "slot": "who_claims_what",
      "source_ids": [
        "s89"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s89 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c327",
      "text": "That person planned to come off KPV for a while to see whether the improvement held up without it.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What people report when they stop taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s89"
      ],
      "source_status": "sourced",
      "why_material": "A stated plan to test the effect by stopping is a separate assertion from the reported benefit.",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c95",
      "text": "A thread asks people with lipedema what KPV or BPC-157 did for their inflammation. It is a request for accounts rather than an account.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s90"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s90 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c96",
      "text": "An X post in Italian promotes KPV for IBS, for pouches in the bowel wall and for gut inflammation, and claims it beat cortisone in animal studies. The post cites nothing for that comparison.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What the promotional X posts about KPV assert",
      "slot": "who_claims_what",
      "source_ids": [
        "s91"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s91 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c97",
      "text": "An X post describes KPV as a gut anti-inflammatory the writer takes in their own stack and finds easy to tolerate.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What the promotional X posts about KPV assert",
      "slot": "who_claims_what",
      "source_ids": [
        "s92"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s92 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c98",
      "text": "An X post recommends KPV on the grounds that several people the writer knows were helped with bowel problems, Crohn's disease and IBS among them.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What the promotional X posts about KPV assert",
      "slot": "who_claims_what",
      "source_ids": [
        "s93"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s93 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c99",
      "text": "A guide posted to a new subreddit presents KPV as an anti-inflammatory tripeptide. It reads as promotion and gives no dosing or side effect detail of its own.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s94"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s94 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c100",
      "text": "A product guide for a 10mg vial of KPV leans on the research into gut and immune effects. Almost nothing in it is first-hand.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Product guides for KPV that quote research instead of results",
      "slot": "who_claims_what",
      "source_ids": [
        "s95"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s95 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c101",
      "text": "A guide on KPV for gut inflammation and skin repair sticks to what the research says, and reports no result of the writer's own.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Product guides for KPV that quote research instead of results",
      "slot": "who_claims_what",
      "source_ids": [
        "s96"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s96 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c102",
      "text": "An X post walks through how KPV is thought to work and what the research shows. Nobody's dose or outcome appears in it.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What the promotional X posts about KPV assert",
      "slot": "who_claims_what",
      "source_ids": [
        "s97"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s97 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c103",
      "text": "An X post mentions the writer's own continuing use of KPV inside a stack and reports it as going well, without giving any detail.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What the promotional X posts about KPV assert",
      "slot": "who_claims_what",
      "source_ids": [
        "s98"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s98 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c104",
      "text": "An X post says the writer prefers KPV to the other peptides they have tried, and names no dose, no length of use and no side effect.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What the promotional X posts about KPV assert",
      "slot": "who_claims_what",
      "source_ids": [
        "s99"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s99 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c105",
      "text": "One person with hidradenitis suppurativa, the condition that brings up recurring painful lumps under the skin, said KPV combined with other peptides cleared their spots and improved their skin within 2 weeks.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Skin, hair and nail reports from people taking KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s100"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s100 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c328",
      "text": "Another person in that thread wrote: 'I take KPV 1mg 2x per day (20 day cycle so far). It seems to help somewhat for wound healing and infection. Overall it has calmed down my immune system significantly.'",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The KPV doses people say they took, and what followed",
      "slot": "who_claims_what",
      "source_ids": [
        "s100"
      ],
      "source_status": "sourced",
      "why_material": "A second person's dose and outcome, quoted as written, was crammed into another person's claim.",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c329",
      "text": "Someone in that same thread raised the possibility of a die-off reaction at the higher KPV doses.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The die-off argument people make about the first weeks on KPV",
      "slot": "who_claims_what",
      "source_ids": [
        "s100"
      ],
      "source_status": "sourced",
      "why_material": "A caution about high doses is a distinct assertion from either person's reported outcome.",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c106",
      "text": "One person with CIRS, a chronic inflammatory illness people link to mould exposure, said KPV swallowed by mouth did nothing at all to their MSH hormone level.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Why the swallowed form of KPV goes worse for some people",
      "slot": "who_claims_what",
      "source_ids": [
        "s101"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s101 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c330",
      "text": "That same person said KPV injected under the skin at 500 micrograms raised their MSH from below 1 up to 28, and that they felt better overall, got sick less often and had an easier gut.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "The KPV doses people say they took, and what followed",
      "slot": "who_claims_what",
      "source_ids": [
        "s101"
      ],
      "source_status": "sourced",
      "why_material": "The injected result is the opposite of the swallowed result in the same report and must stand on its own.",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c331",
      "text": "Another person in that thread wrote that KPV taken by mouth did nothing for their MSH either, and guessed it has to be injected to reach the brain.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Why the swallowed form of KPV goes worse for some people",
      "slot": "who_claims_what",
      "source_ids": [
        "s101"
      ],
      "source_status": "sourced",
      "why_material": "A second independent report of the swallowed form failing, plus that person's reasoning about why.",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c107",
      "text": "A thread argues KPV does more than damp inflammation, and stays on mechanism and research for gut, skin and whole-body use. The first-hand comments under it report less inflammation.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Write-ups and videos about KPV that carry no report of their own",
      "slot": "who_claims_what",
      "source_ids": [
        "s102"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s102 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c108",
      "text": "One person with rheumatoid arthritis takes KPV daily alongside their prescribed medicines, tirzepatide among them, and says it works well for them.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "Single reports of KPV used against something else entirely",
      "slot": "who_claims_what",
      "source_ids": [
        "s103"
      ],
      "source_status": "sourced",
      "why_material": "Materialized from orphan source s103 by ledger repair",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c332",
      "text": "That same thread carries the open worry that KPV, by damping the immune system, could pull against what a prescribed immune medicine is doing. Nobody in the thread has an answer.",
      "tier": "anecdotal",
      "weight": 0.3,
      "section": "What nobody knows about KPV in people",
      "slot": "who_claims_what",
      "source_ids": [
        "s103"
      ],
      "source_status": "sourced",
      "why_material": "An unresolved interaction question is a gap in knowledge, not part of the person's reported outcome.",
      "status": "active",
      "who_claims": "grok-4.3",
      "posted_by": {
        "actor": "grok/grok-4.3",
        "channel": "populate-repair",
        "ts": "2026-06-29T17:41:39.698Z",
        "model": "grok/grok-4.3",
        "rationale": ""
      },
      "source_role": "anecdotal_report"
    },
    {
      "id": "c109",
      "text": "KPV is a peptide three amino acids long - lysine, proline, valine - and this page is where it is catalogued: every claim about it sorted by how strong the evidence behind it is, and tied to its source by a hash chain.",
      "section": "What this KPV page is, and what it is not",
      "tier": "system",
      "weight": 0.35,
      "status": "active",
      "source_ids": [],
      "source_status": "unsourced",
      "who_claims": "miscsubjects protocol",
      "posted_by": {
        "actor": "miscsubjects protocol",
        "channel": "protocol/fill-slots",
        "ts": "2026-06-29T20:42:04.832Z",
        "model": "fill-slots",
        "rationale": ""
      },
      "why_material": "Required constitution slot: what_it_is",
      "slot": "what_it_is",
      "register": null
    },
    {
      "id": "c333",
      "text": "This page records what the published literature and the internet say about KPV. It is not a set of clinical recommendations.",
      "section": "What this KPV page is, and what it is not",
      "tier": "system",
      "weight": 0.35,
      "status": "active",
      "source_ids": [],
      "source_status": "unsourced",
      "who_claims": "miscsubjects protocol",
      "posted_by": {
        "actor": "miscsubjects protocol",
        "channel": "protocol/fill-slots",
        "ts": "2026-06-29T20:42:04.832Z",
        "model": "fill-slots",
        "rationale": ""
      },
      "why_material": "The scope statement and the description of the catalogue structure are separate assertions.",
      "slot": "what_it_is",
      "register": null
    },
    {
      "id": "c110",
      "text": "The hash chain on this page proves a source has not been altered since it was recorded. It says nothing about whether the source is true.",
      "section": "The limits of what this KPV catalogue can tell you",
      "tier": "mechanistic",
      "weight": 0.3,
      "status": "active",
      "source_ids": [],
      "source_status": "unsourced",
      "who_claims": "miscsubjects protocol",
      "posted_by": {
        "actor": "miscsubjects protocol",
        "channel": "protocol/fill-slots",
        "ts": "2026-06-29T20:42:07.449Z",
        "model": "fill-slots",
        "rationale": ""
      },
      "why_material": "Required constitution slot: limitations",
      "slot": "limitations",
      "register": null
    },
    {
      "id": "c334",
      "text": "The KPV evidence gathered here is mostly animal work and personal accounts. What exists from people is thin.",
      "section": "The limits of what this KPV catalogue can tell you",
      "tier": "mechanistic",
      "weight": 0.3,
      "status": "active",
      "source_ids": [],
      "source_status": "unsourced",
      "who_claims": "miscsubjects protocol",
      "posted_by": {
        "actor": "miscsubjects protocol",
        "channel": "protocol/fill-slots",
        "ts": "2026-06-29T20:42:07.449Z",
        "model": "fill-slots",
        "rationale": ""
      },
      "why_material": "The shape of the evidence base is a separate limitation from what the hash chain does or does not prove.",
      "slot": "limitations",
      "register": null
    },
    {
      "id": "c335",
      "text": "No dose, no protocol and no course of care is recommended anywhere on this page. It is a catalogue of what has been reported.",
      "section": "The limits of what this KPV catalogue can tell you",
      "tier": "mechanistic",
      "weight": 0.3,
      "status": "active",
      "source_ids": [],
      "source_status": "unsourced",
      "who_claims": "miscsubjects protocol",
      "posted_by": {
        "actor": "miscsubjects protocol",
        "channel": "protocol/fill-slots",
        "ts": "2026-06-29T20:42:07.449Z",
        "model": "fill-slots",
        "rationale": ""
      },
      "why_material": "The no-recommendations limit is the one readers most need stated on its own.",
      "slot": "limitations",
      "register": null
    }
  ],
  "type": "article",
  "updated": "2026-10-08T11:51:26.195Z",
  "version": 1,
  "hash": "5301083ba2c220a3e7434c79d2fbc6469ddd29438d59c587077be69a3d615982",
  "styling": {
    "scope": "shared",
    "how": "no value on the page is set by hand: each comes from this theme, and each theme value becomes the CSS variable named beside it. PATCH https://miscsubjects.com/api/jarticles/theme changes them.",
    "widget_style": {
      "what": "every widget may carry style: {…}; these are the only keys it reads",
      "rotate": "degrees, a number",
      "offset_x": "pixels, a number",
      "offset_y": "pixels, a number",
      "pulse": "true to pulse"
    },
    "theme": {
      "color": {
        "page_bg": "#f5f5f7",
        "sheet_bg": "#ffffff",
        "ink": "#1d1d1f",
        "soft": "#424245",
        "muted": "#6e6e73",
        "dim": "#86868b",
        "line": "#d2d2d7",
        "accent": "#0071e3",
        "accent_soft": "rgba(0,113,227,0.08)",
        "link": "#0066cc",
        "selection": "rgba(0,113,227,0.18)",
        "widget_bg": "#f5f5f7",
        "widget_border": "#d2d2d7",
        "card_bg": "#ffffff",
        "code_bg": "#f5f5f7",
        "json_bg": "#161b19",
        "json_ink": "#e6e1d4",
        "json_key": "#7fd3c3",
        "json_string": "#e9c46a",
        "json_number": "#f4a261",
        "json_bool": "#c792ea",
        "json_null": "#928d7e",
        "json_punct": "#6b6759",
        "json_bar": "#0e1512",
        "kind_badge_bg": "#0e6e60",
        "kind_badge_ink": "#ffffff"
      },
      "color_dark": {
        "page_bg": "#000000",
        "sheet_bg": "#1d1d1f",
        "ink": "#f5f5f7",
        "soft": "#d2d2d7",
        "muted": "#a1a1a6",
        "dim": "#86868b",
        "line": "#424245",
        "accent": "#2997ff",
        "accent_soft": "rgba(41,151,255,0.12)",
        "link": "#2997ff",
        "selection": "rgba(41,151,255,0.25)",
        "widget_bg": "#2c2c2e",
        "widget_border": "#424245",
        "card_bg": "#1d1d1f",
        "code_bg": "#2c2c2e",
        "json_bg": "#0a0d0c",
        "json_ink": "#e6e1d4",
        "json_key": "#7fd3c3",
        "json_string": "#e9c46a",
        "json_number": "#f4a261",
        "json_bool": "#c792ea",
        "json_null": "#757062",
        "json_punct": "#5d665f",
        "json_bar": "#060807",
        "kind_badge_bg": "#4fc1ab",
        "kind_badge_ink": "#0b0f0d"
      },
      "font": {
        "display": "-apple-system,BlinkMacSystemFont,\"SF Pro Display\",\"SF Pro Text\",\"Helvetica Neue\",Helvetica,Arial,sans-serif",
        "body": "-apple-system,BlinkMacSystemFont,\"SF Pro Display\",\"SF Pro Text\",\"Helvetica Neue\",Helvetica,Arial,sans-serif",
        "mono": "ui-monospace,SFMono-Regular,\"SF Mono\",Menlo,Consolas,monospace",
        "google_fonts": ""
      },
      "size": {
        "body": "17px",
        "small": "17px",
        "eye": "17px",
        "lead": "17px",
        "h1": "52px",
        "h2": "34px",
        "h3": "22px",
        "byline": "17px",
        "h1_measure": "none",
        "code": "17px",
        "json": "17px",
        "widget_title": "17px"
      },
      "leading": {
        "body": "1.7",
        "head": "1.18",
        "lead": "1.5",
        "json": "1.6"
      },
      "weight": {
        "display": "700",
        "head": "700",
        "body": "400",
        "strong": "700",
        "eye": "700"
      },
      "tracking": {
        "eye": "0.14em",
        "display": "-0.03em",
        "body": "-0.006em",
        "badge": "0.08em"
      },
      "layout": {
        "sheet_width": "1000px",
        "text_width": "880px",
        "gutter": "16px",
        "sheet_padding": "56px 64px 64px",
        "sheet_padding_mobile": "24px 18px 40px",
        "sheet_margin": "28px auto 72px",
        "block_gap": "1.15em",
        "widget_gap": "28px",
        "grid_gap": "14px"
      },
      "border": {
        "sheet": "0px solid",
        "sheet_radius": "30px",
        "widget": "1px solid",
        "widget_radius": "24px",
        "card_radius": "24px",
        "badge_radius": "999px",
        "rule": "1px solid",
        "code_radius": "18px",
        "accent_bar": "3px"
      },
      "shadow": {
        "sheet": "0 1px 1px rgba(0,0,0,.02),0 6px 26px rgba(0,0,0,.05)",
        "widget": "none",
        "card_hover": "0 10px 28px -16px rgba(28,27,23,0.35)"
      },
      "motion": {
        "hover": "160ms ease"
      }
    }
  },
  "page": "https://miscsubjects.com/a/kpv",
  "json": "https://miscsubjects.com/a/kpv.json",
  "markdown": "https://miscsubjects.com/a/kpv.md",
  "theme": "https://miscsubjects.com/article-theme.json",
  "calls": [
    {
      "what": "this article as a page (no key)",
      "method": "GET",
      "url": "https://miscsubjects.com/a/kpv",
      "headers": {}
    },
    {
      "what": "this article as its object (no key)",
      "method": "GET",
      "url": "https://miscsubjects.com/a/kpv.json",
      "headers": {}
    },
    {
      "what": "this article as Markdown (no key)",
      "method": "GET",
      "url": "https://miscsubjects.com/a/kpv.md",
      "headers": {}
    },
    {
      "what": "the object with its hash, drafts too",
      "method": "GET",
      "url": "https://miscsubjects.com/api/jarticles/kpv",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)"
      }
    },
    {
      "what": "one piece and that piece’s hash",
      "method": "GET",
      "url": "https://miscsubjects.com/api/jarticles/kpv/at?path=facts",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)"
      }
    },
    {
      "what": "grep: every key or value that matches, with the path to change it",
      "method": "GET",
      "url": "https://miscsubjects.com/api/jarticles/kpv/grep?q=owner",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)"
      }
    },
    {
      "what": "change pieces (set, merge, delete, append, insert, move); if-match is the hash",
      "method": "PATCH",
      "url": "https://miscsubjects.com/api/jarticles/kpv",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
        "content-type": "application/json",
        "if-match": "<hash from the read>"
      },
      "body": {
        "ops": [
          {
            "op": "set",
            "path": "facts.example",
            "value": 1
          }
        ]
      }
    },
    {
      "what": "replace the whole object",
      "method": "PUT",
      "url": "https://miscsubjects.com/api/jarticles/kpv",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
        "content-type": "application/json",
        "if-match": "<hash>"
      },
      "body": {
        "slug": "kpv",
        "title": "…"
      }
    },
    {
      "what": "fetch every source, hash what came back and check the quote is in it",
      "method": "POST",
      "url": "https://miscsubjects.com/api/jarticles/kpv/verify",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
        "content-type": "application/json"
      },
      "body": {}
    },
    {
      "what": "an Obsidian-style command",
      "method": "POST",
      "url": "https://miscsubjects.com/api/jarticles/cli",
      "headers": {
        "x-sheets-key": "$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
        "content-type": "application/json"
      },
      "body": {
        "command": "backlinks",
        "file": "kpv"
      }
    }
  ]
}